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Interferons have been recognized as important mediators of cellular
communication for many years. There are two types of interferon:
Type I interferons have antiviral functions, but Type II interferon
(IFN-g) is more important as an immunomodulating molecule. Type II
interferon has effects on cellular MHC class II expression,
immunoglobulin class-switching, macrophage activation, cellular
proliferation and a number of other functions. The role of IFN-g
during in vivo immune responses has not been studied in great
detail, but the sheep is an ideal species in which to study these
phenomena by using the efferent lymphatic vessel cannulation model.
This allows access to cells and tissue fluid for cytokine analysis
using antibody and genetic probes for the detection of IFN-g.
Bovine IFN-g peptides (amino-terminus, carboxy-terminus and central)
were used to generate antibodies in rabbits. None of the anti-
peptide sera reacted with denatured ovine or bovine IFN-g, nor
neutralized their antiviral effect. Rabbit antibodies to bovine
recombinant IFN-g neutralized ovine IFN-g and detected IFN-g in a
sandwich ELISA when used in combination with a monoclonal antibody
against a human IFN-g carboxy-terminal peptide. The sensitivity of
detection was only 125ng/ml, insufficient for use with efferent
lymph fluid samples.
The expression of MHC class II molecules on cell surfaces is
increased by IFN-g on many cell types. This has been used
previously to measure biologically active IFN-g concentrations in
fluids. Measurement of ovine class II by slot blot was assessed as
a method of adapting this to ovine IFN-g measurement, but the
technique proved to be too problematic for regular use. The
expression of class II on T lymphocytes is influenced by IFN-g in
the surrounding fluid. Analysis by FACS of resting ovine T
lymphocytes shows them to express class II, a situation different to
that in the human. Incubation of efferent lymph cells with IFN-g
enhances the expression of ovine DR-like class II molecules
especially on CD8+ cells, but also on CD4+ cells. The expression of
ovine DQ-like class II molecules was much less influenced by IFN-g.
This differential expression has been seen previously in human
cells. It is likely that such differences are due to variation in
transcriptional control between the two types of molecule.
The IFN-g genes of many species have been cloned, including bovine
IFN-g. Nucleotide primers for the cloning of ovine IFN-g by
polymerase chain reaction were chosen from the bovine sequence.
Cloning of the central 300bp of the gene revealed 98% identity
between ovine and bovine IFN-g at the amino acid level. Subsequent
cloning of ovine IFN-g by other groups showed that allelic variation
of the gene occurs with no alteration in the amino acid structure.
This feature is not found in human IFN-g, but is described in other
ruminant cytokines. Attempts to isolate a lambda clone expressing
an IFN-g fusion protein using the rabbit anti-bovine rIFN-g sera
were unsuccessful.
The immune response may be analysed by studying cells and fluid
delivered by the cannulation of an efferent lymphatic vessel. A
secondary response to ovalbumin was induced in a sheep by
inoculation of a dependent area. The lymphocytes collected were
isolated into CD4+ and CD8+ cells by a magnetic separation technique
(MACS). Their mRNA was isolated, and cDNA generated from it was
subjected to IFN-g-specific PCR. This revealed that both CD4+ and
CD8+ cells contribute to the synthesis of IFN-g during the secondary
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1 INTRODUCTION.
1.1 DISCOVERY AND CLASSIFICATION OF INTERFERONS.
Interferon was discovered by Isaacs & Lindenmann (1957) when they
were looking for a virus-induced factor which could interfere with
viral replication. They described how heat-inactivated influenza
virus induced chicken chorioallantoic membrane cells to secrete a
factor which could prevent subsequent infection of fresh membrane by
live influenza virus. They called this factor, which interfered
with viral growth, "interferon".
Interferon has subsequently been grouped into two types as more
individual interferons have been discovered. Type I interferons are
produced in response to viral infection of cells and are typically
acid and heat resistant. Type II is distinguished from Type I
antigenically and by its heat (56°C for 30 minutes) and acid (pH2
for 30 minutes) lability.
Type I interferons are sub-divided into leucocyte or alpha
interferon (IFN-a), fibroblast or beta interferon (I FN- (3), and
trophoblast, omega or alpha 2 interferon (IFN-w / IFN-an) (Pestka
et al, 1987). The prime function of alpha and beta interferons
seems to be antiviral. Trophoblast, omega, or class II alpha
interferon has antiviral activity, but its prime role appears to be
in signalling between the pre-implantation conceptus and the dam to
prevent rejection (Imakawa et al, 1989).
[NOTE ON NOMENCLATURE: Type I and type II interferon refer to the
early classification of interferons by antigenic and physical
properties. Type I interferons are synonymous with alpha and beta
1
interferons, while type II interferon is gamma interferon. Class I
and class II alpha interferons are subdivisions of the alpha group
defined by nucleotide seguence comparisons. Class I alpha
interferons are the interferons produced in response to viral
infection of cells, while class II alpha interferons are produced by
the placenta of pregnant animals.]
Type II interferon, also known as immune or gamma interferon (IFN-
g), is synthesized by T lymphocytes and natural killer (NK) cells
following exposure to mitogens or antigens (Sandvig et al, 1987). In
addition to its antiviral activity, IFN-g has many immunoregulatory
activities (section 1.4)
1.2 PRODUCTION OF INTERFERONS.
Interferons were first detected in vitro in supernatants from virus-
infected cells. Subsequently Type I interferons have been detected
from all nucleated cells examined, and alpha and beta interferons
have been identified in many species. Interferon secretion can be
induced in vitro by non-viral stimuli including protozoa,
mycoplasma, Rickettsia, bacteria and double-stranded synthetic
ribonucleic acids (Stewart, 1979).
Type II interferon is not induced by viral infection of cells, but
is the product of antigenic or mitogenic stimulation of activated
lymphocytes or NK cells (Croll et al, 1986). T cells may be
activated polyclonally either by mitogen (Wheelock, 1965) or
antibody (Falcoff et al, 1972), or in a clonally-restricted manner
in response to antigen-specific recognition (Green et al, 1969).
Lymphocytes exposed to antigen preparations only produce IFN-g if
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the lymphocytes have been obtained from an individual previously
exposed to the antigen in question (Green et al, 1969). A number of
studies of lymphocyte and mononuclear cell suspensions have shown
interferon-gamma to be produced by T-cells (Falcoff, 1972; Blanchard
et al, 1986). Initially production of IFN-g was thought to be part
of a positive feedback loop involving IL-1, IL-2 and IFN-g. IL-2
production is enhanced by the presence of interleukin 1 (IL-1), and
IFN-g production is enhanced by IL-2. IFN-g has been shown to
increase production of IL-1 by monocytes in response to
lipopolysaccharide stimulation (Newton, 1985). However, the
isolation of T helper subsets has allowed the autocrine requirements
of T cells to be analysed more carefully. One subset, TH2 cells,
use IL-4 as their autocrine growth factor, with IL-1 also being
required for DNA synthesis (Lichtman et al, 1987). Thi cells
utilize IL-2 as their autocrine factor, and IL-1 is not required at
all (Lichtman et al, 1988). IFN-g can act as a growth promoter for
T cells, but the subset of T cells was not identified (Landolfo et
al, 1988)
Natural killer cells are associated closely with the production of
IFN-g in a mechanism requiring both IL-2 and a factor derived from
macrophages (Kawase et al, 1983). Anti-IFN-g sera stain lymphocytes
found within tumours which are thought to be NK cells (Saksela et
al, 1980). Human peripheral blood lymphocytes (PBLs) enriched for
NK cells were shown to be the major source of IFN-g after infection
with influenza or herpes viruses (Djeu et al, 1982). Clones of NK
cells when cultured in the presence of IL-2 secrete IFN-g (Handa et
al, 1983).
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During polyclonal T cell activation of ficoll-gradient isolated
blood mononuclear cells (MNCs) by anti-CD3/Ti antibodies, double
staining for IFN-g and cell markers demonstrated that up to 26% of
IFN-g positive cells carried the CD16 molecule i.e. were putative NK
cells (Sandvig et al, 1987). In these experiments, the CD4+ and CD8+
together only comprise approximately 50% of the IFN-g secreting
cells. The remaining 25% of cells secreting IFN-g carried IL-2
receptors and the majority were erythrocyte-rosetting mononuclear
cells but did not fulfill the criteria for either T-cell, B-cell or
monocyte cell lineages.
1.3 PURIFICATION AND STRUCTURE OF INTERFERONS.
1,3.1 ALPHA INTERFERON.
Alpha interferon has been purified to homogeneity, and shown to form
a family of alpha interferons, which in humans totals 16 or more
unigue protein species (Pestka et al, 1987). Two classes of alpha
interferon have been identified genetically, IFN-ai and IFN-an
(Capon et al, 1985). IFN-dn is also known as IFN-w and will be
discussed in section 1.3.4.
The apparent molecular weights of the class I IFN-as range from
16000 to 27000 and typically contain 165-166 amino acids. The class
I IFN-as are guite homologous in amino acid seguence with greater
than 77% identity between the various individual interferons (Pestka
et al, 1987). They were initially thought to be all unglycosylated,
but there is now evidence for glycosylation in some species of IFN-
a. This is postulated to be 0-linked glycosylation as all but one
human IFN-a seguence lacks an N-linked glycosylation site (Labdon et
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al, 1984). The genes for human IFN-a have been cloned, and at least
15 separate loci have been identified. At least 14 of these encode
functional proteins, but some of the loci represent pseudogenes.
None of the genes identified so far contains an intron, in contrast
to IFN-g. All animal species studied have a large IFN-a family of
genes (reviewed by Weismann & Weber, 1986).
1.3.2 BETA INTERFERON.
Human beta interferon has been purified, and only one protein
species was identified (Knight, 1976). It was of molecular weight
20000, and found to be a glycoprotein. The associated carbohydrate
was thought to be N-linked. Target size determination has shown the
functional unit to be a dimer (Pestka et al, 1983). Beta interferon
is encoded by a single intron-less gene in the human and many
mammalian species, but the bovine (Leung et al, 1984), eguine and
porcine (Wilson et al, 1983) I FN-(3 gene families are known to
contain many genes.
1.3.3 GAMMA INTERFERON.
Gamma interferon has been purified to homogeneity from human
peripheral blood lymphocytes using chromatographic techniques (Yip
et al, 1982; Rinderknecht et al, 1984). Three forms have been
identified by SDS-PAGE separation with apparent molecular weights of
15500-17000, 20000 and 25000 (Pestka et al, 1987). The molecule has
two potential glycosylation sites. The 20000 molecule only has one
site glycosylated, whereas the 25000 molecule has both sites
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glycosylated (Rinderknecht et al, 1984). Isolation of IFN-g by gel
filtration has identified it to have a molecular weight of 40000-
60000, suggesting it exists as a dimer (Yip et al, 1982).
Murine IFN-g has been extensively studied to determine the basic
structure of the molecule. Murine IFN-g is also glycosylated
(Wietzerbin et al, 1979), and sensitive to pH2 (Wiranowska-Stewart
et al, 1980). SDS-PAGE revealed a monomer structure of
approximately 20500 molecular weight, but gel filtration gave a
molecular weight of 41000, again suggesting the active structure is
a dimer (Havell & Spitalny, 1983). Variable glycosylation occurs,
as demonstrated by a change in molecular weight after production in
the presence of glycosylation inhibitors such as tunicamycin, and
the binding of the interferon to a lectin affinity column (Havell &
Spitalny, 1984).
The gene for IFN-g has been cloned for human (Gray et al, 1982;
Devos et al, 1982), mouse (Gray & Goeddel, 1983), rat (Dijkema et
al, 1985), cow (Cerretti et al, 1986), and recently for sheep
(Mclnnes et al, 1990; Radford et al, 1991) and pig (Dijkmans et al,
1990). The genetics of IFN-g are discussed in greater detail in
section 4.1.
1.3.4 OMEGA INTERFERON.
The interferon-ws (also known as class II interferon-as) are 172
amino acids long, and have 58% identity with the class I IFN-a
genes. IFN-w (IFN-an) has molecular mass of 24500 and is presumed
to be N-glycosylated (Adolf et al, 1990). From the seguence data it
is believed to represent the human equivalent of the ovine
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trophoblast protein-1, although no similar role for it has been
defined in humans (Adolf, 1990). Six human loci have been
identified, but five of these are pseudogenes (reviewed by Shephard
et al, 1985).
1.4 IMMUNE FUNCTION OF INTERFERON-GAMMA.
Although IFN-g was first detected as an antiviral factor and is
still defined as an interferon, it has many important functions
which have no apparent connection with its antiviral activity.
Prior to the synthesis of recombinant IFN-g the activities of IFN-g
were difficult to define and separate from those of other
lymphokines, as the source of IFN-g was cell supernatants. All
three interferon species are able to increase expression of MHC
class I molecules on many cell types (Heron et al, 1979; Fellous et
al, 1979; Fellous et al, 1982; Basham et al, 1982), but IFN-g can
also increase the expression of MHC class II molecules on macrophage
lines (Steeg et al, 1982; King & Jones, 1983), B lymphoma cells
(Wong et al, 1983), and many other cell types (see 3.1.3).
Interferon-a/p interacts with IFN-g by antagonizing the increase in
class II on many cells (Morris & Tomkins, 1989).
IFN-g acts as a potent macrophage-activating factor for tumour cell
killing (Schulz & Kleinschmidt, 1983) and for enhancement of the
killing of intracellular parasites (Nathan et al, 1983). Tumour
cell lysis is increased in vitro by synergism with tumour necrosis
factor a (TNF-a) and lymphotoxin (LT) (Stone-Wolff et al, 1984; Lee
et al, 1984). IFN-g is pivotal in the development of macrophage
resistance to infection by Lieshmania major, but reguires the
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presence of either granulocyte-macrophage colony stimulating factor
(GM-CSF), IL-2, or interleukin 4 (IL-4) in the medium, as it is
insufficient alone to induce resistance (Belosevic et al, 1988).
Zlotnik et al (1983a) analysed T-cell hybridomas, and subclones of
them, for production of factors responsible for five different
biological activities. They demonstrated that antiviral activity
(IFN-g) from T cell clones was always associated with macrophage
activating activity (MAF), MHC class II induction factor (IalF), and
B cell helper activity (IL-X), but is not generally associated with
T-cell growth activity (IL-2). IFN-g, MAF, IalF and IL-X were all
sensitive to acid denaturation. The conclusion was that all these
activities were caused by IFN-g. This was later confirmed for IalF
when recombinant IFN-g was found to induce la (Zlotnik et al,
1983b).
IFN-g has a suppressive effect on the MHC class II expression of
small B cells. MHC class II molecules are increased on B cells by
incubation with IL-4 (B cell stimulating factor-1) (Roehm et al,
1984; Noelle et al, 1984; Rousset et al, 1988), but this increase is
antagonized by IFN-g (Mond et al, 1986). IFN-g is also competitive
with IL-4 in the selection of immunoglobulin class-switching. IL-4
promotes immunoglobulin class-switching in mouse B cells from
secretion of IgM, IgG3 and IgG2b to IgGl, IgG2a and IgE. IFN-g
antagonizes this and promotes the class-switching to IgG2a (Coffman
& Carty, 1986; Lebman & Coffman, 1988; Mosmann & Coffman, 1989).
IFN-g upregulates a number of cell surface molecules including
intercellular adhesion molecule 1 (ICAM-1) (Dustin et al, 1988) and
Fc receptor on monocytes (Perussia et al, 1983).
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1.5 INTERFERONS IN CATTLE.
Interferons have been studied in cattle for much longer than in
sheep because of the relative financial values of the two species.
Bovine interferons should be good models from which to base
information for use in sheep research.
Both type I and II interferons were reported in cattle many years
ago. An acid-stable interferon was described with anti-viral
activity on cells from several species (Pollikoff et al, 1962). An
acid-labile interferon has been described which also was active on
heterologous cells (Babiuk & Rouse, 1977).
Bovine IFN-a is similar to the human gene family, having two classes
of gene. Multiple copies of both sub-families exist, and the two
families have approximately 54% identity at the amino acid level
(Capon et al, 1985). Bovine IFN-an (IFN-w) is also known as bovine
trophoblast protein-1. It functions to signal to the dam that a
conceptus is present in the uterus and that the corpus luteum should
be maintained (Imakawa et al, 1989). It may also be involved in the
suppression of the maternal immune response to the foetus.
Recombinant bovine IFN-axl protein has been used in clinical work
and found to have a beneficial antiviral and immunomodulatory effect
in bovine respiratory disease due to parainfluenza-3 virus
(Martinrod et al,1988), and shipping fever due to Pasteurella
multocida (Lynn & Phillip, 1988).
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Interferon beta has been purified by controlled pore glass
chromatography, and when assayed by SDS-PAGE has a molecular weight
of 21000 (Allen et al, 1988). There are at least five copies of the
I FN-(3 gene in the bovine genome compared with a single I FN-3 gene in
the human genome (Leung et al, 1984).
Interferon gamma has been found to be a single copy gene encoding a
precursor protein of 166 amino acids, and a predicted mature protein
of 143 amino acids with a molecular weight of 16858. It has 63%
amino acid identity with human IFN-g, and 47% with murine IFN-g.
1.6 INTERFERONS IN SHEEP AND GOATS.
Interferons were first reported to exist in sheep when sheep cells
were infected in tissue culture by mycoplasma (Rinaldo et al, 1973),
and Bluetongue, Chikungunya and Herpes simplex viruses (Rinaldo et
al, 1975). These interferons were certainly Type I interferons.
More recently ovine interferons have been produced from fibroblasts
with poly inosinic: poly cytidylic acid, and from T lymphocytes by
antigenic and mitogenic stimulation (Entrican et al, 1989). These
two types of interferon had physical characteristics (heat and pH
stability/lability) typical of IFN-p and IFN-g respectively.
Much work has been carried out on ovine trophoblast protein-1 which
is secreted by trophoectoderm cells of the preimplantation sheep
embryo (Roberts et al, 1989). This has antiviral activity and its
cDNA seguence is similar to bovine IFN-an (Imakawa et al, 1987;
Imakawa et al, 1989).
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A seemingly unique interferon, lentiferon (LV-IFN), of sheep and
goats has been described which is produced by lymphocytes in contact
with lentivirus-infected macrophages (either maedi-visna virus- or
caprine arthritis-encephalitis virus-infected) (Narayan et al, 1985;
Lairmore et al, 1988). This interferon is similar to IFN-a in
resistance to heat and acid conditions, whilst it is resistant to
freeze-thawing and protects some cell lines from viruses not
protected by known IFN-a. This LV-IFN also possesses the ability to
induce expression of la antigens on macrophages (Kennedy et al,
1985). Although data has not been presented, it has been asserted
that LV-IFN activity is associated with a 54- to 64-kilodalton
nonglycosylated protein, its production requiring the interaction of
monocytes and lymphocytes (Zink & Narayan, 1989). LV-IFN production
is blocked by anti-MHC class II antibodies. LV-IFN inhibition of
caprine arthitis-encephalitis virus (CAEV) replication is thought to
be indirect by inhibiting monocyte maturation, and also direct by
inhibiting viral gene expression in macrophages. LV-IFN
consequently has properties of both IFN-a and IFN-g, and may even be
a mixture of the two. Further biochemical and molecular data is
required to define this factor(s).
The physical properties of goat interferons have been examined
(Yilma et al, 1988). The stability/lability to both heat and pH
were typical of Type I and II interferons. Also shown was that CAEV
induced high levels of interferon in synovial fluid during acute
exacerbations of the infection, and also in response to
intraarticular injection of CAEV. The interferon had physical
properties typical of IFN-g.
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1.7 CLINICAL USES OF INTERFERON-GAMMA.
Murine IFN-g has been used as an adjuvant in the Plasmodium yoelii
murine malaria model, when a Triton X-100 lysate of infected
erythrocytes was used as a vaccine (Heath et al, 1989). Injection
of IFN-g at the same time as the vaccine into mice with either
cellular or humoral immune defects enhanced the number of mice
protected compared with those receiving vaccine alone. Similar
results have been demonstrated with the use of IFN-g as an adjuvant
in cattle (Anderson et al, 1988). Cattle were more resistant to
vesicular stomatitis virus (VSV) challenge when IFN-g had been used
as an adjuvant with VSV "G" protein than when no adjuvant was used.
They also demonstrated enhanced secondary antibody responses after
boosters of the same antigen without IFN-g. The mode of action is
unknown at present, but does not involve a second mediator
stimulated by the interferon. Localization of lymphocytes to the
vaccination site does occur, but the significance is unknown. The
most likely mechanism is that of improved antigen presentation
associated with elevated MHC class II expression.
Liposomes are membranous vesicles of naturally occurring
phospholipids, separated by agueous compartments. The incorporation
of interferon-gamma into liposomes can activate blood monocytes to
lyse virus-infected cells in both a human and murine system (Swenson
et al. 1988).
The use of interferons as antiviral agents has been best studied for
IFN-a, but bovine IFN-g has also been examined. IFN-g has more
potential as an immunomodulatory substance, but its effect on
prevention of bacterial infections has been controversial.
Treatment of piglets 24 hours prior to Actinobacillus
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pleuropneumoniae challenge abolishes disease, but similar treatment
of calves with bovine IFN-g 24 hours prior to Pasteurella
haemolytica challenge exacerbates the pneumonia, seeming to enhance
the ongoing inflammation (Bielefeldt-Ohmann, 1990). Recombinant
bovine IFN-g cannot prevent pneumonia caused by Haemophilus somnus
challenge, but reduced morbidity and mortality in calves
immunosuppressed by glucocorticoids (Chiang et al, 1990).
The immunomodulatory effect of IFN-g has been assessed on the
mammary gland of cows. Infusion of bovine rIFN-g during the dry
period increases the bacterial killing capabilities of phagocytes
harvested 24 hours later (Fox et al, 1990). Experimental
intramammary E. coli challenge was resisted much better by cows 24
hours after intramammary infusion of rIFN-g than by control cows,
and clinical disease was less severe and of shorter duration. No
treated cows died, whilst untreated cows suffered 42% mortality
(Sordillo & Babiuk, 1991).
1.6 THE IMPORTANCE OF STUDYING INTERFERON-GAMMA IN THE SHEEP.
The size and docility of the sheep permits the cannulation of
lymphatic vessels and the chronic collection of lymphatic fluid.
This has allowed the analysis of lymphocyte migration through lymph
nodes and the study of the development of immune responses. With
the growing number of monoclonal antibodies to sheep lymphocyte
surface antigens and the recent development of assays for
lymphokines, the opportunity now exists for a much more detailed
analysis of the cellular output from an antigen-stimulated lymph
node and the cytokines produced by and which interact with such
cells. These studies cannot be performed in small laboratory
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animals because the chronic cannulation of lymphatic vessels leads
to a progressive depletion of lymphocytes and so prejudices the
physiological integrity of the animal (Miyasaka & Trnka, 1986).
The sheep popliteal lymph node efferent cannulation model allows
access to the initial immune response of the sheep to an antigen
injected into the distal limb. This may be a naive or a memory
response from the sheep. The cannulation delivers both lymphocytes
exiting the node, which will reflect the response taking place, and
also the supernatant of the cells, which will allow analysis of
lymphokine and antibody levels exiting the node. The lymphocytes
may be analysed in a number of ways, including FACS analysis of
surface antigens (e.g. CD4, CD8, MHC class II), cytokine levels in
lymphatic fluid and production on further culture, and mRNA levels
of cytokines and surface molecules. A variety of technigues for
studying the secretion of cytokines have been developed in the last
few years, including ELISA assays and the intracellular staining for
cytokines. These new types of assays have not yet been used in
sheep immunology, but they represent a novel method of determining
cellular involvement in the active immune response.
Unfortunately ELISA assays for ovine IFN-g were not available at the
beginning of this thesis. The development of antibodies to ovine
IFN-g was a prime reguirement of the project so that
characterization of the molecule and measurement of its presence in
lymphatic supernatants could be performed. Initial attempts to
obtain antibodies reactive to native IFN-g were by the use of
peptides derived from the bovine IFN-g sequence for the immunization
of rabbits. Subsequent work utilized recombinant bovine IFN-g and
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polyclonal sera to it, and also a monoclonal antibody reactive with
a human carboxy-terminal peptide. ELISA methodologies were
developed. The techniques are described in chapter 2.
A second method for assaying IFN-g in supernatants is by the
measurement of MHC class II upregulation on cell surfaces. The
availability of both ovine cell lines and anti-sheep MHC class II
monoclonal antibodies made this technique a second possibility for
the quantitation of IFN-g. The study of different class II subsets
and their differential upregulation by IFN-g was an area of interest
as sheep T cells express class II at rest, unlike human T cells.
The attempts to develop a MHC class II cell assay, and the
regulation of class II on T cells are described in chapter 3.
The production of IFN-g can be assessed at the protein level or the
mRNA level. The latter depends upon the availability of an
appropriate DNA/RNA probe, or polymerase chain reaction protocol.
Either technique requires the ovine IFN-g gene to be cloned in part.
The cloning of part of the ovine IFN-g gene by PCR, and attempts to
isolate a cDNA clone are described in chapter 4.
The production of IFN-g by human lymphocytes during an in vivo
immune response has been assessed by intracytoplasmic fluorescent
staining. The absence of appropriate monoclonal antibodies denied
the application of this technique to sheep lymphocytes. The PCR in
chapter 4 was optimized and the levels of IFN-g mRNA in Concanavalin
A-stimulated lymphocytes were assessed using this technique. This
protocol was then applied to IFN-g mRNA levels in T cell subsets in
efferent lymph during an in vivo secondary immune response. A
magnetic cell separation technique was used to isolate the T cell
subsets. The results of this work are described in chapter 5.
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2 PEPTIDE STUDIES ON OVINE INTERFERON-GAMMA.
2.1 INTRODUCTION.
Interferon-gamma is an important immunoregulatory lymphokine which
displays pleiotropic effects (reviewed by Trinchieri and Perussia,
1985). Its major effects are thought to relate to its ability to
activate macrophages, to induce Major Histocompatibility Complex
molecules, and to influence antibody isotype switching. Its role in
the development of primary and secondary immune responses at the
lymph node level has not been ascertained to date. Access to this
stage of the immune response is possible by chronically-cannulating
the lymphatic vessels of sheep and analysing the draining cells and
fluid (Hall & Morris, 1964). The ability to dissect the role of
IFN-g in the immune response in this system is however dependent on
the availability of reagents specific for ovine IFN-g. One of the
major objects of this section of work was to develop antibody
reagents which would react specifically and sensitively to ovine
IFN-g.
Antibodies have previously been described which react specifically
with human (Langford et al, 1981; Johnson et al, 1982), murine
(Langford et al, 1983), and porcine IFN-g (Charley et al, 1988), but
cross-reactivity with IFN-g of other species has been poor due to
low seguence identities at the amino acid level (40% between human
and murine IFN-g [Gray & Goeddel, 1983]; 59% between human and
porcine IFN-g [Dijkmans et al, 1990]). Antibodies to IFN-g of these
three species are consequently unlikely to react with ovine IFN-g.
Bovine IFN-g has been cloned and expressed (Cerretti et al, 1986)
and antibodies to it are more likely to bind ovine IFN-g due to the
close phylogenetic origin of the two species. However neither
16
polyclonal antisera nor monoclonal antibodies to bovine IFN-g are
readily available. Instead it was proposed that synthetic peptides
derived from the bovine sequence be used for the generation of anti-
peptide antibodies. The degree of identity between bovine and ovine
IFN-g was unknown, so regions of close homology between the human,
murine, rat and bovine sequences were considered. These homologous
regions are also likely to be in regions of the molecule important
for structure and function.
[NOTE ON NOMENCLATURE: the signal sequence of human IFN-g was
originally thought to 20 amino acids long, but is now thought to be
23 amino acids in length. The amino acids of the mature cleaved
protein have been numbered throughout this thesis on the basis of a
signal sequence of 20 amino acids. The numbering of peptides cited
in other papers has been altered if necessary to conform to this
standard. A peptide is described by quoting its first and last
amino acid e.g. peptide 1-10 is the peptide from amino acid 1 to
amino acid 10]
2,1,1 IMPORTANT REGIONS OF INTERFERON-GAMMA DEFINED BY ANTI-PEPTIDE
SERA AND AMINO ACID DELETIONS.
The first antibodies raised against IFN-g were derived from the
immunization of rabbits with partially purified supernatant from
Staphylococcal enterotoxin A-stimulated human lymphocytes (Langford
et al, 1981). The sera were found to neutralize IFN-g but not IFN-
a/p in an antiviral assay (50% Sindbis virus cytopathogenic effect
reduction assay on human amnion WISH cells). IFN-g was therefore
assumed to be antigenically dissimilar to IFN-a/p.
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The cloning, sequencing and expression of the cDNA for human IFN-g
(Gray et al, 1982) allowed study of the molecule by the use of
synthetic peptides and antisera to them (Johnson et al, 1982). This
approach eliminated the problem of partial purity of the immunizing
protein which afflicted the previous polyclonal antisera. The amino
terminal portion of the molecule was the first to be studied for its
functional importance. The peptide synthesized represented the
first twenty N-terminal amino acids of the mature molecule inferred
from the cDNA sequence. Sera were tested by an anti-peptide ELISA
and also by neutralization of the antiviral activity. Comparison
with sera raised against native interferon-gamma showed that the
anti-peptide sera reacted with peptide by ELISA much more strongly
than did the anti-interferon sera, but that the anti-interferon sera
was neutralizing in the antiviral assay to a much higher titre than
the anti-peptide sera. This suggested that anti-interferon sera
contained antibodies to additional determinants on the interferon
molecule which are important in the antiviral action.
There is much evidence for the functional importance of the amino
terminus of human IFN-g. Protease digestion of the amino terminus
of IFN-g leading to the removal of 11 or 14 amino acids (numbered
with the CYS-TYR-CYS as 1-2-3) renders the protein devoid of
biological activity and causes a dramatic change in secondary
structure (66% a-helix and 0% p-sheet before, and 6% a-helix and
36% p-sheet afterwards) (Hogrefe et al, 1989). Leist et al (1985)
found that rabbit antisera to both peptides 1-59 and 24-59 bound to
rIFN-g, but only anti-(l-59) neutralized the antiviral activity.
Disruption of rIFN-g by acid treatment did not alter binding of
anti-(24-59) indicating the structure in this region was little
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disturbed by the acid treatment. Monoclonal antibodies to peptide
4-21 have been found to neutralize human IFN-g antiviral activity
(Ichimori et al, 1987).
The cDNA cloning of murine IFN-g (Gray & Goeddel, 1983) allowed an
N-terminal peptide to be synthesized and antisera produced.
Additional experiments were carried out to compare the cross-
reactivity of anti-murine peptide and anti-human peptide sera on
both peptides and natural immune interferon in ELISA and
neutralization assays. The degree of cross-reaction ranged from 4
to 30% for anti-murine peptide sera in a neutralization assay with
human IFN-g, and 5 to 12% for anti-human peptide sera in the
reciprocal assay. Cross-reactivity was similar in the anti-peptide
ELISA. Anti-native murine or human IFN-g sera cross-reacted less
than 1% in both neutralization assay and ELISA (Langford et al,
1983).
Studies with four monoclonal antibodies to recombinant murine IFN-g
showed that binding of 12,5I-rIFN-g by three of the four MoAbs could
be inhibited by a synthetic peptide corresponding to amino acids 1-
39 of IFN-g, but not with peptide 95-133. The monoclonal antibodies
also bound labelled 1-39 peptide, and one of the three antibodies
(5.102.12) inhibited both antiviral activity and macrophage
activation of rIFN-g. Polyclonal antisera to the two peptides were
neutralizing and were shown to inhibit binding of labelled IFN-g to
the membrane receptor. These data suggest that the interaction
between the cellular receptor and IFN-g involves both the amino and
carboxyl termini of the IFN-g molecule (Russell et al, 1986). The
monoclonal antibody (5.102.12) was further studied to define the
reactive epitope at the amino terminus of IFN-g (Magazine et al,
1988). In a competitive RIA, peptides 1-39, 1-20, 3-20, and 5-20
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all inhibited binding of 5.102.12 to recombinant IFN-g, whilst
peptides 7-20, 1-10, 10-30 and 21-44 had no effect. It was
predicted by the Chou and Fasman algorithm that IFN-g has a
secondary structure of predominantly a-helical structure, with amino
acids 12-20 in a loop formation on the surface of the molecule, and
that the peptide inhibition data suggest that the epitope for
monoclonal antibody (5.102.12) lies on this loop of IFN-g.
There is conflicting evidence for the importance of the carboxy
terminus in receptor binding. Human IFN-g molecules proteolytically
truncated by 13 amino acids at their C-terminus have been shown to
have reduced biological activity (Arawaka et al, 1986; Leinikki et
al, 1987). Similarly re-engineered human rIFN-g deleted of its C-
terminal 14 amino acids was 100-1000 times less effective in anti-
chlamydial, antiviral and antiproliferative activities than full
length IFN-g, whilst rIFN-g modified to possess four serine residues
at positions 129-132 was 10-50 times less potent than full length
IFN-g in the same experiments (de la Maza et al, 1987). Others,
however, have demonstrated that truncated molecules deleted of 15
amino acids (Honda et al, 1987; Rose et al, 1983) or 23 amino acids
(Sakaguchi et al, 1988) retain full antiviral activity. The
discrepancies in remaining antiviral activity may be due to
differences in cells used in the assay and the IFN-g receptors on
their surfaces.
A number of monoclonal antibodies against carboxy-terminal peptides
have not possessed neutralizing activity (Ichimori et al, 1985;
Altrock, 1986; Favre et al, 1989; Lord et al, 1989), whilst a
monoclonal antibody to human rIFN-g which is reactive against
peptide (132-137) is described as blocking antiviral and anti¬
proliferative activity (Seelig et al, 1988).
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Russell et al (1986) produced a polyclonal serum against a carboxy-
terminal peptide, amino acids 98 to 136 of the murine sequence,
which was neutralizing in an antiviral assay and also in a
macrophage activating assay. Similarly a monoclonal antibody made
against the same peptide was found to neutralize both the antiviral
and macrophage priming activities of IFN-g (Russell et al, 1988).
Peptides encoding the terminal nine amino acids of murine IFN-g were
shown to induce antisera which neutralized its antiviral and
immunoregulatory activities (Langford et al, 1987). These results
imply that the carboxyl terminus, as well as the amino terminus, is
important in receptor binding.
Peptide studies have been of considerable importance in predicting
the tertiary structure of human IFN-g. The preparation of peptides
covering the whole of murine IFN-g and the generation of antisera to
them all has led to the demonstration that only the N-terminal and
the C-terminal peptides are important in receptor binding (Jarpe &
Johnson, 1990). This data, circular dichroism spectra showing
mainly alpha-helical structure, and the protein secondary structure
predicted by the method of Chou and Fasman (1974b), predicted the
tertiary structure to be six a-helices with five turns. This
prediction was incorporated in a model, based on the four a-helix
bundle model, as demonstrated by crystallography for interleukin 2
(Brandhuber et al, 1987). The model proposed that IFN-g be found as
a monomer, contrary to much chromatographic evidence (Yip et al,
1982). The model allowed the N- and C-terminal helices to be
closely associated, and to form the receptor binding site of the
molecule. The accuracy of this model has been refuted by the recent
description of the tertiary structure of human IFN-g derived from x-
ray crystallography (Figure 1) (Ealick et al, 1991). Human IFN-g
crystallized as a dimer of identical subunits, with each subunit
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containing six alpha-helices and no beta-sheet regions. The first
four helices of one subunit form a cleft that accommodates the
carboxy-terminal helix of the other subunit. The structure of
bovine IFN-g has been predicted using the human structure as a
model.
The object of the work described in this chapter was to generate
antisera that would specifically react with ovine IFN-g and may be
used to quantitate ovine IFN-g concentrations in lymphatic fluid.
The use of peptides as immunizing molecules would also allow an
assessment of the important functional regions of the ovine IFN-g
molecule.
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2.2 MATERIALS AND METHODS.
2.2.1 GENERATION OF ANTI-BOVINE INTERFERON-GAMMA PEPTIDE POLYCLONAL
RABBIT SERA.
The three peptides shown below were synthesized in the Department of
Veterinary Pathology by Mr D. Thompson. They were made using a
Cambridge Research Biochemicals Pepsynthesizer II by the
fluoronylmethoxycarbonyl (FMOC) polyamide solid phase method
(Dryland & Shephard, 1986). The amino acids were purchased as
pentafluorophenyl esters (Milligen, Millipore, UK). The solid
support used for peptide synthesis was polydimethylacrylamide resin
(Pepsyn KA, Milligen, Millipore, UK). Cysteine was coupled to the
resin by 4-hydroxymethylphenoxyacetic acid. This was deprotected
with 20% piperidine in dimethylformamide before addition of a second
amino acid. The cycle of esterification and deprotection was
continued until the whole peptide was synthesized. It was cleaved
from the resin with trifluoroacetic acid (TFA). Purification was by
reverse phase chromatography on a Zorbax ODS column (Du Pont,
Delaware, USA) using a Gilson HPLC system with an Apple II computer
control unit. A gradient of acetonitril (Rathburn Chemicals Ltd.,
HPLC grade) was generated from 0% to 100% in 0.1% TFA pH2 over a
period of 30 minutes. Absorbance was detected at 230nm and recorded
on a Shimadzu C-R3A chromatopac. The peptide peak was collected and
freeze-dried prior to use.
Each peptide was used to immunize two rabbits. Peptides were not
coupled to a carrier protein. Initial immunizations were of 200pg
of peptide in Complete Freunds Adjuvant (Sigma). A second
immunization was of 200pg of peptide dissolved in PBS.
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PEPTIDE RABBITS SEQUENCE
42-68 R144 + R145 CESDKKIIQSQIVSFYFKLFENLKDNQV
112-137 R146 + R147 CAINELIKVMNDLSPKSNLRKRKRSQN
1-23 R155 +. R156 CSYGQGQFFREIENLKEYFNASSP
The rabbits were immunized on two occasions, two to three weeks
apart, and then bled from the ear vein. Repeat immunizations of
peptide in PBS were periodically performed to maintain antibody
titres. Sera were tested for reaction to the peptide concerned and
an irrelevant peptide of the same length (usually a tuberculin
peptide) using the direct ELISA described below.
2.2.2 DIRECT ELISA TO TEST ANTI-PEPTIDE ANTISERA.
Peptide was diluted in 0.1M carbonate buffer pH9.5 to 20pg/ml. 75pl
was applied to each well of a 96-well polystyrene ELISA plate which
was left overnight at 4°C. The wells were washed at each step with
PBS/0.05% Tween 20 five times. Wells were blocked with 2% BSA/PBS
for 30 minutes at 20°C. A doubling-dilution series of rabbit
antisera, diluted in 2% BSA/PBS, was applied to the wells for one
hour at 20°C. The wells were washed before addition of 75pl of
1/1000 goat anti-rabbit alkaline phosphatase (Sigma). After
incubation for 1 hour, the ELISA was developed with 0.1% p-
nitrophenyl phosphate disodium (Sigma) in 0.1M glycine, 0.05N NaOH,
0.5mM ZnCls, and 0.5mM MgCl2 for 1 hour at 37°C, and the colour
reactions measured at OD 405nm on a Titertek Multiskan plate reader.
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2.2.3 GENERATION OF CONDITIONED MEDIA CONTAINING OVINE INTERFERON-
GAMMA.
Fresh spleen and mesenteric lymph nodes were obtained from young
adult sheep slaughtered at Gorgie abattoir, Edinburgh. Lymphocytes
were obtained from the tissues by gentle teasing apart with sterile
forceps and scissors. Cells were washed three times in HBSS + 1%
foetal calf serum, with centrifugation at 1500 x g for 5 minutes
each time. Cells were counted, with viability being assessed by
trypan blue exclusion. Cells were resuspended at 5 x 10s /ml in
Iscoves medium (Sigma) supplemented with bovine serum albumin
(500pg/ml), human transferrin (25pg/ml), palmitic, oleic and
linoleic oils (all at lpg/ml), fungizone (25gg/ml) and
penicillin/streptomycin (lOU/ml of each). Concanavalin A (Sigma)
was added to all except one flask at lOpg/ml. The other flask had
no con A added. Cells were incubated at 37°C in 5% carbon dioxide.
After 24 hours the supernatant was collected by centrifugation and
stored at -20°C until use. Each supernatant was tested in the
antiviral assay and shown to be positive (G Entrican, personal
communication). Titres of the supernatant ranged from 1/100 to
1/800. The flask that had been incubated unstimulated tested
negative in the antiviral assay and con A was added to the
supernatant at lOpg/ml after collection. This was the control
medium.
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2.2.4 DIRECT ELISA TO DETECT OVINE INTERFERON-GAMMA WITH ANTI-
PEPTIDE ANTISERA.
Supernatant from both ovine and bovine concanavalin A-stimulated
lymphocytes (75pl) was applied to a 96-well ELISA plate overnight at
4°C. The supernatant was removed and the plate washed five times
with PBS/0.05% Tween 20. The rest of the ELISA followed the
protocol of section 2.2.2.
2.2.5 INHIBITION ELISA FOR OVINE INTERFERON-GAMMA.
An inhibition ELISA was designed to measure ovine IFN-g
concentrations. Sera from the rabbits (R144, R145, R146, and R147)
previously described were titrated against peptide by direct ELISA,
and they were subseguently used in the inhibition assay at four
dilutions which fell on the linear part of the titration curve.
Preimmune rabbit serum was used at the same dilutions. A number of
different supernatants from conditioned media were tested to see if
they could inhibit the binding of sera to peptides. In one
experiment a positive supernatant was concentrated 23 times by
ultrafiltration over a YM10 membrane (Amicon) before being used to
inhibit the sera.
All wells of a 96-well ELISA plate were blocked with 2% BSA/PBS for
30 minutes at 20°C and then washed in PBS. 90pl of conditioned
medium was added to the initial wells of four columns and double
diluted down the columns in medium from unstimulated cells. Each
column had lOpl of one of the four dilutions of sera added to each
well. All the sera were now at their previously determined
dilutions. Each medium and serum were incubated together for 60
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minutes at 20°C. A similar set of ELISA plates had been coated with
appropriate peptide as described for the anti-peptide ELISA. After
these wells were washed, 75pl of the serum/medium from each well was
added to the corresponding peptide-coated well, and the rest of the
ELISA followed the protocol of section 2.2.2.
2.2.6 PURIFICATION OF RABBIT IMMUNOGLOBULIN.
Antibodies were precipitated from serum by the addition of 0.313g/ml
solid ammonium sulphate at 20°C (50% ammonium sulphate final
concentration). The serum was slowly stirred overnight at 4°C. The
precipitate was collected by centrifugation at 3000xg for 30 minutes
in a MSE high-speed centrifuge. The precipitate was dissolved in
PBS and dialysed for 48 hours against three changes of lOmM sodium
phosphate buffer, pH8.0. The dialysate was fractionated on a DEAE-
cellulose (Whatman DE52) column previously eguilibrated with lOmM
sodium phosphate buffer, pH8.0. The protein-containing fractions
were tested by the direct ELISA for anti-peptide activity and
positive fractions pooled. Purity of the IgG was assessed by
immunoelectrophoresis.
2.2.7 IMMUNOELECTROPHORESIS OF PURIFIED RABBIT IMMUNOGLOBULIN G.
Purified immunoglobulin G was electrophoresed through 1% agarose in
0.5X veronal buffer (see Appendix 2) at 40V for 1 hour. The
parallel well was filled with a 1/4 dilution of goat anti-rabbit
whole serum (Sigma) in PBS. The gel, was incubated for 16 hours at
4°C in a moist atmosphere. The gel was then washed for 48 hours in
two changes of PBS before staining with 0.025% Coomassie Brilliant
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Blue R (Sigma) in a 50:45:5, methanol:water:acetic acid mix for 30
minutes. The gel was destained in a 87:8:5, water:acetic
acid:methanol mix.
2.2,8 BIOTINYLATION OF PURIFIED RABBIT IMMUNOGLOBULIN G.
Purified IgG from the rabbits immunized with peptides was dialysed
against 0.1M sodium hydrogen carbonate, pH 8.4, for 24 hours with
three changes of buffer. The protein concentration of the dialysate
was measured by spectrophotometry at 280nm. 4mg of each IgG sample
was diluted with buffer to a final concentration of Img/ml.
Biotin-amidocaproate N-hydroxysuccinimide ester (Sigma) was added to
the IgG at 75pg biotin/mg IgG. The mix was rotated for 5 hours at
20°C and then dialysed against PBS/0.05% sodium azide overnight.
2.2.9 DEVELOPMENT OF SANDWICH ELISA FOR OVINE IFN-q.
The biotinylated polyclonal rabbit sera were used to attempt to
develop a sandwich ELISA for interferon-gamma by capturing the
interferon with one antibody and detecting with a second
biotinylated antibody.
Each assay used three 96-well polystyrene ELISA plates. Each plate
was coated with 75pl of the previously purified immunoglobulins
(section 2.2.6) at 50pg/ml (280nM) in carbonate buffer, pH9.0, for
16 hours at 20°C. Columns 1-4 were coated with R144/5 immuno¬
globulin (peptide 42-68), columns 5-8 with R146/7 immunoglobulin
(peptide 112-137), and columns 9-12 with R155/6 immunoglobulin
(peptide 1-23). The wells were washed with PBS/azide + 0.05% Tween
20. Wells were blocked with 2% BSA/PBS/azide for 30 minutes at
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20°C. 75pl of neat conditioned media was applied to columns 1-2,5-
6, and 9-10, whilst control medium was applied to the remaining
columns of wells. Thus each coating antibody was tested with
interferon-containing medium and negative medium. Media were left
in wells for 24 hours at 4°C and then washed out three times. 75pl
of one biotinylated antibody was added to each well of one plate for
3 hours at 4°C. Row A of the plate was incubated with 5pg/ml of
antibody, and each row down was a double dilution of this, i.e. Row
B - 2.5pg/ml, Row C - 1.25pg/ml, etc. Each of the three plates was
incubated with either R144/5 biotin, R146/7 biotin, or R155/6
biotin. The wells were washed as before and then incubated with
75pl of 1/4000 Extravidin Alkaline Phosphatase (Sigma) for 90minutes
at 4°C. After a final round of washes the plates were developed
with p-nitrophenyl phosphate disodium in 0.1M glycine, 0.05N NaOH,
0.5mM ZnCla, and 0.5mM MgCl2 for 60 minutes at 37°C. The optical
density of the wells was determined at 405nm with a Titertek
Multiskan plate reader. The experiment was performed three times.
2.2.10 MONOCLONAL ANTIBODY HB 8291.
A monoclonal antibody, HB 8291, was obtained from the American Type
Culture Collection. HB 8291 was originally generated in a fusion of
the BALB/c myeloma cell line SP2/0-Agl4 [HRPT-] with spleen cells
from a BALB/c mouse immunized with a 19-mer synthetic polypeptide
identical to amino acid sequence 128-145 of human interferon-gamma,
coupled to keyhole limpet haemocyanin (Altrock BW, 1986). The




The monoclonal antibody HB 8291 is a mouse IgGl which recognises the
immunizing peptide, native IFN-g, recombinant IFN-g, and denatured
IFN-g. It does not neutralize the antiviral activity. It was
produced in both murine ascites and tissue culture cell supernatant.
Immunoglobulin was purified from ascitic fluid on a protein G-
sepharose chromatography column (Pharmacia). Binding buffer was
borate buffered saline (BBS) (see Appendix 1) and elution buffer
2.5M glycine. Purified antibody was biotinylated in an identical
fashion to rabbit immunoglobulin.
2.2.11 GENERATION OF RABBIT ANTI-BOVINE INTERFERON-GAMMA POLYCLONAL
SERA.
Bovine recombinant IFN-g was donated by Ciba-Geigy. Two 10 week
old, male New Zealand White rabbits were immunized subcutaneously
once with 25pg of interferon in complete Freund's adjuvant (CFA),
followed by 25pg of interferon in PBS intravenously two weeks later.
One week later the rabbits were bled from the ear vein and the
antibody titre assayed. Initial assay was by ELISA against two of
the bovine interferon-gamma peptides (1-23 and 112-137) as
previously described for testing the anti-peptide antisera.
Antisera were purified by 50% ammonium sulphate precipitation and
DEAE-cellulose chromatography as previously described for the rabbit
anti-peptide sera. Immunoglobulin was biotinylated as previously
described.
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2.2.11.1 WESTERN BLOT ASSESSMENT OF RABBIT ANTISERA AND MOUSE
MONOCLONAL ANTIBODY HB 8291 AGAINST RECOMBINANT PROTEIN.
The sera and monoclonal antibody were tested in a western blot
against recombinant protein. Recombinant interferon-gamma
preparation was boiled in loading buffer (Appendix 1) to denature
the protein and 500ng loaded onto each track of a BIORAD minigel
system. The preparation was fractionated on a 12% SDS-PAGE gel at
200V for 30 minutes in running buffer. The proteins were transfered
electrophoretically to nitrocellulose membrane (Hybond C, Amersham,
Aylesbury, Bucks) using a BIORAD Trans-Blot SD Semi-Dry
Electrophoretic Transfer Cell and transfer buffer at 120mA for 40
minutes (Bjerrum & Schafer-Nielsen, 1986). Following transfer,
marker tracks were stained with 0.5% amido black (BDH, Poole,
Dorset) and the remainder of the membrane cut into strips, blocked
with 5% dried cow's milk (Marvel, Cadbury's), and incubated with
anti-rabbit or anti-mouse Ig alkaline phosphatase. Blots were
washed before development in alkaline phosphatase substrate
(Appendix 1).
2.2.12 SANDWICH ELISA USING RABBIT ANTISERA AND MOUSE MONOCLONAL.
Sandwich ELISAs similar to those described in section 2.2.9 were
performed using either R167/8 or HB 8291 as the coating antibody at
20pg/ml in PBS, and biotinylated R167/8 or HB 8291 as the detector
antibody.
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2.2.13 FUSION PROTOCOL FOR GENERATION OF ANTI-INTERFERON-GAMMA
MONOCLONAL ANTIBODIES.
6 week old female BALB/c mice from the animal house at R(D)SVS,
University of Edinburgh, were immunized with recombinant bovine
interferon--gamma on several occasions.
DATE PROCEDURE
13/9/90 2.5pg bov rIFN-g CFA SUBCUT
1/10/90 5.0pg bov rIFN-g I FA SUBCUT
6/2/91 TEST BLEED: MOUSE 2 1/800; MOUSE 1 1/100
15/2/91 2.0pg bov rIFN-g PBS I/P MOUSE 2
19/2/91 FUSION MOUSE 2
4/3/91 2.0pg bov rIFN-g PBS I/P
14/3/91 TEST BLEED: MOUSE 1 1/3200
30/4/91 2.5pg bov rIFN-g PBS I/V MOUSE 1
3/5/91 FUSION MOUSE 1
Fusions were carried out essentially as described by Kohler and
Milstein (1975). A mouse myeloma line was used, NSO/1 (Galfre &
Milstein, 1981), which had been selected for non-secretion and non-
expression of immunoglobulin heavy and light chains, and also
contained a mutation of the hypoxanthine-guanine phosphoribosyl
transferase (HPRT) gene. NSO/1 were grown in RPMI 1640 media with
15% foetal calf serum, lOOmM sodium pyruvate, and lOOmM 2-glutamine
(Gibco, Scotland). Fusion of cells was achieved with 50%
polyethylene glycol in PBS (PEG 1500, Boehringer Mannheim, Gmbh, W.
Germany). Fused cells were plated out in 96-well plates at 2 x 105
cells per well in lOOpl of selecting media. Each well also
contained lOOpl of mixed thymocyte medium (MTM) to provide growth
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factors for the fused cells. Selecting medium was RPMI 1640 with
the addition of 15% foetal calf serum, L-glutamine, sodium pyruvate
and HAT (Sigma). The HAT supplement gave final concentrations of 1
x 10~4M hypoxanthine, 4 x 10-7M aminopterin and 1.6 x 10~5M
thymidine.
Tissue culture supernatants from confluent layers of hybridoma cells
were tested in an interferon-gamma specific sandwich ELISA. This
ELISA was designed using rabbit anti-bovine interferon-gamma IgG as
the capture antibody. The IgG was purified by 50% ammonium sulphate
precipitation and DEAE-cellulose chromatography as performed
previously. 50pl of antibody was applied to the ELISA plate at
20pg/ml in 0.1M carbonate buffer, pH 9.5, for 3 hours at 4°C.
Excess antibody was washed off and the wells were blocked with 2%
BSA/ PBS for 3 hours at 4°C. 50pl bovine recombinant interferon-
gamma was applied at 200ng/ml in 2% BSA/ PBS for 16 hours at 4°C.
The excess was washed off with ice-cold PBS five times, one minute
each time. Test supernatants were then applied and incubated for 2
hours at 4°C. The plates were again washed. A 1/100 dilution of
anti-mouse Ig Horseradish Peroxidase (SAPU, Carluke, Scotland) was
applied for 2 hours at 4°C. The anti-rabbit IgG reactive component
had previously been removed by affinity chromatography on a rabbit
IgG-sepharose column. The plate was washed prior to development
using 20mg o-phenylenediamine (Sigma) in 0.05M NaaHPCU, O.024M
citric acid, and 0.005% H2O2. The reaction was stopped with 50pl of
2M sulphuric acid, and the results read on a Titertek Multiskan
plate reader at an OD of 435nm.
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2.3 RESULTS.
2.3.1 ANALYSIS OF BOVINE INTERFERON-GAMMA TO IDENTIFY PEPTIDES OF
POTENTIAL USE.
The availability of the human, murine, rat and bovine IFN-g
sequences allowed identification of conserved and variable regions
of the IFN-g molecules. Figure 2 shows the four sequences aligned
and the conserved regions are marked.
The amino acid sequence of bovine IFN-g (Cerretti et al, 1986) was
examined for secondary structure (CF and GOR), hydropathicity (KD)
and antigenicity (Jameson-Wolf) using the GCG7 computer program from
the University of Wisconsin. The plotted results are shown in
Figure 3.
A plot indicating a hydrophilicity and hydrophobicity of more than
1.3 according to the Kyte-Doolittle algorithm (Kyte & Doolittle,
1982) was generated by the GCG7 computer program and is shown
(Figure 4).
Potential T cell epitopes may be predicted using the Rothbard
algorithm (Rothbard & Taylor, 1988). The four amino acid motif
(charged or glycine-/-hydrophobic-/- hydrophobic-/-polar or glycine
or charged) and the five amino acid motif (charged or glycine-/-
hydrophobic-/-hydrophobic-/-hydrophobic or proline-/-polar or
glycine or charged) were used to predict the presence of T cell
epitopes with bovine interferon-gamma (Figure 5).
The peptides synthesized are depicted within the bovine sequence
(Figure 6).
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2.3.2 TESTING OF ANTIPEPTIDE ANTISERA.
The peptides synthesized were 1-23 amino-terminal, 112-137 carboxyl-
terminal, and a central region 42-68. The rabbits were immunized
with uncoupled peptide. All the rabbits developed antibodies
reactive to the peptides. The antisera could be diluted to a high
degree before reactivity disappeared (Figure 7). A positive
response in the ELISA was defined as being twice the average value
generated by normal rabbit serum in the assay. The titre is thus








2.3.3 DIRECT ELISAs AGAINST CONDITIONED MEDIA.
ELISA plates were coated with crude preparations of ovine
interferon-gamma from Concanavalin A-stimulated lymphocytes
(conditioned medium). The conditioned medium had been tested for
the presence of interferon by the antiviral assay (Entrican et al,
1989). Some preparations were further concentrated by
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ultrafiltration through a PM10 membrane (Amicon), which would retain
all molecules with molecular weight more than 10 kDa (i.e. including
IFN-g). In all the assays performed preimmune rabbit serum was as
reactive to conditioned medium as the antipeptide sera, and all sera
were unreactive to control medium containing no IFN-g (Figure 8).
Sera at low dilutions bound non-specifically to the ELISA wells in
which conditioned medium had been included.
2.3.4 DIRECT ELISA USING BOVINE CONDITIONED MEDIA.
Conditioned medium was generated using bovine lymphocytes as the
IFN-g producing cells. This medium tested positive in the antiviral
bioassay. The ELISA procedure was as before. There was no
significant difference between the reactivity of the antipeptide
sera and preimmune sera at any dilution (Figure 9). Interestingly
none of the sera, even at low dilutions, gave the high results found
when ovine conditioned medium was used.
The guestion of reactivity of the antisera with ovine or bovine IFN-
g remained unresolved.
2.3.5 INHIBITION ELISA FOR OVINE INTERFERON-GAMMA.
The rabbit sera certainly possessed antipeptide activity and this
may be able to detect native IFN-g, but a more sensitive and
specific assay was thought to be required which did not rely on the
binding of conditioned medium to a plate. The inhibition ELISA was
developed as a theoretically more sensitive method. The sera against
peptides 42-68 and 112-137 were used in this assay. The sera were
used at final dilutions which lay on the linear part of the
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titration curve against the specific peptide, and were hence present
in limiting amounts (Figure 7). Sera from rabbit R144 (42-68) was
used at 1/640, 1/1280, 1/2560 and 1/5120. Sera from the other three
rabbits were all used at 1/2560, 1/5120, 1/10240 and 1/20480. A
variety of conditioned media were used in the assay, including the
Amicon-concentrated material previously described.
No consistent difference was observed between the signal generated
after inhibition by neat medium and diluted medium, and that
generated after negative control medium was included. This was true
for all four rabbit sera at each of the dilutions. A representative
graph for one of the sera is included (Figure 10).
2.3.6 PURIFICATION OF RABBIT ANTI-PEPTIDE IMMUNOGLOBULIN G.
Rabbit serum against peptide 42-68 (R144/5) was combined and then
purified for IgG by chromatography. Sera against the other peptides
were separately purified and subsequently assayed by the direct
peptide ELISA. The pre- and post-purification reactivity to peptide
were tested in a similar ELISA. The recovery rate of anti-peptide
IgG is shown below.
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R146/7 PRE 12800 30 384000
POST 3200 51 163200
R155/6 PRE 5120 16 81920
POST 640 63 40320
The above results show that R144/5 (42-68) had a recovery of 78%,
R146/7 (112-137) had a recovery of 43% and R155/6 (1-23) had a
recovery of 49%. The "lost" antibody may be immunoglobulin M which
binds to the DEAE-cellulose column, or it may be immunoglobulin G
which has bound to the column in a non-specific manner.
Immunoelectrophoresis was performed to analyse the purity of the
protein fraction recovered from the DEAE-column. All three
preparations contained a single major band corresponding to IgG.
The anti-peptide IgG fractions were used in a direct ELISA against
conditioned medium (section 2.2.3). For all three preparations,
there was a higher reading against conditioned medium than against
control medium at all or most of the IgG dilutions. The difference
between the reactions was however not great enough to allow good
discrimination between conditioned and control media. Unfortunately
preimmune rabbit serum reacted identically in the ELISA. To avoid
this problem a sandwich ELISA was developed using the IgG fractions
as capture antibodies and the biotinylated IgG as detector
antibodies.
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2.3.7 DEVELOPMENT OF A SANDWICH ELISA FOR OVINE INTERFERON-GAMMA.
The sandwich ELISA was used with three different conditioned media
preparations, including the bovine conditioned medium, as the
reactivity of the antibodies to ovine interferon-gamma was still not
resolved. In all the ELISAs, wells that included conditioned medium
had higher readings than those that included control medium. The
readings from the wells containing the conditioned medium were at
most 10% higher than the readings from the control wells (Figure
12). This difference was insufficient to allow development of the
sandwich ELISA in its current form.
The coating antibody had a profound effect on the result obtained.
Wells which contained R144/5 (42-68) as coating antibody recorded
results approximately one third that of wells coated with R155/6 (1-
23). Wells coated with R146/7 (112-137) were approximately two
thirds the value of R155/6 (1-23). This was consistent for all
three detector antibodies and at all concentrations of coating
antibody tested (0.15-10pg/ml).
2.3.8 ASSESSMENT OF THE PROTEIN CONTENT OF THE RECOMBINANT BOVINE
INTERFERON-GAMMA PREPARATION.
On an SDS-PAGE gel stained with Coomassie Blue the preparation
contained a major and a minor protein band with estimated molecular
weights of 17,000 and 18,000 respectively (Figure 13). The mature
recombinant protein is described as being of 16,858 molecular weight
(Cerretti et al, 1986) which would correspond with the major band.
The origin of the minor band was unknown. The preparation was
examined using the antipeptide sera.
39
2.3.9 GENERATION OF RABBIT ANTI-BOVINE INTERFERON-GAMMA POLYCLONAL
SERA.
Rabbit polyclonal antisera to the recombinant bovine IFN-g were
generated as described (section 2.2.11). The sera from rabbits R167
and R168 were assessed for antibodies to the rIFN-g by a direct
ELISA against peptides 112-137 and 1-23. Both rabbits were positive
when tested against peptide 112-137. R167 was positive at 1/1600
dilution, and R168 was positive at 1/100 dilution. Both rabbits
were negative when the sera were tested against peptide 1-23. In
each ELISA the specific anti-peptide serum was highly positive
against its peptide and negative against a tuberculin peptide. This
initial ELISA not only measured an aspect of the antibody response
to the bovine rIFN-g, i.e. recognition of peptide epitopes, but also
provided good evidence that the recombinant protein supplied by
Ciba-Geigy was bovine IFN-g. The IFN-g was tested for antiviral
activity in the Semliki Forest virus/ ST6 ovine cell line assay and
was highly potent in this test. The R167 antisera neutralized this
effect to a titre of 1/1000 (G. Entrican, personal communication).
2.3.10 DEMONSTRATION THAT ANTIPEPTIDE SERA AND MONOCLONAL ANTIBODY
HB 8291 REACT WITH BOVINE INTERFERON-GAMMA.
The hybridoma cell line HB 8291 (see section 2.2.10) was generated
to a human carboxyl-terminal peptide and its reactivity to bovine or
ovine interferon-gamma was unknown.
All the rabbit antisera (anti-peptide and anti-bovine rIFN-g) and
the mouse monoclonal HB 8291 were tested by immunoblotting against
recombinant bovine interferon-gamma which had been separated by SDS-
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PAGE. The immunoblots are shown in Figures 14 and 15. Preimmune
rabbit serum did not react with any proteins on the blot. Figure 14
shows that the rabbits immunized with the amino- and carboxyl-
terminal peptides (1-23 and 112-137), and those immunized with the
bovine rIFN-g, all reacted with a protein of molecular weight 17000.
A faint band was visible on the original blot just above the major
band at approximately 18000 MW. This was interpreted as being the
18000 MW minor band visible on the coomassie stained SDS-PAGE of the
recombinant preparation. Figure 15 shows that the monoclonal
antibody HB 8291 reacts with a broad protein band of approximately
18000 MW indicating that the larger band contains the carboxyl-
terminal seguence and that the smaller band may represent a
degradation product not containing the critical epitope for HB 8291.
The reaction of the rabbit anti-carboxyl peptide antisera indicates
that the 17000 MW protein still contains epitopes recognised by the
poyclonal sera, and hence part or all of the peptide 112-137 is
still present in the 17000 MW protein.
2.3.11 SANDWICH ELISA USING R167/8 AND HB 8291 IMMUNOGLOBULINS.
When R167/8 biotin was used as the detector antibody, rIFN-g was
detected in wells coated with either R167/8 or HB 8291 (Figure 17),
but not in wells coated with irrelevant antibodies and using the
rIFN-g at 500ng/ml. Sensitivity with HB 8291 as the coating
antibody was twice that with R167/8. IFN-g was detected down to a
concentration of 125ng/ml. The recombinant preparation had a quoted
activity of 2.5 x 10® units/mg (Ciba-Geigy), which gives a maximal
sensitivity of 625 units/ml in this ELISA system.
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When biotinylated HB 8291 was used as the detector antibody, IFN-g
was not detected even at high IFN-g concentrations. The
biotinylation was not at fault as blots of the antibody could be
easily detected by an alkaline phosphatase method. The monoclonal
antibody HB 8291 could be detected on a dot blot down to a level of
25pg.
2.3.12 RESULTS FROM HYBRIDOMA EXPERIMENTS.
Mice primed for a fusion with bovine rIFN-g were tested using the
modified sandwich ELISA and one serum found positive was tested to
assess the sensitivity of this system. A rIFN-g concentration of
62ng/ml was detectable, the best detection thus far in any of the
sandwich ELISAs devised.
Three mouse hybridoma fusions were performed using this sandwich
ELISA as the screening method. No monoclonal antibodies were
detected. The number of total hybridomas grown was less than
expected. This problem affected all hybridoma work performed within
the Department of Veterinary Pathology at that time. It was
subsequently determined to be the result of foetal calf serum which
was capable of supporting established hybridoma lines but not the
reguirements of recently fused cells.
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2.4 DISCUSSION.
Peptides used for the generation of antisera should represent
regions of the molecule which are likely to be exposed on the
surface of the molecule, and hence these regions are likely to be
antibody-binding. Antibody production against peptides can also
depend upon the presence of T cell epitopes within the peptide
seguence, especially if uncoupled peptides are to be used.
Historically, peptides have been chosen on the basis of the
predicted secondary structure of the protein. Secondary structure
predictions were initially based on the potential of amino acids to
be present in a-helices, |3-sheets or turns (Chou & Fasman, 1974b).
Values for each amino acid were derived from X-ray crystallography
(Chou & Fasman, 1974a). Helix or p-sheet initiation sites were
identified where sufficient of each type of amino acid were
clustered, and these conformations were deemed to continue until
broken by a sequence of tetrapeptides which act as "breakers". A
similar method was used by Garnier et al (1978) to derive regions of
helix, sheet or turn. From Figure 3 it can be seen that the Chou-
Fasman prediction of secondary structure (Chou St Fasman, 1974b) is
for seven alpha helices and four beta sheet regions. The Garnier-
Osguthorpe-Robson prediction of secondary structure (Garnier et al,
1978) is similar to that of Chou-Fasman but they predict that the
second alpha helix goes from amino acid 30 to amino acid 48, whilst
Chou-Fasman predict this helix ends by amino acid 39. Both CF and
GOR predictions show an absence of alpha helix or beta sheet
structure for the carboxyl twenty amino acids.
Later, exposed regions of proteins were located by plotting the
hydropathic characteristics of the amino acids using a 6-10 amino
acid window on the protein sequence of interest (Hopp & Woods, 1981;
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Kyte & Doolittle, 1982). This approach was based on the concept
that highly charged clusters of amino acids are almost always
exposed to an aqueous environment and strongly hydrophobic clusters
are usually buried in the interior of the protein. However, this
method is poor at predicting whether regions of proteins with
intermediate hydropathicity are exposed on the surface or hidden
inside the protein. The predicted hydropathicity of bovine IFN-g
was thus taken into consideration. The plot for bovine IFN-g is
shown in Figure 3 as "KD hydrophilicity". Both the amino and
carboxyl-terminal regions are predicted to be hydrophilic, but the
central 44-68 region is hydrophobic. The surface probability shows
two main regions predicted to be exposed to the exterior, at amino
acid residues 37-49 and 125-135.
A similar type of prediction (Emini et al, 1985) can be made using
values for the "solvent accessibility" of the individual amino acids
(Janin et al, 1978). Amino acids with high "solvent accessibilities"
are likely to be on the surface of the molecule. This method
produces a "surface probability" plot with different values from the
hydropathicity plots, but suffers from the same limitations. The
plot for bovine IFN-g is shown in Figure 3 as "Surface Probability".
Highly mobile regions of proteins have been found to correlate with
known antigenic determinants (Atassi, 1984; Tanier et al, 1984;
Westhof et al, 1984) and consequently these flexible regions may be
plotted, using values of atomic oscillation based on x-ray
diffraction (Karpus & Schulz, 1985). Although these plots are
informative they do not predict all antigenic peaks.
Antigenic predictions have usually utilized only one of the above
methods, but a more recent method has been described which
integrates all the previous methods to give an indication of
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potentially exposed surface peaks of a protein and hence regions
likely to be useful for the production of anti-peptide antibodies
reactive to native protein (Jameson & Wolf, 1988). The plot for
bovine IFN-g is shown in Figure 3 as "Jameson-Wolf (Antigenic
Index)". It can be seen that this predicts high antigenicity for
the amino- and carboxy-termini, but a region of low antigenicity for
the central 42-68 peptide. This latter probably reflects the
hydrophobic prediction for this region.
Although proteins with the same function in different species may
have differences in amino acid sequence they will commonly retain
the same functional regions. Consequently in these regions the
amino acids are more likely to be conserved. Comparison of the IFN-
g sequences of different species may allow prediction of the ovine
IFN-g sequence. This feature is shown in Figure 2. The region with
highest conservation of residues is the carboxyl region 109-135,
where 20 of 27 residues are identical in three of the four
sequences. Region 44-68 has a high degree of identity, with 18 of
25 residues the same in three of the four sequences. A region with
less identity is 1-26 (12 of 26 residues).
A combination of the above methods determined which peptides were
synthesized for the production of antisera reactive with native
bovine IFN-g. The two regions with the highest degree of homology
are in the central region, 42-67, and the carboxyl terminus, 112—
135. Two-thirds of the amino acids of each region had sequence
identity in three of the four sequences assessed. These sequences
formed the basis for two of the peptides synthesized. The surface
probability plot indicates the two regions likely to be found at the
surface of the IFN-g molecule are 37-49 and 125-135. Two regions
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predicted to be of likely high antigenicity by the Jameson-Wolf plot
are the amino (1-27) and carboxyl (125-146) termini. Regions 35-47
and 84-97 are also thought to have a high antigenic index.
Peptide sequences which bind to mouse T cell receptors may be
predicted by the method of Rothbard & Taylor (1988). This may
indicate the likelihood of B lymphocytes reactive with uncoupled
peptides receiving T lymphocyte help. Bovine IFN-g was examined in
Figure 5 and the carboxyl-terminal, 109-135, and the central region,
44-68, contain two Rothbard 4 amino acid motifs, whilst the amino-
terminal region, 1-23, contains one predicted epitope. These
regions should thus be able to stimulate T cell responses if used
without carrier proteins.
The anti-peptide sera generated against the amino- and carboxyl-
termini of bovine IFN-g were reactive with denatured recombinant
bovine IFN-g, but none of them seemed to react strongly with native
or denatured ovine IFN-g when tested by ELISA, western blot or viral
neutralization assay. The first two test methods suffer from the
disadvantage that they rely on sufficient IFN-g being bound to an
ELISA plate or membrane for subsequent detection by antibodies in
the antisera. In the absence of large amounts of purified IFN-g
protein this can be difficult to achieve convincingly. Consequently
the absence of a reaction by these methods must be interpreted with
caution. It may only reflect that too little IFN-g was bound to the
ELISA plate or nitrocellulose membrane, which is difficult to
confirm without a positive control antibody. A neutralization assay
depends on the activity of the IFN-g preparation for its readout
system (i.e. the presence of IFN is detected regardless of the
presence of antibodies) but this assay only detects antibodies which
disrupt the molecule-receptor interaction. It will not detect
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antibodies which bind to native protein but fail to block this
interaction, and these may be the predominant antibodies formed to
peptides, depending on the location of the peptide regions in the
native molecule.
The inhibition ELISA was an attempt to increase the sensitivity of
the ELISA technigues being used. It relied upon native IFN-g
blocking binding of antibodies to wells coated with peptide. The
negative results can be explained by considering that the
antipeptide sera is reactive to a linear seguence which may not
exist as such in the native molecule. A high percentage of the
antibodies would be reactive only to the peptide, with a remaining
low percentage also being reactive to native interferon, possibly
with low affinity. The inhibition ELISA relies on a significant
percentage of the antipeptide antibodies being reactive to the
native IFN. These antibodies are the only ones in which blocking by
native IFN is possible, and hence a decreased ELISA reading will
register. A low percentage change in ELISA reading would not be
detectable in this ELISA system given the coefficient of variation
inherent in the ELISA. It is unlikely that the antipeptide sera
would contain enough antibodies reactive to native IFN-g to enable
the assay to work.
The detection of bovine rIFN-g by HB 8291 on a western blot may be
explained by the linear nature of the IFN-g molecule beyond amino
acid 125 and the high degree of identity between human and bovine
IFN-g in this region. The human peptide seguence used to generate
monoclonal antibody HB 8291 is very similar to the carboxyl-terminal
seguence of bovine IFN-g. If the three amino acids (128-130) at the
amino end of the peptide are ignored, the two seguences share 14 of
16 residues, and one of the differences is at the extreme carboxyl
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end. Antibodies to a linear peptide 128-146 of human IFN-g are
likely to react with native IFN-g because the three dimensional
structure of human IFN-g has been shown to be linear from amino acid
125, and bovine IFN-g is predicted to be similar (Ealick et al,
1991). This level of identity and linear nature should allow some
cross-reactivity of the monoclonal antibody with bovine IFN-g. On a
western blot HB 8291 only detected bovine rIFN-g which was present
at more than lOOng per track. This suggests that it had low
affinity for bovine rIFN-g and in the patent application HB 8291 is
described as having higher affinity for the immunizing peptide than
for native human IFN-g (Altrock, 1986). The sandwich ELISA using HB
8291 as coating antibody detected IFN-g down to 125ng/ml in 50pl,
i.e. 6.25ng. This level of detection however remains several orders
of magnitude below that required. Most commercial ELISAs for human
or murine IFN-g are based on monoclonal antibodies used in a
sandwich ELISA technique and can detect as low as lOpg.
The unreactivity of sera generated against peptide 42-68 suggest
that the central peptide site is relatively inaccessible or that
ovine IFN-g varies from bovine IFN-g in this region. Reference to
the cloned sequences (described in chapter 4) shows the amino acid
sequence is only different at one amino acid, where a leucine
replaces a phenylalanine, a relatively conserved substitution. This
may be sufficient difference to affect binding of a monoclonal
antibody, but within a polyclonal antisera to a peptide there should
be antibodies reactive to short amino acid sequences not containing
this amino acid, or affected conformationally by it. The more
likely reason is therefore that the site is inaccessible to
antibodies. This is supported by the crystallographic structure of
human IFN-g. The tertiary structure of bovine IFN-g was predicted
from this structure and is shown in Figure 18. The amino- and
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carboxyl-termini (helices A and F; 7-18 and 107-124 respectively)
are on the molecule surface, while the central region (helix C; 44-
64) is buried in the core of the dimer. Unfortunately this tertiary
structure was not published until 1991, more than a year after the
choice of the peptides used here for immunization.
The antisera generated against the amino- and carboxyl-terminal
peptides are reactive with denatured bovine rIFN-g by western blot,
but appear to be unreactive with native IFN-g by sandwich ELISA, and
this adds to the evidence that the regions the antisera bind to are
not linear in the native molecule, but have a degree of secondary
structure. Reference to the three-dimensional structure of human
IFN-g (Ealick et al, 1991) reveals that amino acids 7-18 and 107-124
are within alpha helical regions of the molecule. Antisera to a
linear peptide 1-23 of bovine IFN-g are conseguently unlikely to
bind region 7-18 in native IFN-g but may bind this region when its
secondary structure is removed by detergent denaturation. Similarly
antisera to linear peptide 112-137 are unlikely to bind native IFN-
g. Antibodies within this preparation may bind native IFN-g if they
are reactive with the region 125-137 which is linear in the native
molecule.
Antibodies to a peptide should have a high degree of specificity,
but it may be difficult to obtain a good antipeptide serum which
will react well with native IFN molecules. The difficulty in
showing that the anti-peptide sera bind to native IFN-g has been
experienced with rabbit sera to human peptides 1-20, 1-59, 24-59,
36-59 and 87-96 (Leist et al, 1985). Only two of 14 rabbits
produced antibodies which recognised native IFN; one to unlinked
peptide 1-59 and the other to unlinked peptide 24-59. Leist et al
concluded that it was difficult to obtain antisera to peptides which
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reacted well with native IFN molecules, and that hybridoma
technology was a better method of obtaining specific high-affinity
antibodies to IFN if a suitable immunogen is available.
Antibodies to peptides react primarily with linear epitopes which
may not be present in the secondary and tertiary structure of the
complete protein. Only five epitopes have been fully characterized
by X-ray diffraction of antibody-antigen complexes (Amit et al,
1986; Sheriff et al, 1987; Padlan et al, 1989; Tulip et al, 1990).
All five epitopes were of the discontinuous type comprising 15-22
amino acids split between several surface loops. Laver et al (1990)
commented that anti-peptide antibodies that seem to bind native
protein were most likely binding to denatured protein within the
protein preparation, and that the reactivity of sera generated
against native protein which binds to peptides is likely to be the
result of contamination of the immunizing protein preparation with
denatured protein. This theory may partly explain the reactivity of
the anti-bovine rIFN-g sera (R167/8) with peptide 112-137 by ELISA
as the presence of denatured IFN-g in the preparation cannot be
excluded. Another explanation may lie in that amino acid sequence
125-137 is not predicted to be in helix F of the tertiary structure
but probably extends away from the dimer and may be linear (Ealick
et al, 1991). Antibodies against this linear region could therefore
strongly bind a linear peptide.
There are many reports of the successful use of peptides as
immunogens, but most of these use peptides coupled to large carrier
proteins such as ovalbumin. The carrier protein is thought to serve
two main purposes. The coupled peptides are more likely to assume
conformations found in the native whole protein than are free
peptides. Antibodies which bind these peptides are more likely to
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bind native IFN-g. The carrier protein also provides the basis for
the generation of immune help from T cells for the peptide-reactive
B cells. T-cell recognition depends upon processing of the antigen
and subsequent presentation of peptides with MHC class II molecules.
T-cell recognition tends to be limited to a small number of
immunodominant si'tes within the protein. Overlapping epitopes
containing these immunodominant sites are seen by different T cells
with different receptors. Large proteins such as ovalbumin are
likely to contain several T-cell epitopes and will consequently
stimulate helper T cells with a variety of T cell receptors.
Algorithms have been devised to predict the sites of T cell epitopes
within proteins. Berzofsky et al (1987) proposed that T-cell
immunodominant sites tend to be amphipathic structures, usually a-
helices but occasionally p conformations with turn and coil
propensities. Rothbard & Taylor (1988) observed a 4 or 5 amino acid
primary sequence pattern within many T-cell epitopes. This pattern
is consistent with one turn of an amphipathic helix. Indeed
Berzofsky et al (1987) summarized the requirements for a T cell
epitope as the "potential to form stable amphipathic secondary
structures". The structure of the class II histocompatibility
molecules have been derived (Brown et al, 1988) from the
crystallographic structure of the class I molecules (Bjorkman et al,
1987). The molecules form a platform of eight antiparllel p-strands
topped by two a-helices. A groove between the a-helices provides a
peptide-binding site. Identification of endogenous peptides found
within class I peptide-binding grooves has revealed peptides in
extended conformations (Madden et al, 1991). Studies with peptide-
MHC class II interaction suggest that the bound state of the
peptides is conformationally complex (Brown et al, 1988) and it is
unlikely that a predictive model as simple as that used by Barzofsky
or Rothbard will be highly accurate. Peptides isolated from class
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II molecules have had no discernible sequence motifs (Rudensky et
al, 1991). As T cells recognise peptides in association with MHC it
may be unnecessary to couple peptides to carrier proteins if the
peptides are predicted to assume amphipathic helix conformation or
contain a Rothbard motif. All of the peptides used for immunization
in this project contained Rothbard motifs, hence predicting that
each peptide should contain an immunodominant site. A limitation of
this technique is that the epitopes from which the algorithms were
devised all react with the MHC from in bred mouse strains. The
generation of T cell help in rabbits would require T cell epitopes
capable of reacting with rabbit MHC molecules. The generation of
IgG antibodies against the free peptides indicates that they were
not only immunogenic to B cells but also to T cells. The presence
of a successful immune response to the peptides did not however
ensure that the resulting antisera reacted with native protein.
The results of this section of work seem to confirm the comments of
Leist et al (1985) that peptides are a poor method of generating
antisera reactive with native IFN-g. The generation of monoclonal
antibodies would seem to be a more efficient and successful method.
The availability of recombinant protein material makes this
possible. This was the direction in which this section of work
would have proceeded, but problems with the hybridoma technology




Diagram to show the three-dimensional structure of human interferon-
gamma. Alpha helices are represented by cylinders and the non-
helical regions by tubes. The amino (N) and carboxyl (C) ends of
the dimer are marked. The alpha helices are labelled A-F
corresponding with the a-helices indicated on Figure 18. (Amended
from Ealick et al, 1991).
Figure
Figure 2.
Amino acid sequences of human (h), bovine (b), murine (m) and rat
(r) IFN-g derived from the cDNA sequences. Consensus
sequences are marked * when all four sequences are identical, and =j=
when three of the four sequences are identical.
Figure 2.
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Computer-generated map of bovine IFN-g assessed for secondary
structure and antigenicity by the methods of Chou & Fasman (1974)
(CF), Gamier et al (1978) (GOR), Kyte & Doolittle (1982) (KD), and
Jameson & Wolf (1988). The protein is numbered from 1-166, i.e.
includes the 23 amino acid signal peptide, hence the peptides
synthesized are now 24-46, 65-91 and 135-160. The plot was
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Figure 4.
Chou-Fasman plot of bovine IFN-g with Kyte-Doolittle hydrophobicity-
hydrophilicity predictions superimposed. Saw-tooth regions
represent beta sheet, wide jagged lines represent alpha helix, and
turns represent beta turn regions. The glycosylation sites are
marked P. Hydrophobic and hydrophilic regions are marked as shown
on the diagram.
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Bovine IFN-g amino acid sequence with Rothbard motifs
marked (underlined).
Figure 5.
Rothbard four amino acid motif
1 50
SYGQGQFFRE IENLKEYFNA SSPDVAKGGP LFSDILKNWK DESDKKIIQS
100
QIVSFYFKLF ENLKDNQVIQ RSMDIIKQDM FQKFLNGSSE KLEDFKKLIQ
146
IPVDDLQIQR KAINELIKVM NDLSPKSNLR KRKRSQNLFR GRRAST
Rothbard five amino acid motif
1 50
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100
QIVSFYFKLF ENLKDNQVIQ RSMDIIKQDM FQKFLNGSSE KLEDFKKLIQ
146
IPVDDLQIQR KAINELIKVM NDLSPKSNLR KRKRSQNLFR GRRAST
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Figure 6.
Bovine interferon-gamma amino acid sequence marked with
the peptides synthesized (underlined). S1-S20 indicates
putative signal sequence.
Figure 6.
MKYTSYFLAL LLCGLLGFSG SYGQGQFFRE IENLKEYFNA SSPDVAKGGP
SI S20|1 30
LFSDILKNWK DESDKKIIQS QIVSFYFKLF ENLKDNQVIQ RSMDIIKQDM
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A. Direct ELISA of sera from rabbits immunized with peptide 42-68.
Wells coated with peptide 42-68. Doubling dilutions of sera and
'preimmune sera used.
B. Direct ELISA of sera from rabbits immunized with peptide 112—
137. Wells coated with peptide 112-137. Doubling dilutions of sera
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Figure 8.
A. Direct ELISA of sera from rabbits immunized with peptide 42-68
(R1445) and preimmune sera (NRS). Wells coated with conditioned
medium (+) or control medium (-). Conditioned medium contains IFN-
g, control medium does not. Doubling dilutions of sera and
preimmune sera used.
B. Direct ELISA of sera from rabbits immunized with peptide 112-137
(R1467) and preimmune sera (NRS). Wells coated with conditioned
medium (+) or control medium (-). Conditioned medium contains IFN-
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Direct ELISA of sera from rabbits immunized with peptide 42-68 (R144
and R145), 112-137 (R146 and R147), or preimmune sera (NRS). Wells
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Inhibition ELISA to detect ovine IFN-g. Antisera from rabbit R144
at four dilutions preincubated with dilutions of conditioned medium
before incubation in wells coated with peptide 42-68.
Figure 10 .
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Representative example of a sandwich ELISA to detect ovine IFN-g in
conditioned medium. Wells coated with IgG from rabbits immunized
with peptide 112-137. Wells incubated with conditioned medium (+)
or control medium (-). Detection by biotinylated IgG from rabbits














SDS-PAGE of bovine recombinant interferon-gamma stained with




Western blot of bovine recombinant IFN-g using polyclonal rabbit
sera for detection.















Western blot of bovine rIFN-g using monoclonal antibody HB 8291 for
detection. Molecular weight markers are shown.
Lane Contents
a bovine IFN-g 125ng
b bovine IFN-g 250ng
c bovine IFN-g 500ng
 
Figure 17.
Sandwich ELISA to detect bovine rIFN-g. Wells coated with sera from
rabbits immunized with bovine rIFN-g (R167/8) or with monoclonal
antibody HB 8291. Bovine rIFN-g incubated in wells in doubling
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Figure 18.
Bovine interferon-gamma amino acid sequence marked with the
predicted tertiary structure. Peptides synthesized are underlined.
(Ealick et al, 1991)
Figure 18.
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3 THE MAJOR HISTOCOMPATIBILITY COMPLEX.
3.1 INTRODUCTION.
The major histocompatibility complex (MHC) class II antigens are
cell membrane glycoproteins consisting of two distinct chains, a and
P, which are encoded in the MHC gene region of all vertebrate
species examined. They determine the immune response of an animal
to a wide range of foreign antigens (Benacerraf, 1981). The class
II molecules bind peptide fragments of foreign antigen (Babitt et
al, 1985; Buus et al, 1986) and present them to CD4+ T cells. The T
cell will only recognise peptides in association with certain
restricted allotypes of class II molecules,and this is known as
class II antigen restriction. The CD4 molecule and the T cell
receptor both bind to the class II heterodimer (Doyle & Strominger,
1987).
The class II proteins were originally discovered in the mouse, and
only later in man. The mouse has two types of class II heterodimer
named I-A and I-E. The human has three subsets, known as HLA-DR, -
DQ and -DP. These subsets have been defined serologically (Tosi et
al, 1978), biochemically (Shackelford et al, 1981) and
immunogenetically (Shaw et al, 1980). The HLA-DR molecule is the
major antigen restricting element in CD4+ cell recognition of
peptide. It is primarily responsible for stimulating helper T
cells. HLA-DQ restricted T cell clones are relatively rare in
immune reactions, but association between specific alleles and
autoimmune diseases is strong. This feature has led to the proposal
that -DQ molecules may stimulate "suppressor-inducer" cells (Altmann
et al, 1991), while -DR molecules stimulate "helper-inducer" cells,
and that the HLA-DQ locus may have suppressive influence over the
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HLA-DR locus (Hirayama et al. 1987). HLA-DP molecules present
antigens similarly to HLA-DR molecules, and no other function has
been determined for them to date.
3.1.1 THE MHC OF MAN AND MOUSE.
3.1.1.1 PROTEIN STRUCTURE OF MHC CLASS II.
The MHC class II heterodimer consists of two transmembrane
glycoprotein chains. Each chain contains two extracellular domains
of 90-100 amino acids, a transmembrane region of 20-25 amino acids
and an intracellular region of 8-15 amino acids. The a chain has
molecular weight of 34000, and is non-covalently linked to the (3
chain which has a molecular weight of 29000 (Shackelford et al,
1981). The molecular weights are different mainly due to variable
levels of glycosylation (Shackleford & Strominger, 1983). The
domain structure of class II molecules is similar to that of MHC
class I molecules, but the four domains of class I are arranged as
one chain of three domains, and a single domain of fh-microglobulin.
The membrane-proximal domains of class II (P2 and a2) are immuno-
globulin-like, with homology to class I a3 and [^-microglobulin
respectively. Comparison of class I with the sequence of class II
aligns class I al domain with class II al, and class I a2 with class
II pi. The secondary structure of human class I and class II
molecules has been examined by Fourier transform infrared
spectroscopy and circular dichroism (Gorga et al, 1989). Comparison
of HLA-A2, HLA-B7, and HLA-DR1 has revealed the amounts of alpha-
helix and beta-sheet to be not significantly different between the
three. The al and a2 domains of class I HLA-A2 are aligned to form
a platform of eight antiparallel p-strands topped by two a-helices
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(Bjorkman et al, 1987). A groove between the a-helices provides a
binding site for processed foreign antigens. Polymorphic regions of
class I are similarly polymorphic in class II, and conserved amino
acids give evidence of comparable a-helices. The antigen-binding
site of class II has been hypothesized to be structurally homologous
to that of class I, with a platform of |3-sheets and two a-helices
forming the peptide-binding area (Brown et al, 1988). Most of the
allelic variation in class II has been localized to the al and (11
domains, and domain-shuffling experiments have demonstrated that the
polymorphism of the (11 domain of E(1 and A[1 chain genes are the prime
determinant in restriction. The allelic variation is concentrated
in short "diversity regions", where at least three amino acid
allelic substitutions have been detected (Kappes & Strominger,
1988).
The MHC class I and II heterodimers present peptide to T cell
receptors. Some peptides have been isolated and microseguenced
(Jardetzky et al, 1991). Peptides bound to class I HLA-B27 are
nonamers, mainly derived from abundant cytosolic or nuclear proteins
such as histone, ribosomal proteins and members of the 90K heat-
shock protein family. A motif could be identified within the
peptides. Peptides associated with mouse class II I-Ato and I-Eto are
found to be 13 amino acids or more in length and to derive from
membrane-bound proteins (class II proteins and Murine Leukaemia
Virus env protein) and exogenous proteins (BSA) (Rudensky et al,
1991). An invariant chain-derived peptide has also been identified.
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3.1.1.2 DNA STRUCTURE OF HUMAN MHC CLASS II.
The domain structure of class II proteins is reflected in the DNA
arrangement of exons and introns in human class II genes (Kaufman et
al, 1984). The a chain genes contain 5 exons encoding the signal
sequence, al extracellular domain, a2 extracellular domain,
transmembrane and cytoplasmic region, and the 3' untranslated (UT)
region. The p chain genes are identical save that the cytoplasmic
region is encoded in separate 24bp exon 5, and the 3' UT coding
region nominally becomes exon 6.
At the genomic level, a combination of pulse field gel electro¬
phoresis and Southern blotting have shown that all the class II
genes are contained in a 1Mb region (Hardy et al, 1986). A map of
the MHC class II region is shown in Figure 19.
The DR subregion contains a variable number of (3 chain genes
depending on haplotype, and a single functional a chain gene. The
DR3 haplotype has been examined and contains three DRB genes
(Rollini et al, 1985). Two of the three genes encode functional
proteins with different antigenic properties. The third gene is a
pseudogene containing frame shifts in the first and third exons, and
deletion of the second exon altogether (Rollini et al, 1987). The
DR4 subregion also contains a P chain pseudogene and two functional
P chain genes (Spies et al, 1985; Andersson et al, 1987).
The DQ subregion encodes single DQA and DQB genes. Within the same
region are two additional genes, the DXA and DXB genes (Jonsson et
al, 1987). They are extremely similar to the DQ genes and are
thought to have arisen by gene duplication. The DX genes can be
considered as DQ pseudogenes. The DQ genes have also been linked to
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the DOB gene (Kappes & Strominger, 1988). The DQ genes are the only
ones known to produce functional proteins. Although DOB produces no
detected protein, its mRNA is found in B cells at low levels
(Tonnelle et al, 1985).
The DP subregion contains single DPA and DPB genes, along with two
related pseudogenes DPA2 and DPB2 (also known as SXA and SXB). The
pseudogenes contain frame shifts and defective splice junctions,
along with deletions of a promoter, signal sequence and 3' UT region
in DPA2 (Gustafsson et al, 1987; Kappes & Strominger, 1986). Within
the DP subregion also lies the DZ(N)A gene, which like DOB is
transcribed in B cells but no protein has been detected (Trowsdale &
Kelly, 1985). DZA transcription in fibroblasts can be induced by
IFN-g, whereas DOB cannot.
Two new class II-like genes have been described which map between
the DP and DQ regions. The genes are proposed to be called HLA-DMA
and -DMB. The genes encode transcripts found within total B cell
RNA, but not in T cell lines. IFN-g treatment of epithelial and
fibroblast lines resulted in de novo synthesis of mRNA for HLA-DM
(Kelly et al, 1991). The proposed heterodimer would possess a
different distal domain structure, as there are several cysteine
residues in both proteins which allows prediction of a more rigid
structure with restricted peptide binding capacity.
3,1.1.3 INVARIANT CHAIN ASSOCIATION WITH MHC CLASS II.
The MHC class II heterodimer is associated intracellularly with a
31000 MW transmembrane glycoprotein known as the invariant chain
(Ii). The name invariant chain is due to its lack of electro-
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phoretic polymorphism (Charron et al, 1979). This glycoprotein
associates with class II molecules in the endoplasmic reticulum.
Initial suggestions that the Ii chain influences the intracellular
transport of class II molecules have been questioned with the
finding that afl dimerization can occur in the absence of the
invariant chain, although the rate of transport is reduced
(Claesson-Welsh & Peterson, 1985). A role for Ii in regulating the
endocytosis of class II antigens (Stockinger et al, 1989) has not
been confirmed (Peterson & Miller, 1990). It may be that the
invariant chain facilitates assembly and/or transport, while not
being essential. The Ii chain inhibits binding of endogenous
peptides to the class II heterodimer in the endoplasmic reticulum by
blocking peptide access to the peptide-binding groove. In the
endosomal compartment of cells the Ii chain is dissociated from the
class II molecule, and exogenous peptide is able to bind into the
groove. The Ii chain is thus thought of as being the factor which
distinguishes the endogenous from the exogenous antigen presentation
pathway (Teyton et al, 1990).
Invariant chain and class II genes are regulated together during in
vitro stimulation of endothelial cells and dermal fibroblasts by
IFN-g (Collins et al, 1984). The treatment of mice with recombinant
murine IFN-g leads to the induction of la antigens and also
invariant chain in a variety of tissues. Differential expression is
found in bronchial epithelium, kidney tubules and colonic epithelium
where Ii is induced but la is not (Momburg et al, 1986).
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3.1.2 THE MHC OF THE SHEEP.
3.1.2.1 PROTEIN STRUCTURE OF OVINE MHC CLASS II.
MHC class II proteins have been described in sheep and characterized
using a number of monoclonal antibodies. Sheep class II a chain is
approximately 32000-35000 molecular weight, and the (3 chain is
26000-29000 (Puri et al, 1985; Hopkins et al, 1986). Both chains
are glycosylated with complex, sialated N-linked oligosaccharides
(Puri et al, 1987a; Dutia et al, 1990a). The a and p chain
oligosaccharides are MW 6000 and 3000 respectively. This is similar
to both man and mouse, but in man one of the a chain oligo¬
saccharides is Endoglycosidase H sensitive, implying a non-sialated
sugar chain. Monoclonal antibody studies involving sequential
immunoprecipitations have shown that sheep class II molecules can be
divided into four structurally and serologically distinct subsets
(Puri & Brandon, 1987). In addition, one monoclonal antibody could
detect as many as 10-12 distinct class II molecules on the
lymphocytes of one outbred sheep . This is evidence that the sheep
MHC class II region can be divided into two, and possibly three,
subregions. The divisions of the sheep class II region have been
further confirmed by N-terminal amino acid sequencing of both alpha
and beta class II molecules from one sheep. DRa/IEa-like and
DQa/IAa-like subunits were identified. The DRa-like chain exhibited
very little polymorphism, whilst the DQa-like chain consisted of two
closely-related subunits of a polypeptides which may be explained by
either allelic variation or the presence of two DQA genes. The
sequence from most of the beta chains showed insufficient homology
for correlation with human p chain sequences. Affinity purification
of the DQa-like chain led to co-purification of a P chain with
homology to human DQP. At least 16 different p polypeptides were
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identified from a single sheep, and the sequence data led to the
conclusion that at least nine non-allelic p genes exist (Puri et al,
1987c).
Monoclonal antibodies developed in the Department of Veterinary
Pathology, University of Edinburgh react with specific ovine MHC
class II molecules defined by N-terminal amino acid sequencing, two-
dimensional immunoblotting and studies with transfected cell lines
expressing sheep DR-like or DQ-like a and p chains (Dutia et al,
1990a; Dutia et al, 1990b).
3.1.2.2 DNA STRUCTURE OF OVINE MHC CLASS II.
Southern hydridizations have been performed on ovine genomic DNA
using human cDNA probes for DRA, DRB, DQA, DQB, DPA, DZA, DOB, and a
cosmid clone was used to probe for DPB (Scott et al, 1987). The
pattern of hybridization suggested that only one gene is present
coding for each of DRA, DZA and DOB. No DPA-like gene was
detectable. Two DQA genes are known to exist and have been
sequenced and shown to be transcribed in resting macrophages (Scott
et al, 1991a). One gene is extremely polymorphic whilst the other
is both polymorphic and subject to deletion in some sheep
haplotypes. The evidence for deletion comes from the absence of a
hybridizing band in a southern genomic blot using the gene as the
probe. Nucleotide comparison shows that the two ovine DQA genes are
relatively divergent (78%) in the al domain, but have high degree of
identity over the more membrane proximal regions of the molecule.
Typical diversity regions are present in the al domain in a similar
position to those in the human molecule. Comparisons with other
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species indicate that ovine DQA genes are most closely related to
bovine DQA genes and HLA-DQA1 and -DQA2 genes, than to bovine DRA,
HLA-DRA or HLA-DPA1 genes.
The Southern hybridization data of Scott et al (1987) showed
extensive cross-hybridization between the p chain genes. This meant
that the number of genes in each subregion could not be accurately
determined, but it was postulated that there were three or more DQB
genes, and at least two DRB genes. The presence of variable number
of DQB genes has also been reported in cattle (Andersson & Rask,
1988). Two DPB genes were thought to exist. The presence of
hybridizing bands on a Southern blot only yields information about
gene presence, but gives no information about their ability to
transcribe functional mRNA. Recently the nucleotide sequences of a
class II DQB gene and a DRB pseudogene have been reported. No
evidence was given about the transcription of the DQB gene. The DQB
gene was shown to be more similar to the bovine DQB and the HLA-
DQB1/2 genes, than to the DRB genes. The ovine DRB pseudogene
possesses premature termination codons in both exons 3 and 4, is
lacking a defined exon 2, and the 3' donor splice site of exon 3 is
atypical (Scott et al, 1991b).
A brief report has suggested the existence of at least eight
distinct a-chain genes and fourteen p-chain genes (Deverson et al,
1988). The cDNA for the sheep class II genes have so far not been
cloned and the regulation of the functional molecules has not been
studied. In situ hybridization has localized the MHC gene region to
chromosome 20 (Mahdy et al, 1989).
There is no evidence for the existence of ovine equivalents to the
bovine MhcBota DYA and DYB genes (van der Poel et al, 1990).
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The ovine MHC used to be called OLA (Ovine Lymphocyte Antigen), but
it has been proposed that in future the Ovine MHC is known as
MhcOvar (Klein et al, 1990). The bovine MHC would change from BoLA
to MhcBota.
3.1.3 IMPORTANCE OF MHC CLASS II.
The immune response genes were originally discovered in inbred
guinea pigs and mice. They determined the immune response to
synthetic polypeptides, and were later known to exert their action
on the carrier parts of the immunogenic molecule and not on the
immunoglobulin epitope (Benacerraf, 1981). The response to
pathogens varies among strains of mice, a feature reflecting the
contribution made by the immune response genes. Extensive
allotyping of human class I and II molecules has allowed the
association between disease and both class I and class II phenotypes
to be determined for some human autoimmune diseases. There is much
evidence that HLA-DQ alles are associated with predisposition to
autoimmune diseases such as pemphigus vulgaris (Scharf et al, 1989)
and Type 1 diabetes mellitus (Todd,1990). Infectious disease has
also been linked to immune response genes in humans. A case-
controlled study of over 2000 people from the Gambia showed that
distinct class I (HLA-Bw53) and class II (DRB1*1302-DQB1*0501)
phenotypes are linked to resistance to trypanosomiasis, and this
effect was eguivalent to the protection against malaria derived from
the sickle cell anaemia gene (Hill et al, 1991). These MHC
phenotypes occur more commonly in healthy humans than in children
suffering from severe malarial anaemia or cerebral malaria. They
are also extremely rare phenotypes outside the malarial regions of
Africa. The simplest explanation for these associations is that
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they relate to the ability of the HLA molecules to present antigen
in either a class I- or class II-restricted manner. Inability to
present important epitopes would reduce the cytotoxic T-cell control
of the liver stage of malaria (class I), or reduce the antibody
defence against malarial anaemia (class II). This study is the
first to provide direct evidence for diseases influencing a
polymorphic trait in mankind. A similar effect may hold for
diseases and breeds of animal. The study of the structure and
function of ovine class II may lead to a better understanding of its
association with disease in sheep.
The specific immune response state to some pathogens has been linked
to ovine MHC. Ovine class I antigens have been linked to the
ability to respond to intestinal parasites (Outteridge et al, 1984),
Bacteroides nodosus (a cause of footrot) (Outteridge et al,
1989),and Corynebacterium pseudotuberculosis (cause of caseous
lymphadenitis) (Millot, 1989). MHC class I haplotypes have been
linked to susceptibility to scrapie (Millot et al, 1988; Millot,
1989), but other authors dispute this finding (Cullen et al, 1984;
Cullen, 1989). No such disease association with MHC class II in
sheep has been documented.
Recent evidence has suggested that the MHC class II heterodimer may
be a cellular receptor for maedi-visna virus (Dalziel et al, 1991),
although molecules of a different molecular weight have also been
found to bind to visna (Crane et al, 1991). The subset of class II
molecules involved was not determined, and may be all subsets or a
subpopulation. This virus causes disease with only low prevalence,
but some breeds (notably Texel sheep from Holland and Border
Leicester sheep from the United States) seem more susceptible
(Narayan & Clements, 1990). If the cellular receptor is MHC class
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II, then the structure of this molecule may play some part in
determining disease susceptibility. Factors which increase
expression of class II molecules on cells may also play an important
part in the pathogenesis of maedi-visna. Lentiferon (discussed in
section 1.6), is a leucocyte-derived interferon which is produced
when leucocytes contact visna virus- or CAEV-infected
monocyte/macrophages. It has been shown to increase class II
expression on spleen and lymph node cells (Kennedy et al, 1985).
The differential upregulation of class II molecules by IFN-g may
also have a role in infection of cells.
In contrast to resting human lymphocytes resting sheep lymphocytes
express class II molecules. The CD4+ and T19+ cells express 3-4
times more DR-like than DQ-like molecules, while CD8+ cells have
variable DR-like and more DQ-like than the other cell types. It is
thought likely that the differential expression is indicative of a
difference in function of sheep DR-like and DQ-like molecules, and
hence a difference in the function of cells expressing them (Dutia
et al, 1990b). The effect of IFN-g on the expression of these two
subsets of class II molecules has not been examined before. The
induction patterns on different cell types may reveal the role of
IFN-g in the potentially different functions of these molecules.
80
3.2 MATERIALS AND METHODS.
3.2.1 ISOLATION OF SHEEP MHC CLASS II.
The object of this procedure was the purification of sheep MHC class
II protein. It was isolated on a Sepharose 4B column coupled to
purified monoclonal antibody SW73.2 (Hopkins et al, 1986).
The SW73.2 hybridoma was grown as an ascites tumour in Lewis rats.
The antibody was purified from the ascites fluid by 5% caprylic acid
precipitation followed by 50% ammonium sulphate precipitation. The
antibody was dialysed against 0.1M NaHCCh/ 0.5M NaCl pH8.4 for 24
hours with several changes of buffer. The preparation was assayed
for class II reactivity by both ELISA and western blot. The
antibody was mixed with CNBr-activated Sepharose 4B which had been
washed in ImM HC1. The suspension was rotated end-over-end for 3
hours at 20°C. The Sepharose 4B was blocked with 1M ethanolamine
pH8.0 for 1 hour, and then washed with TEA/DOC pH8.0 and
TEA/DOC/NaCl pH11.5. (Appendix 2). The column was stored in PBS/
0.1% NaN3.
Sheep splenocytes were prepared by disrupting spleen tissue with an
electric blender into a single cell suspension, washing away large
particles and then lysing the cells in Lysis Buffer (Appendix 2) at
4°C. The resultant lysate was centrifuged at 1500xg for 15 minutes
to remove major debris, and then at 10,000xg for 1 hour to remove
nuclei.
The column was equilibrated in Lysis Buffer before the spleen lysate
was pumped through at 20ml/hr. The column was washed through with
clean Lysis Buffer and then the sheep MHC class II molecules were
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released from the column with TEA/DOC/NaCl pH11.5 and collected in
aliquots. The aliquots were returned to neutral pH with 1M HC1.
Samples from each aliquot were coated onto an ELISA plate and tested
for the presence of MHC class II by reaction with SW73.2 antibody in
a simple ELISA assay. Positive fractions were pooled and used in
the subsequent slot blot assay.
3.2.2 MHC CLASS II INDUCTION SLOT BLOT ASSAY.
Initial experiments using the slot blot apparatus were performed to
determine the optimum detergent concentration required for a clean
blot and good detection. Dilutions of lymphocytes were lysed in
four different detergent solutions: 0.1% sodium dodecyl sulphate
(SDS), 0.25% SDS, 0.25% sodium deoxycholate (DOC), and 0.5% DOC, all
prepared in 25mM Trizma pH8.0, 500mM NaCl. These experiments
revealed that 0.25% DOC gave the sharpest and most defined titration
bands of the four.
A sheep intestinal adenocarcinoma cell line ST6 (Norval et al, 1981)
was grown in RPMI + 5% FCS + sodium pyruvate (lOOmM) + L-glutamate
(lOOmM). Cells were harvested and plated out in 96-well tissue
culture plates (Nunc, Copenhagen, Denmark) at 1 x 104 per well in
400pl of the above medium. They were grown for 24 hours at 37°C in
5% COa before lOOpl of conditioned medium (see 2.2.3 for production)
was added to the wells. Cells were incubated for a further 24 hours
at 37°C in 5% CO2 before they were dislodged from the wells with the
tip of a pipette and the cells and supernatant harvested. 200pl of
0.02% disodium EDTA was added and any remaining cells collected.
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Cells were centrifuged at 400xg for 5 minutes and then resuspended
in the remaining culture fluid before lysing them in 400pl of 0.25%
sodium deoxycholate in 25mM Tris pH7.5 with 500mM NaCl.
The lysate was applied through a BIORAD SLOT BLOT onto Hybond C
(Amersham, Bucks) nitrocellulose, which had been eguilibrated in
25mM Tris pH7.5 with 500mM NaCl (TBS). lOOpl of TBS was applied to
each slot and drawn through by vacuum before 200pl of each lysate
was applied to each well and drawn through by vacuum. The samples
were washed through with 200pl of TBS. 200pl of a 1 in 10 dilution
of the purified ovine class II protein (from section 3.2.1) and
doubling dilutions beyond this was was applied to the membrane.
The membrane was removed and blocked with 5% dried milk powder in
PBS. It was then incubated in 1/10 dilution of tissue culture
supernatant of SW73.2 monoclonal antibody overnight before being
washed five times in 1% dried milk powder in PBS over 30 minutes.
The membrane was then incubated in goat anti-rat IgG horseradish
peroxidase (SAPU, Carluke) at 1/1000 in 1% dried milk powder/PBS for
1 hour. It was washed again prior to development in
diaminobenzidine-HaCh, including 1:20 v/v of C0CI3 (Hopkins et al,
1986).
3.2.3 MHC CLASS II ELISA ASSAY ON FIXED OVINE CELLS.
Sheep adenocarcinoma cells (ST-6) were grown and treated with
conditioned medium as in 3.2.2. Instead of dislodging the cells
from the wells they were fixed to the plate with 20% acetone in
methanol for 5 minutes. The cells were then rehydrated in PBS and
the plate blocked with 2% BSA in PBS for 1 hour. Cells were assayed
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against two monoclonal antibodies, VPM16 (anti-class II) and VPM19
(anti-class I) which were available in the Department of Veterinary
Pathology, University of Edinburgh. Each well was incubated with
lOOpl of undiluted monoclonal antibody tissue culture supernatant
for 1 hour. The wells were washed with PBS 5 times over 10 minutes.
Each well was incubated with lOOpl of a 1/1000 anti-mouse Ig
horseradish peroxidase (SAPU, Carluke) for 1 hour, and then washed
again in PBS. The wells were incubated with o-phenylenediamine
(lmg/ml)(Sigma) in 0.1M citrate-phosphate buffer containing 0.006%
H2O2 for 20 minutes before the reaction was terminated by the
addition of 50pl of 2M H2SO4. The optical density at 492nm was
measured in a Titertek Multiskan plate reader.
3.2.4 MHC CLASS II FACS ASSAY ON OVINE LYMPHOCYTES.
Lymphocytes were collected from an ovine prefemoral efferent
lymphatic duct which was chronically cannulated with an indwelling
nylon tubing. Cells were counted and 2 x 107 lymphocytes were
washed twice in ice-cold PBS/ 1% foetal calf serum. They were
cultured in two 1" plastic dishes in 2 ml of RPMI 1640 + 15% foetal
calf serum + L-glutamine (lOOmM) + sodium pyruvate (lOOmM), at 5 x
10s cells/ml in 5% CO2 at 37°C. To one dish was added lOng (25IU)
of bovine recombinant interferon-gamma (Ciba-Geigy, Switzerland);
the other dish was not treated. After 3 days the cells were
harvested, washed twice in ice-cold buffer [PBS/1% BSA/0.1% NaN3]
before 50pl aliguots were dispensed into Rh tubes at 2 x 10&/ml. To
each tube two monoclonal antibodies were added. Firstly 25pl of
VPM36 (an anti-ovine MHC class II DQa specific IgGl MoAb) or VPM38
(an anti-ovine MHC class II DRa specific IgGl MoAb) (Dutia et al,
1990b) to stain different class II populations was added, followed
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by 25p.l of a biotinylated lymphocyte marker. The lymphocyte markers
used were either SBU-T4 (a-CD4), SBU-T8 (a-CD8) (Maddox et al,
1985), VPM30 (a-B-cell) (Naessens & Howard, 1991) and CC15 (a-T19)
(Clevers et al, 1990). These four monoclonal antibodies mark out
cells bearing molecules corresponding to the CD4 and CD8, together
with a B cell marker and a marker of CD4~, CD8~ T cells (largely
made up of T cells bearing the gamma/delta T cell receptor).
Cells were incubated with tissue culture supernatants of the
monoclonal antibodies for one hour at 22°C. Cells were washed twice
in buffer. Resuspended cells were mixed with 25pl anti-mouse IgGl
fluoroscein isothiocyanate and 25pl of streptavidin-phycoerythrin
(Amersham) and incubated for one hour at 22°C. Cells were washed
once in buffer and analysed using a FACScan (Becton Dickinson) with
a 488nm argon ion laser. Dead cells were eliminated from analysis
by setting a forward scatter threshold. Cells were initially
assessed using linear parameters for forward and side scatter. Live
gates were set to limit analysis to small lymphocytes and ten
thousand cells were analysed per sample. Subseguent analysis used
the Becton Dickinson LYSIS programme.
This experiment was repeated with the addition of a 1 in 1000
dilution of rabbit anti-bovine rIFN-g (R167) to the culture medium
at the beginning of the incubation.
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3.2.5 MHC CLASS II FACS ASSAY ON OTHER OVINE CELL LINES.
The ST-6 cell line used previously (3.2.3), and an ovine skin
fibroblast cell line (321), were cultured in T75 flasks in 20ml of
RPMI 1640 + 5% foetal calf serum + sodium pyruvate (lOOmM) + L-
glutamine (lOOmM). When the cells were confluent 5ml of conditioned
media was added to the flask and culture continued for 24 or 72
hours. The cells were harvested by trypsinization and washed twice
in buffer before being dispensed at 2 x 106/ml into Rh tubes, (50pl)
and then stained using 50pl of VPMs 16 (anti-DQ-like and DR-like p
chain), 19 (anti-class I), 41 (anti-DQ-like p chain), 37 (anti-DR-
like p chain) or 5 (anti-IgM) (Appendix 3). Each antibody was added
to different tube. Cells were analysed on the FACScan as before
with the exception that side scatter amplification was logarithmic
due to the complexity of the cells.
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3.3 RESULTS.
3.3.1 MHC CLASS II INDUCTION SLOT BLOT ASSAY.
When the ST-6 cells were used the results generated were unreliable.
On some occasions every slot on the membrane was strongly positive.
Occasionally the results seemed to yield the expected titration
series of the class II control and the class II induction profiles
corresponding with the known dilution series of the conditioned
media (Figures 21 and 22). However, on many occasions the detergent
alone gave a positive dark slot on the membrane. The occasions when
this occurred were not predictable and modifications to the
procedure did not eliminate this feature. Without reliable controls
it was felt that the technigue could not be used confidently for
studies on the action of IFN-g on MHC class II.
3,3.2 MHC CLASS II ELISA ASSAY ON OVINE CELLS.
The method of cell ELISA described in section 3.2.4 used murine
MoAbs to sheep class II. At no time did the use of the murine MoAbs
produce meaningful results.
Rat MoAbs had been used successfully for a short period at the
Moredun Research Institute (G. Entrican, personal communication).
Loss of the rat anti-class I monoclonal cell line had forced him to
change to the use of the same mouse MoAbs. He also found that the
assay became of no value.
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3.3.3 MHC CLASS II FACS ASSAY ON OVINE LYMPHOCYTES.
The use of efferent lymphocytes for the study of MHC class II
induction gave much better results than either of the previous
techniques. This technique allowed the differential increase in MHC
class II DR-like (VPM38-reactive) and DQ-like (VPM36-reactive)
molecules to be assessed. Collection of 10,000 events on the FACS
gave sufficient numbers of CD4+ and CD8+ cells for analysis, but the
numbers of T19+ and VPM30+ cells were small as efferent lymph fluid
typically contains only 5% of each cell type. This meant that
approximately 500 events were collected for each cell type, a figure
which allows only limited interpretation. Results from one
experiment are presented in Tables 1, 2, and 3, and Figures 23, 24,
25, and 26. Similar results were obtained in two further
experiments using efferent lymphocytes from the same sheep.
The results confirm that each subset of unstimulated small efferent
lymphocytes expresses DR-like molecules. The expression of DR-like
molecules is altered by incubation with rIFN-g but expression of DQ-
like molecules is little changed. Only 15-20% of CD4+ and CD8+ T
lymphocytes express DR-like molecules before incubation and there is
a very variable degree of expression (Table 1 and Figure 23A and
24A). Incubation with rIFN-g increases the number of cells
expressing class II DR-like molecules by a factor of two for CD4+
lymphocytes and by a factor of three for CD8+ lymphocytes.
Examination of the FACS plots for both lymphocyte subsets shows the
degree of expression of class II is still highly variable and that
flow cytometry cannot discriminate separate populations of class II
positive cells even after incubation. B lymphocytes are relatively
homogeneous in their expression of class II, with a discrete
population of high expressing cells (Figure 26A). Three-quarters of
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B lymphocytes express DR-like molecules prior to incubation with
rIFN-g and this is increased to 86% after incubation (Table 1). The
discrete population of high expressing cells is maintained. T19+
cells express more DR-like class II (37%) than other T cells (15-
20%) but still possess variable degrees of expression. Incubation
with rIFN-g increases the number of class II positive cells and DR-
like molecules to higher degrees on most T19+ cells (Tables 1, 2, 3,
and Figure 25).
Only 4-6% of CD4"* and CD8+ lymphocytes express DQ-like class II
molecules both before and after incubation with rIFN-g (Table 1 and
Figures 23B and 24B). Two thirds of B cells expressed DQ-like
molecules both before and after incubation with rIFN-g. Only small
increases in number of cells expressing and degree of expression
were noted after incubation with rIFN-g (Table 1, 2, 3, and Figure
26B).
Inclusion of IFN-g neutralizing antibody in the culture medium
totally abrogated the upregulation of class II on lymphocytes.
3.3.4 MHC CLASS II FACS ASSAY ON OTHER OVINE CELL LINES.
The ovine cell lines were initially negative for class II. After
culture with conditioned medium there was no change in the FACS
profile for MHC class II expression on these cells (data not shown).
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3.4 DISCUSSION.
3.4,1 THE RELATIONSHIP BETWEEN MHC CLASS II AND INTERFERON-GAMMA.
Regulation of expression of MHC class I and class II plays a
critical role in the initiation and development of an immune
response. MHC class I molecules are found on most cells in the body
and are involved in target recognition by CD8+ (frequently cytotoxic
and sometimes suppresssor) T cells. MHC class II antigens are
mainly expressed on B cells, thymic epithelium, activated T cells,
macrophages and Langerhans cells, and are involved in the
restriction of CD4+ (usually helper) T cells (Kappes & Strominger,
1988). Class II antigens have also been found on some fibroblasts,
tumour cells, epithelial cells and endothelial cells, amongst
others. Quantitative variation of class I and II antigens at the
cell surface plays a central role in immuno-regulation (Janeway et
al, 1984; Kaufman et al, 1984).
The initial steps in an immune response are the uptake of antigen by
accessory cells and its presentation to T cells. The main cells
involved in this are macrophages due to their phagocytic capacity
and their ability to present antigen to other cells of the immune
system. Langerhans cells within the skin and dendritic cells within
lymphoid tissue have similar antigen presentating roles. The
accessory cells present processed antigen to helper T lymphocytes in
association with class II molecules. Efficient presentation depends
upon the expression of class II molecules. MHC class II is commonly
inducible by IFN-g and only rarely by IFN-a or -p (reviewed by
Cresswell, 1987; Pestka et al, 1987; Kappes & Strominger, 1988;
Stzein et al, 1984), while class I molecules are upregulated by all
three of the interferon species (Pestka et al, 1987).
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IFN-g seems to play a major part in the regulation of the immune
response by virtue of its effect on antigen presentation by
macrophages (Unanue, 1984). Murine macrophages do not express class
II constitutively or do so at low levels. Factors which may
stimulate class II expression on macrophages would be important in
initiating the immune response. Macrophages and melanoma cells were
initially shown to express class II in response to IFN-g (King &
Jones, 1983; Basham & Merigan, 1983). Many other cell types express
no MHC class II molecules under normal circumstances, but may be
induced to express them under the influence of IFN-g. IFN-g has
been shown to induce the de novo synthesis of class II antigens in
many cells including human endothelial cells and dermal fibroblasts
(Collins et al, 1984), keratinocytes (Griffiths et al, 1989),
thyroid epithelial cells (Todd et al, 1985), and human osteogenic
carcinoma, colorectal cancer, and melanoma cells (Shaw et al, 1985).
Upregulation or induction of expression of MHC class II antigens by
IFN-g can be inhibited by IFN-a and -p on mouse macrophages (Inaba
et al, 1986; Ling et al, 1985), and on mouse fibroblasts and glial
cells (Morris & Tomkins, 1989), or enhanced by other cytokines such
as tumour necrosis factor a (TNF-a) (Pujol-Borrell et al, 1987).
The magnitude of a T helper-cell immune response is a function of
the product of antigen concentration and the number of class II
molecules expressed on antigen presenting cells (APCs) (Matis et al,
1983). As the concentration of antigen is outwith the control of
the immune system, the primary regulation of response lies with the
variation in class II molecules on APCs. IFN-g is the main
upregulator of class II cell surface concentration, and hence of
importance in the immune response.
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The section of work described in this chapter has attempted to
utilize the ability of IFN-g to increase the number of MHC class II
molecules on cell surfaces. Initially this was with the object of
assaying IFN-g in tissue fluids during immune responses. The
standard method for assaying interferons has been by a viral plague
reduction assay. This method depends upon plague formation by a
standard dose of specific virus on specific susceptible cells, and
its interference by dilutions of interferons. This method does not
discriminate between the three types of interferon, unless specific
anti-interferon sera are included in the assay to confirm the
effects are due to those interferons. It has been shown that the
IFN-a/Ps are more active in the antiviral assay than IFN-g on an
activity per molecule basis (Blalock et al, 1980). The activity of
fewer molecules of either of the class I interferons may therefore
mask the presence of the IFN-g molecules unless suitable anti-
interferon sera are available to increase the specificity of the
assay. Conseguently alternative bioassays and ELISAs have been
described to measure human and mouse IFN-g.
Measurement of IFN-g by changes in MHC class II expression has
previously been described. Cells used varied from a mouse IL-2-
dependent T cell line, a human B lymphoblastoid line, a human
chronic erythroid leukaemia cell line (Nouri-Aria et al, 1988),
murine macrophage cell line (Le Moal et al, 1989), and mouse
intestinal epithelial cells (Whiting & Bland, 1990). Induction of
class II is thought to be an IFN-g-specific property using these
cell lines and it only detects biologically active IFN-g molecules.
Measurement of class II was by radioimmunoassay or by enzyme-linked
immunostaining which was assessed by colour change. All bioassays
suffer in that they are time-consuming, results generally taking
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one-to-two days. Other, as yet undescribed, cytokines may also be
active in the assays. As an ELISA assay was not available for ovine
IFN-g a class II induction assay was developed.
The poor results obtained using both ELISA and slot blot technology
are not uncommon during the development of class II assays.
Background readings seem to have been the major problem with the
ELISA assay described here. Lysis solution present in the slot
without cellular proteins was sufficient to cause a strong positive
signal on many occasions. The basis for this non-specific result is
unknown, but could involve non-specific binding of the monoclonal
antibody, the conjugate or the developing substrate.
/
The difficulty in obtaining consistent results supports the idea
that the guantitation of MHC class II molecules on cell surfaces is
difficult using standard technigues (Whiting & Bland, 1990). These
authors went to great lengths to eliminate background readings from
their assays which were due to nonspecific binding of radiolabelled
conjugate to the cells, and eventually solved their background
problems by using an inhibition radioimmunoassay incorporating
Sephacryl beads as the solid phase.
The cell ELISA using ST-6 cells did not give any meaningful results
using murine monoclonal antibodies. This problem was also found at
Moredun Research Institute when they attempted to use the same
murine antibodies, but rat MoAbs did initially yield results (G.
Entrican, personal communication). It is possible that the fixation
technigue using 20% acetone in methanol altered the epitopes
recognised by the murine MoAbs, but not those recognised by the rat
MoAbs. A variety of different murine anti-class II MoAbs were tried
in the cell ELISA procedure with no success.
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Although the ELISA, cell ELISA and slot blot techniques were not
useful, the later results show that the differential upregulation of
MHC class II subsets by IFN-g on ovine mononuclear cells may be
monitored by the use of FACS analysis. The use of bovine rIFN-g on
bovine mononuclear cells has already been reported, but only the
initial optimization of the IFN-g stimulation of cells was performed
(Walrand et al, 1989). The results presented here elucidate the
situation in ovine lymphocytes a little further.
FACScan analysis of cell membrane expressed class II gives a good
indication of alterations in cellular expression of the molecules.
The class II expression profile is found to cover a range of levels
from none through to medium levels of expression. Incubation of
ovine lymphocytes with rIFN-g causes a generalized increase in the
level of MHC class II expression, but does not induce discrete
populations of cells with different degrees of class II expression.
The effects of IFN-g on discrete populations of cells cannot
therefore be assessed using this technique.
Both ST-6 cells and ovine skin fibroblast cells (321) presented a
problem in the FACScan analysis because of their tendency to clump
during processing. A limited number of experiments were performed
using these cells. Neither cell type expressed MHC class II either
before or after treatment with Con A-conditioned medium. These
results are in agreement with those of Nash et al (1992) who
performed similar experiments on primary ovine fibroblasts. Wong et
al (1984) found that IFN-g did not influence class II expression on
murine fibroblast lines.
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Lymphocytes cannot be used to measure IFN-g concentrations by class
II induction assays because the lymphocytes themselves may be
induced to produce lymphokines which affect class II expression.
Polyclonal T cell activators such as plant lectins and anti-CD3
monoclonal antibodies release lymphokines from T cells including
IFN-g, IL-4, IL-10 and IL-6 (IFN-(32). These are all known to
increase class II expression on some cells. IFN-g can act on
natural killer cells to upregulate its own synthesis (Hardy &
Sawada, 1989). Class II expression on T cells is also subject to
antagonistic influences, such as IL-4, and synergistic influences
such as TNF-a. These could influence class II expression and would
render the assay meaningless as a measure of IFN-g. However the
effect of rIFN-g on lymphocyte class II expression can be assessed
using the FACScan technigue. Blockage of the effect on expression
by IFN-g neutralizing antibodies confirms the role of this cytokine
on class II regulation.
3.4.2 EFFECTS OF rlFN-g ON OVINE LYMPHOCYTE CLASS II EXPRESSION.
The effects of recombinant bovine or ovine IFN-g on ovine T cells
have not previously been studied, nor have the subsets of MHC class
II which are upregulated, or the mononuclear cell subsets which
express class II been examined. It was of interest to determine the
effect of rIFN-g on MHC class II molecules and its effect on the
different subgroups of these molecules. It would then be possible
to assess the contribution of IFN-g on the regulation of ovine class
II which is found on small resting T lymphocytes in contrast to
class II expression on human T lymphocytes.
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Resting sheep T cells express MHC class II molecules to a greater
extent than human T cells (Dutia et al, 1990b). Secondary
challenge of antigen-primed sheep results in efferent lymph
containing twice as many DR+, and four times as many DQ* small T
lymphocytes. Each cell expressed a profound increase in class II
expression, increasing from 2xl04 molecules per cell found on
resting T cells to four times this number on the T cells draining an
active lymph node (Hopkins et al, in preparation). The factor(s)
responsible for this increase in expression have not been
identified.
Lentiferon, produced during the interaction of lentivirus-infected
macrophages and lymphocytes (section 1.6), increases MHC class II
expression (measured using a pan-specific monoclonal antibody) on
cultured sheep macrophages (Kennedy et al, 1985). Lentiferon has
not been purified or cloned, and the effects descibed could be due
to the presence of a mixture of cytokines in the supernatant. If it
truly exists it may however be involved in the regulation of class
II on T lymphocytes.
The induction of MHC class II DR-like molecules by rIFN-g described
here demonstrates that sheep T cells express IFN-g receptors and
that IFN-g can influence class II expression. The DR-like increase
may be influenced by IFN-g induced secretion of a second factor from
other cells in the lymph, but only IFN-g, IL-4 and IL-10 are known
to induce MHC class II molecules in other animal systems. From work
involving murine T cell clones, it has been demonstrated that IFN-g
is antagonistic towards the proliferation of cells responsible for
the synthesis and release of both IL-4 and IL-10 (Mosmann & Moore,
1991). Conseguently it is unlikely that either of these two
cytokines have a significant role in the expression of class II on T
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cells. Although DR-like molecules were upregulated by IFN-g, the
results show there was little effect on DQ-like molecule expression
and this suggests that the regulation of DQ-like molecules differs
from that of DR-like molecules in sheep T lymphocytes as in other
species and cell types. The results are in contrast to those found
after incubation of ovine alveolar macrophages with bovine rIFN-g.
Ovine DR-like, DQ-like and DP-like molecules were all significantly
upregulated by rIFN-g which suggests that in this cell type all
three class II subsets are subject to the same major regulatory
factors (Nash et al, 1992).
MHC class II molecules are found in low numbers on resting human T
cells (Engelman et al, 1980) and are upregulated during activation
following antigenic or mitogenic stimulation. Some exchange of
class II molecules occurs between responder and stimulator cells
during a mixed lymphocyte reaction (Yu et al, 1980), but la
molecules are known to be actively synthesized by T cells. IFN-g
augments the expression of HLA-DR on pokeweed mitogen-stimulated
human T cells (Miyawaki et al, 1984).
3.4.3 EFFECTS OF IFN-g ON HUMAN T LYMPHOCYTES.
The effect of IFN-g on human T lymphocytes has been assessed
previously with respect to various parameters (Landolfo et al,
1988). They found that human T cells possess specific receptors for
IFN-g comparable to B cells in affinity and number of binding sites.
IFN-g does not induce an antiviral state in human T cells, nor
induce (2'-5')oligoadenylate synthetase. (2'-5')oligoadenylate
synthetase is responsible for the activation of an endoribonuclease
which cleaves both viral and cellular RNA (Dougherty et al, 1980),
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and hence is important in the regulation of viral and cellular
macromolecular synthesis. IFN-g does, however, induce MHC class I
and enhances T cell proliferation to mitogens. I FN-a and -(3 both
induce an antiviral state and the synthesis of (2'-5')oligoadenylate
synthetase in human T cells. The authors deduced that the
transduction signal of IFN-g from the receptor into the
intracellular compartment proceeds along metabolic pathways
different from those of IFN-a/p. IFN-g has been demonstrated to
cause enhanced production of IL-2 by T cells (Frasca et al, 1985)
and increased expression of IL-2 receptor (Webb & Goeddel, 1987).
IFN-g is also an essential factor for the proliferation and
differentiation of cytotoxic lymphocytes (Landolfo et al, 1985).
3.4.3 THE ROLE OF MHC CLASS II ON T CELLS.
The role of MHC class II on T lymphocytes is unclear. Activated
ovine T cells can stimulate allogeneic T cells in the mixed
lymphocyte reaction (MLR), but resting T cells do not possess this
ability. This is probably due to the low numbers of class II
molecules on these cells (Hopkins et al, in preparation). The
magnitude of T cell proliferation is related to the number of class
II molecules presented on cell surfaces, along with the antigen
concentration (Matis et al, 1983). Proliferation of allogeneic T
cells induced by activated sheep T cells can be blocked by pre¬
incubation with an anti-class II monoclonal antibody in a dose-
dependent manner. (Hopkins et al, in press). T cells may stimulate
allogeneic T cells in MLR, but antigen presentation to autologous T
cells has only been demonstrated in a few instances in vitro.
Antigenic peptides associated with class II in isolated lipid
membranes are sufficient to stimulate murine T cell hybridomas, but
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normal resting T cells are unaffected (Watts et al, 1984; Beverley
et al, 1986). Viral peptides were presented to T cell clones in a
class II-restricted manner, but whole inactivated virus could not be
presented, indicating that T cell clones lack the ability to
endocytose or process antigen efficiently (Hewitt & Feldman, 1989).
Similar results were obtained with presentation of autoantigen
peptide and whole protein by T cell clones (LaSalle et al, 1991). T
cells have been demonstrated to present denatured protein in some
reports (Treibel et al, 1986), but the purity of the T cell
populations was not fully assessed in others reporting the same
(Gerrard et al, 1985). Native antigen targeted to T cell surface
molecules, such as HIV gpl20 or a mouse monoclonal antibody to the
transferrin receptor, can be processed and presented in a class II-
restricted manner (Lanzavecchia et al, 1988a,b). This implies that
T cells are capable of normal processing and presentation of
antigens but are limited by their ability to capture antigen.
The differential expression of class II on resting lymphocytes is
indicative of a difference in function between the DR-like and DQ-
like molecules, and the effect of IFN-g on the expression of these
molecules further enhances this hypothesis. If DQ-like molecules
are merely acting as antigen presenting molecules for stimulator
cells it would be expected that both DR and DQ would be regulated
similarly. DQ-restricted precursor CD4+ T cells are relatively
freguent in humans, but the proliferative response they induce in
autologous or allogeneic MLR is small compared with that against DR
molecules (Fujisawa et al, 1991). HLA-DR, -DQ, and -DP molecules
are differentially expressed on human T cells after activation
(Oshima & Eckels, 1990).
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A greater expression of class II molecules on T cells is likely to
lead to increased interaction between T cells in which enhancement
or suppression of function may be forthcoming. DQ molecules are
proposed to be the products of dominant immune suppression (Is)
genes and are responsible for stimulating "suppressor-inducer" cells
(Altmann et al, 1991). The Is genes would then determine whether,
and to what extent, an immune system can produce active suppression
to a specific antigen. CD4+, DQ-restricted "suppressor-inducer"
cells would be involved in activating an MHC class I-resticted, CD8+
suppressor cell which would in turn act on CD4+, DR-restricted
helper T cell.
3.4.4 EFFECTS OF rlFN-g ON MHC CLASS II ON B LYMPHOCYTES.
Class II expression on ovine B cells was at a high level before
culture with IFN-g. The expression was increased slightly both in
cell numbers expressing class II, and the level of expression by
cells. These findings are contrary to those found with human and
murine B cells. Class II molecules on human and murine B cells are
under a different control mechanism to other cells. They are
upregulated by interleukin 4 (IL-4) (Roehm et al, 1984; Noelle et
al, 1984; Rousset et al, 1988) and interleukin 10 (IL-10) (Go et al,
1990), but down-regulated by IFN-g (Mond et al, 1986). It can be
postulated that during an immune response B cells bind specific
antigen via surface immunoglobulin, and subseguently endocytose it.
The antigen may then be processed and presented on the cell surface
in association with MHC class II. T cells with the appropriate TCR
will be induced to secrete cytokines. If the T cell secretes IL-4
or IL-10 it will upregulate the expression of class II and increase
the antigen presenting capabilities of the B cell. If however the T
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cell secretes IFN-g, it will downregulate class II and hence
decrease the antigen presenting ability of the B cell. These
cytokines may thus stimulate B cell proliferation or suppression.
More work is reguired to further determine whether IFN-g upregulates
class II on ovine B cells, or whether this is an aberant result.
3.4.5 MECHANISMS OF REGULATION OF MHC CLASS II.
Class II genes are a family of related genes encoding proteins of
similar function. They are commonly regulated in a coordinate
manner with respect to tissue distribution and induction. Typically
B cells express all class II genes, and macrophages increase the
expression of all class II molecules when stimulated by IFN-g.
Cells from patients with Bare Lymphocyte Syndrome typically have
loss of expression of all class II genes, which suggests that a
defective trans-acting factor is reguired for the expression of all
the class II genes (Glimcher & Kara, 1992). However examples of
non-coordinate regulation do occur. There are a range of responses
to IFN-g even within the clones of a single tumour. Only one of
twenty-one clones from a human metastatic melanoma expressed high
levels of HLA-DQ after treatment with human recombinant IFN-g,
whilst all the clones expressed high levels of -DR and -DP antigens
(Anichini et al, 1988). Human dermal fibroblasts are differentially
affected by IFN-g. Both HLA-DR and -DP-restricted T cell clones
were induced to proliferate by IFN-g treated dermal fibroblasts,
while -DQ-restricted clones failed to proliferate. Although the
expression of DQ was low on these fibroblasts the stimulation of the
T cells did not correlate with the quantity of -DR or -DP antigens
present (Maurer et al, 1987). HLA-DQ expression is commonly not
found on haematopoietic precursor cells that express HLA-DR and -DP
molecules (Radka et al, 1986), even though -DQ is expressed with -DR
and -DP molecules on mature B cells (Gonwa et al, 1983). A B
lymphoblastoid line has been identified which expresses HLA-DQ, but
not HLA-DR or HLA-DP (Ono et al, 1991). This clone can be induced
to express the other class II genes by cellular fusion with a murine
B lymphoma, indicating the defect lies with a trans-acting factor.
The up-regulation of class II DR molecules by IFN-g has been shown
to be due to increased transcription (Rosa & Fellous, 1988; Fertsch-
Ruggio et al, 1988). Evidence for post-transcriptional control was
surmised from data that some cell lines produce mRNA for class II,
but no class II antigen is found on the cell surface, and that
increases in class II mRNA are twenty-fold the increases in
transcription as assayed by nuclear run off (Rosa & Fellous, 1988).
Others argue that this effect is due to the long half-life of class
II mRNA, but the rapid decline in transcription on removal of IFN-g
(Kern et al, 1989).
The marked induction of DR-like molecules and the small effect on
DQ-like molecules suggests that the two classes of molecule are
under different transcriptional control. The gene promoter
seguences of ovine class II genes are unknown, but the human and
mouse class II genes have been examined extensively. The 5'
upstream flanking regions of most of the functional class II genes
contain several cis-acting elements (Figure 20). Two highly
conserved enhancer regions upstream of the transcription initiation
site are thought to be the major control elements in the class II
promoter region. These regions are known as the X and Y boxes
(Mathis et al, 1983) and are found between -61 and -108. The Y box
is a lObp motif found approximately 40 to 90 base pairs upstream of
the transcription start site, and contains an inverted CCAAT
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sequence which is known to be a general transcriptional activator.
The X box is located a conserved distance (19 to 20 bases pairs)
upstream of the Y box. The X box is composed of 14 base pairs. At
the 3' end of the X box and overlapping the 5' interspace region is
a seven to eight base pair stretch, known as the X2 box. Deletion
of the X and Y boxes abolishes promoter and enhancer activity in
cells and in in vitro transcription systems. The binding of nuclear
protein to the Y box of the HLA-DQA gene is markedly reduced
compared its binding to other class II gene promoters (Nishimura et
al, 1990). A further region, the S box motif, 15 to 17 base pairs
upstream from the X box, has an important role. An IFN-g consensus
sequence (ATAAGTCAG) at -264 to -256 is found in the 5' regions of
MHC class I, class II and p2-microglobulin (Basta et al, 1987).
Enhancer regions are found in the first intron of the HLA-DRA gene
which are similar to essential enhancers found in SV40 and polyoma
viral enhancers (Sullivan et al, 1987). A "TATA" box is found
upstream of the cap site at -30, and is important in accurately
initiating transcription (Breathnach & Chambon, 1981). A further
control element has been described, the immunoglobulin octamer
ATTTGCAT, (at -45 to -52) which was originally found in the
promoters of immunoglobulin light and heavy genes, and is known to
enhance reporter genes (Parslow et al, 1984). This is found only in
HLA-DRA.
A model has been proposed which explains the inducible nature of
class II genes in different tissues (Sullivan et al, 1987). Cells
with high levels of constitutive class II expression, such as B
cells, have active tissue-specific enhancers, active promoters and
an absence of repressor factors. In human T cells, which do not
have constitutive expression of class II but may be induced to
express class II, the promoter region is blocked by repressors but
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the enhancer region is functional. The repressors can be bypassed
by cell activation, or by viral trans-activators. In tissues with
no constitutive expresson of class II, such as antigen presenting
cells, the enhancer and promoter regions are inactive but the
repressors acting on the promoter can be modified by IFN-g-induced
factors, allowing transcription to proceed. In non-inducible cells
the promoters and enhancers are non-functional and IFN-g-induced
factors cannot remove the repression.
3.4,6 FUTURE WORK.
It may be postulated that ovine class II expression on lymphocytes
is acting under a complicated network of enhancers, promoters and
trans-acting factors. T lymphocyte expression of class II may be
subject to gene-specific factors which upregulate the DR-like gene
or downregulate the DQ-like gene. Conseguently differential
expression of these two gene products is seen upon IFN-g
stimulation. The gene control boxes of sheep class II genes have
not been seguenced, but future work in the department is intended to
pursue this. The effects of IFN-g on this region, either itself or
by a second intracellular messenger, would be a useful aspect of
this work to follow. There may be an interaction of visna virus
with the class II genes if the class II molecules are the cellular
receptors for the virus. The mechanism of upregulation of class II
expression by lentiferon would be a interesting subject for
examination. This does depend upon the existence of lentiferon to
be confirmed by gene cloning first.
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Figure 19. The genetic organization of the human MHC.
Figure 20.
Promoter region of HLA-DR gene 5' to exon 1. The X, Y and Z boxes
are marked along with the "TATA" box (T) and the immunoglobulin
octomer (0). The numbers refer to the number of nucleotide base
pairs upstream of the exon.
Figure 20.
Figure 21.
Induction of MHC class II molecules on ovine ST-6 cells after 24
hours stimulation with lymphocyte conditioned media.
1 Negative control medium
2 Mesenteric lymph node conditioned medium (IL-2 and
concanavalin A for 24 hours)
3 Spleen conditioned medium (concanavalin A for 48
hours)
4 Medium cultured with resting spleen cells for 48
hours and then concanavalin A added after harvest
5 Immunopurified ovine class II protein in doubling
dilution
Figure 22.
Induction of MHC class II molecules on ovine ST-6 cells after 24
hours stimulation with lymphocyte conditioned media.
1 ST-6 cells stimulated with medium alone
2 Immunopurified ovine class II protein in doubling
dilution
3 Medium cultured with resting mesenteric lymph node
cells for 48 hours and then IL-2 and conanavalin A
added
4 Mesenteric lymph node conditioned medium (48 hours
with IL-2 and concanavalin A)
5 Upper two- spleen conditioned medium
Lower two- as above after blocking by R144 sera
6 Upper two- as above after blocking by R145 sera




A. FACS profile CD4+ cells stained for MHC class II DR after
incubation for 72 hours with or without bovine IFN-g.
AH07791004 - incubation in absence of bovine IFN-g
AH07791014 - incubation in presence of bovine IFN-g
AH07791002 - cells stained with irrelevant monoclonal antibody
B. FACS profile CD4+ cells stained for MHC class II DQ after
incubation for 72 hours with or without bovine IFN-g.
AH07791003 - incubation in absence of bovine IFN-g
AH07791013 - incubation in presence of bovine IFN-g







A. FACS profile CD8+ cells stained for MHC class II DR after
incubation for 72 hours with or without bovine IFN-g.
AH07791006 - incubation in absence of bovine IFN-g
AH07791016 - incubation in presence of bovine IFN-g
AH07791002 - cells stained with irrelevant monoclonal antibody
B. FACS profile CD8+ cells stained for MHC class II DQ after
incubation for 72 hours with or without bovine IFN-g.
AH07791005 - incubation in absence of bovine IFN-g
AH07791015 - incubation in presence of bovine IFN-g







FACS profile T19 + cells stained for MHC class II DR after incubation
for 72 hours with or without bovine IFN-g.
AH07791008 - incubation in absence of bovine IFN-g
AH07791018 - incubation in presence of bovine IFN-g





FACS profile VPM30+ cells stained for MHC class II DR after
incubation for 72 hours with or wihtout bovine IFN-g.
AH07791010 - incubation in absence of bovine IFN-g
AH07791020 - incubation in presence of bovine IFN-g
AH07791002 - cells stained with irrelevant monoclonal antibody
B. FACS profile VPM30+ cells stained for MHC class II DQ after
incubation for 72 hours with or without bovine IFN-g.
AH07791009 - incubation in absence of bovine IFN-g
AH07791019 - incubation in presence of bovine IFN-g






Table 1. Figures from one experiment showing the percentage of each
lymphocyte subset positive by FACS for MHC class II DR or DQ
molecules before and after incubation with bovine rIFN-g.
Table 2. Figures from the same experiment showing the modal channel
number of each lymphocyte subset by FACS for MHC class II DR or DQ
molecules before and after incubation with bovine rIFN-g.
Table 3. Figures from the same experiment showing the mean channel
number of each lymphocyte subset by FACS for MHC class II DR or DQ










CD8' 16.8 49.8 6.3 7.4
VPM30' j 76.0 86.5 59.1 66.1












CD8+ 10.85 34.46 4.73 7.29
VPM30+ ; 270.01 279.94 168.83 181.48
T19+ 28.76 105.57 ND ND
CONTROL MODAL VALUE = 5.46
Table 3.








CD8+ 23.69 58.67 37.11 14.01
VPM30" 192.57 255.23 | 120.16 147.84
T19 + 78.53 127.10 ND ND
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4 MOLECULAR BIOLOGICAL STUDIES ON OVINE INTERFERON-GAMMA.
4.1 INTRODUCTION.
Early attempts to study the biology of IFN-g were significantly
hampered by the lack of a source of pure IFN-g uncontaminated by
other cytokines. This was a problem common to most cytokine studies
in the early 1980s. Only with production of recombinant IFN-g could
the biology of this cytokine be more accurately defined. A number
of strategies have been used to clone the IFN-g gene, and in some
species the IFN-g gene has been isolated using human IFN-g cDNA as a
probe.
4.1.1 CLONING OF HUMAN INTERFERON-GAMMA.
The first isolation and characterization of a cDNA seguence encoding
IFN-g was described by Gray et al (1982). They prepared
polyadenylated RNA from human peripheral blood lymphocytes that had
been stimulated with Staphylococcal enterotoxin B and
desacetylthymosin al for 48 hours. IFN-g activity was determined by
translation of RNA in Xenopus laevis oocytes and subseguent assay in
a standard antiviral assay. RNA from the most active fraction was
converted to cDNA and cloned into pBR322. Transformed bacterial
clones were transfered onto nitrocellulose filters and replicate
filters were screened with one of two probes. One filter was
screened with 32P-labelled cDNA prepared from the RNA of the
stimulated lymphocytes, the other filter was screened using a
similar probe derived from unstimulated lymphocytes producing no
detectable interferon. Positive clones were isolated. The longest
open-reading frame found was for a protein of 166 amino acid
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predicted length. The first 20 amino acids were hydrophobic and
thought to constitute a signal seguence similar to those of the IFN-
a. The cDNA obtained in the initial isolation was subseguently used
to assess the structure of the IFN-g gene (Gray & Goeddel, 1982).
At the same time Devos et al (1982), isolated a very similar clone
coding for the identical protein. One further isolation of human
IFN-g cDNA is reported, in which the isolate was identical in amino
acid sequence except for the presence of a glutamine residue instead
of a lysine residue at position 9. This was expressed and found to
be active (Nishi et al, 1985).
Other papers have reported the construction of synthetic genes for
human IFN-g (Alton et al, 1983; Tanaka et al, 1983) which have been
used for recombinant protein synthesis.
Analysis of all the seguences for human IFN-g describe a mature
protein length of 146 amino acids with a hydrophobic signal sequence
of 20 amino acids, but amino-terminal sequencing of the natural
mature protein showed it to begin with a pyroglutamate residue and
not the predicted cysteine (Rinderknecht et al, 1984). This was
thought to occur by cleavage of the translated protein at residue
24, a glutamine, and subsequent cyclization of this to
pyroglutamate. Furthermore, DNA constructs which code for synthesis
of IFN-g containing the Cys-Tyr-Cys residues at the amino-terminal
end produce protein which has only 10% of the antiviral activity of
recombinant protein lacking these residues (Burton et al, 1985).
The carboxyl-terminus of natural IFN-g seems to be quite variable
and at least six different termini have been observed.
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4.1.2 CLONING INTERFERON-GAMMA GENES OF OTHER SPECIES.
The cDNA isolated for human IFN-g has been used as a probe to
isolate murine IFN-g from a genomic phage library (Gray & Goeddel,
1983), rat IFN-g from a genomic phage library (Dijkema et al, 1985)
and bovine IFN-g from a cDNA phage library (Cerretti et al, 1986).
Comparison of the species sequences shows all of them to code for
proteins containing two potential N-glycosylation sites, although
not in conserved sites. This has been demonstrated in human IFN-g
and explains the two molecular species resolved on SDS-PAGE gels.
The larger species of 25,000 Da has both sites glycosylated, whilst
the smaller species of 20,000 Da has only the first site
glycosylated (Rinderknecht et al, 1984). Only a small amount of
nonglycosylated protein (15,500 Da) has been detected (Kelker et al.
1984). The sequences of the various species of IFN-g thus far
cloned have a relatively low degree of identity. Human and bovine
IFN-g have 63% identity (Cerretti et al, 1986), while human and
rodent IFN-gs have only 40% identity (Gray & Goeddel, 1983; Dijkema
et al, 1985). These low degrees of identity explain the species
specificity of IFN-g action on cells.
4.1.3 GENOMIC STRUCTURE OF INTERFERON-GAMMA.
The human cDNA isolated by Gray et al (1982) was used as a probe in
a Southern hybridization of human genomic DNA. The hybridization
revealed that the IFN-g gene was either present as a single gene
copy or as a tandem gene. Hybridization to a 3' untranslated region
of the gene showed only one band in all the hybridizations, hence
supporting the theory that IFN-g is a single gene (Gray & Goeddel,
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1982). The cDNA has been used to isolate clones from genomic
libraries and determine the structure of the gene. Human IFN-g was
shown to have three introns by both seguencing of clones (Gray &
Goeddel, 1982) and also by electron microscopy of DNA-cDNA
heteroduplexes (Taya et al, 1982). The smallest intron was found in
a region conserved between the three interferon species (a, (3 & g),
although both a and fl have no introns. Murine and rat IFN-g genes
have similar structure. The human gene was found to be on
chromosome 12 (Naylor et al, 1983; Trent et al, 1982), whilst the
genes for IFN-a and -p are on chromosome 9 (Owerbach et al, 1981;
Shows et al, 1982; Trent et al, 1982). IFN-g has been shown by
Southern blotting to be a single-copy gene in human, mouse, rat and
cattle. This is in marked contrast to the interferon-a family of
genes of which a dozen members have been found to date (Capon et al,
1985).
4.1.4 SOME OBJECTIVES WITHIN THE THESIS.
In order to dissect cytokine functions, it is now becoming virtually
essential to know the cytokine gene sequence. This allows synthesis
of recombinant cytokine uncontaminated by other proteins.
Recombinant protein allows experiments to define the role of that
particular cytokine in immune phenomena. The production of large
quantities of a recombinant cytokine allows development of
monoclonal antibodies to it which may be used to neutralize its
effects or to develop a sensitive and specific assay for native
protein. Very large quantities of recombinant cytokines may have
therapeutic uses (eg IFN-g as a vaccine adjuvant).
The isolated gene, once cloned, can itself be used to study the
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structure of the genomic gene(s) and their activation. It can also
be used to assess mRNA levels on a variety of cells and various
states of activation. It also allows analysis of the cytokine-
receptor interactions by altering the functional regions of the
cytokine using site-directed mutagenesis of the gene.
The essential for all these potential experiments is having the gene
cloned, sequenced and available in ready quantities. Unfortunately
ovine IFN-g had not been cloned at the beginning of this project. A
strategy to obtain the cDNA for part of this gene was therefore
devised.
4.1.5 CLONING STRATEGIES AVAILABLE.
Several methods are available to clone a gene when the gene has been
sequenced in other species. Commonly used methods have involved
synthesizing double-stranded DNA from poly-adenylated RNA and
inserting this into a lambda phage vector, thus creating a phage
library which can be screened with:
1) a closely-related labelled DNA sequence (ie bovine, human, murine
or rat IFN-g);
2) a labelled oligonucleotide corresponding to an assumed conserved
region of the gene;
3) a mixed oligonucleotide derived from amino acid sequence data
which contains all the possible codons for the amino acids;
4) an antibody to the desired protein (i.e. antisera to recombinant
bovine IFN-g) in order to detect recombinant protein sequences
expressed as fusion proteins in appropriate phage vectors.
Antibodies can be used to screen similar libraries in mammalian or
insect cell expression vectors.
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An alternative is to clone the species genome into a phage vector
(genomic library) and screen with labelled DNA or oligonucleotide.
This method does not enrich the desired sequence prior to screeing,
and consequently many more phage must be screened before it is
likely that the desired clone is found. When the nucleotide
sequence of the gene itself or a related-species gene is known the
polymerase chain reaction may be used.
4.1.5.1 NUCLEIC ACID HYBRIDIZATION.
The isolation of a cDNA clone for a gene by a nucleic acid
hybridization protocol is a very specific method in which the degree
of specificity can be altered by changing the washing conditions.
The cDNA clone will yield data on the gene sequence and will allow
manipulation of the gene for expression experiments.
4.1.5.2 ANTIBODY SCREENING OF EXPRESSION VECTOR.
Isolation of a clone by the antibody screening method has the
advantage that the gene is in frame and expressed already by the
bacteria. Aqtll (Young & Davis, 1983b) and AZAP (Short et al, 1988)
are phage vectors which contain cloning sites within the lacZ gene
and are under a strong E.coli promoter. A gene sequence cloned
within this site, if in the correct orientation and reading frame,
will be transcribed and translated with the p-galactosidase gene to
form a fusion protein. Fusion of a foreign protein into a stable Eh
coli protein can enhance the stability of the foreign protein and
this has been demonatrated in several cases (Kupper et al, 1981;
Stanley, 1983; Davis et al, 1981). The infected bacteria may be
grown up in large quantities for the generation of fusion protein,
which may represent from 0.1% up to 4% of the total E.coli protein
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(Young & Davis, 1983b; Snyder et al, 1987). Isolation of genes is
best performed with affinity-purified antisera to the protein, or
with a pool of monoclonal antibodies (Young & Davis, 1983a).
Polyclonal antisera commonly contain antibodies reactive to E. coli
proteins which must be removed prior to screening. Monoclonal
antibodies may react with similar epitopes present on unrelated
proteins, hence single monoclonal antibodies should not be used for
screenings. The success of a library screening is largely dependent
on the quality of the library and the probe.
4.1.5.3 POLYMERASE CHAIN REACTION.
More recently the very powerful technique of polymerase chain
reaction (PCR) has allowed the rapid and relatively easy cloning of
many genes for which the sequence was known for one species (Saiki
et al. 1985). Oligonucleotide primers are chosen from the known
sequence which may be expected to bind to the same gene in another
species. An oligonucleotide identical to a 5' region and an
oligonucleotide complementary to a 3' region are used. Employing
these primers the PCR specifically amplifies the sequence of the
gene between the primers. A single amplified product of roughly
known size is expected. The power of the technique is such that a
very small quantity of template DNA is required (down to femtomole
levels). Each round of extension theoretically doubles the quantity
of amplified DNA present. A PCR of 30 cycles will generate 22S
copies of the gene product, assuming 100% efficiency. Thus
beginning with lng of template (the region between the primer
sites), 268pg of product could be generated. Realistically however
substrates become limiting before this level and efficiencies are
initially only 80-90%.
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The polymerase chain reaction depends for its initiation on the
annealing of oligonucleotide primers to the template DNA. Primers
should be complementary to the template strands of DNA. Perfectly
complementary primers are ideal but mismatches can be overcome by a
lower annealing temperature. This does, however, allow promiscuous
binding to similar sequences in unrelated genes present in the DNA.
Consequently spurious bands or smearing may be seen on a gel.
The PCR technique is a rapid technique for isolating DNA sequences,
and was the first choice for the cloning of a section of the ovine
IFN-g cDNA as the bovine sequence was already known.
4.1.6 EXPRESSION OF RECOMBINANT INTERFERON-GAMMA.
Recombinant IFN-g has been expressed in a number of cell types.
Gray et al (1982) were the first to express the human protein, both
in E. coli and in monkey COS-7 cells. E. coli lysates had activity
of 250 units/ml, whilst COS-7 cells produced 50-100 units/ml. This
indicated that glycosylation was not essential for IFN-g activity.
Devos et al (1982) transformed AP8 monkey cells with their cDNA
isolate to yield a clone producing 100 units/ml. Chinese hamster
ovary cells have been transformed amd found to produce IFN-g at high
levels (20,000-100,000 units/ml) (Haynes & Weissmann, 1983; Scahill
et al, 1983). Yeast cells have also been used in production of
recombinant IFN-g (Derynck et al, 1983) but relatively low
expression was achieved. Tanaka et al (1983) synthesized the
recombinant protein using the novel technique of chemically
synthesizing the gene from 62 oligonucleotides incorporating codons
known to be used by genes highly expressed in E.coli. Despite
this, the expression attained was poor. This was thought to be due
to inefficient promoter function. Codon usage is known to be
different between eukaryotic and prokaryotic cells, and it is
thought that this may be a significant reason for the poor yields of
IFN-g obtained from bacterial and yeast cultures. Non-glycosylation
of the protein was initially considered to be a potential problem as
the sugar residues were of unknown relevance to the functioning of
the protein, however bacterial recombinant protein is active to a
comparable level.
Bovine IFN-g has been expressed in E.coli to a level of 115,300
units/ml in an antiviral assay (Cerretti et al, 1986). It has also
been expressed in E. coli by Ciba Geigy to a purity of 2.5 x 10s
units/mg of protein (Data Sheet, Ciba Geigy).
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4.2 MATERIALS AND METHODS.
4.2.1 ISOLATION OF RNA FOR USE AS TEMLATE FOR PCR.
Mesenteric lymph nodes were obtained from a freshly killed sheep.
Lymphocytes were teased from the node under sterile conditions using
forceps and scissors into ice-cold Hanks Buffered Salt Solution.
Debris was allowed to settle for five minutes before cells were
pipetted from the debris and centrifuged three times at 400xg for 5
minutes, resuspending in RPMI 1640 medium containing 5% foetal calf
serum after each spin. The lymphocytes were resuspended in 10ml of
medium and counted. They were then cultured at 5 x 106 cells/ml in
RPMI 1640 medium containing 10% foetal calf serum, lOOmM L-glutamine
and lOOmM sodium pyruvate in a 5% CO2 atmosphere. Concanavalin A
(Sigma) (5pg/ml) was added at the beginning of the incubation
period. The cells were cultured for eight hours before being washed
twice in ice-cold PBS before lysis in 20ml of 4M guanidinium
thiocyanate (GTC) (Appendix 4).
RNA was isolated by the method of Chirgwin et al (1979). 10ml of
the GTC lysate was layered above 2ml of 5.7M caesium chloride in a
Beckman SW40Ti polyallomer ultracentrifuge tube. The tubes were
centrifuged in a Beckman L70 ultracentrifuge at 28000 RPM for 16
hours at 4°C. The GTC and CSCI2 were removed and the pellet
containing RNA washed with 70% ethanol. The pellet was resuspended
in 500pl of diethylpyrocarbonate (DEPC)-treated distilled water and
the RNA was precipitated with 2 volumes of ethanol at -70°C
overnight before centrifugation at 12000xg for 10 minutes. At this
stage the pellet was resuspended in water and then extracted in an
egual volume of phenol/chloroform and then chloroform to remove
cellular protein. It was then precipitated with 2 volumes of 100%
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ethanol before the pellet was finally resuspended in water and the
concentration of RNA was estimated from spectrophotometry at 260nm
and 280nm.
Single-stranded cDNA was synthesized from the isolated RNA using
oligo dT-primed reverse transcription of 1.28pg of total RNA
(Amersham cDNA synthesis kit) (Gubler & Hoffman, 1983).
Incorporation of a-32P-dCTP in this reaction allowed the yield of
cDNA to be estimated. Stock cDNA at 1.7ng/pl was used in polymerase
chain reaction experiments to clone part of the ovine interferon-
gamma gene.
4.2.2 POLYMERASE CHAIN REACTION TO CLONE PART OF THE OVINE
INTERFERON-GAMMA GENE.
4.2.2.1 POLYMERASE CHAIN REACTION.
Primers used for PCR were designed from the bovine interferon-gamma
seguence (Cerretti et al, 1986). Primers contained 20 or 21
deoxynucleotides. The 5' primer was identical and the 3' primers
were complementary to the coding strand of bovine interferon-gamma.
PRIMER SEQUENCE NUCLEOTIDES
343E (5') 5'-GGGCCTCTCTTCTCAGAAATT-3' 238-258
474F (3') 5'-GAGGTTAGATTTTGGTGACAG-3' 520-540
344E (31) 5'-TGACTTCTCTTCCGCTTTCT-3' 541-560
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Primers were synthesized by the Oswel DNA Service (University of
Edinburgh), purified by HPLC, and dissolved in sterile distilled
water. Each oligonucleotide was supplied with the 5' terminus
hydroxylated.
PCR was carried out in lOOpl reaction volumes containing 0.4pM
primers, 250pM deoxyribonucleotides (Pharmacia), 6.7mMMgCl2,
170pg/ml bovine serum albumin, 67mM Trizma pH 8.8, 1.7ng single-
stranded cDNA, and 1.5U of Tag polymerase (Boehringer Mannheim,
Gmbh, Germany). Automatic thermal cycling was performed on a Techne
PHC-1 machine, using temperatures of 95°C for 0.6 minutes, 53°C for
0.6 minutes and 75°C for 1.5 minutes. Thirty cycles were performed.
A final extension at 75°C for 3 minutes was employed to complete
synthesis of most products. 10pl of the reaction was run on a 2%
agarose gel to detect products.
4.2.2.2 CLONING OF THE PCR PRODUCT.
The DNA was to be cloned into the blunt-ended Sma I site of pTZ18R
(Pharmacia), conseguently the PCR products were modified prior to
gel purification to ensure that most strands had blunt ends and that
5' ends were phosphorylated and could be ligated.
The PCR reaction mix was cleaned to remove protein and
deoxyribonucleotides. It was extracted with an egual volume of
phenol/chloroform, twice with egual volumes of chloroform, and
finally precipitated by the addition of 1/10 volume of 3M sodium
acetate and two volumes of 100% ethanol. The DNA was held at -20°C
for 1 hour to allow precipitation and then centrifuged at 12000xg
for 10 minutes. The pellet was washed with 70% ethanol and vacuum
dried. DNA was resuspended in distilled water before treatment with
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1 Unit of Klenow fragment of DNA polymerase (NBL, UK) in T4 kinase
buffer (Appendix 4) for 30 minutes at 30°C to ensure the PCR product
had blunt ends. The reaction was then treated with ImM ATP and 1
Unit of T4 kinase (NBL, UK) for 1 hour at 37°C to phosphorylate the
5' termini.
The PCR product was gel purified on a 1.5% Seaplague (FMC) low-
melting temperature agarose gel in 1 x TAE (Appendix 4) and
containing 0.5pg/ml ethidium bromide, run at 4V/cm for 3 hours. The
band was visualized and cut out of the gel whilst viewing under UV
light.
4.2.2.3 PREPARATION OF pTZ18R VECTOR.
5pg of pTZ18R plasmid were digested by Sma I restriction
endonuclease (NBL, UK) to linearize the phagemid and leave blunt
ends. 1.5pg of phagemid was then dephosphorylated at its 5' termini
using calf intestinal phosphatase (CIP, Boehringer Mannhein, Gmbh,
Germany). Treatment was with 1 Unit for 15 minutes at 37°C,
followed by 1 unit for 45 minutes at 56°C. This was to prevent
self-ligation by recircularization of the DNA. The DNA was purified
by phenol/chloroform extraction, chloroform extraction, ether
extraction and ethanol precipitation.
4.2.2.4 LIGATION OF PCR PRODUCT INTO pTZ18R.
Ligation was performed in agarose using the method of Struhl (1985).
PCR product in Seaplaque agarose was heated to melt the agarose
(70°C for 10 minutes). 200ng of linearized, CIP-treated pTZ18R was
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combined with Ong, 200ng or 400ng of the PCR product in ligation
buffer (Appendix 4) with 5 Units of T4 ligase, and incubated at 15°C
for 16 hours.
4.2.2.5 BACTERIAL CELL TRANSFORMATION AND ISOLATION OF PLASMID DNA.
Escherichia coli, strain JM101 (Yannish-Perron et al, 1985), was the
recipient bacteria for recombinant plasmids derived from pTZ18/19.
It has the following genetic characteristics:
F' traA36 proA+ proET laclg lacZAM15/supE thi A(lac-proAB)
Competent stock was prepared according to the method of Chung et al
(1989). Overnight cultures of JM101 cells were centrifuged at
1500xg for 10 minutes and resuspended in 1/10 volume of 1 x TSS
(Appendix 4). Cells were frozen at -70°C in lOOpl aliguots until
required. When cells were to be transformed, an aliquot was thawed
on ice, plasmid added, and kept on ice for 20 minutes to allow DNA
uptake. 0.9ml of LB medium (Appendix 4) was then added and the
suspension shaken at 37°C for 60 minutes to allow expression of the
antibiotic resistance gene. Cells were plated out on LB agar plates
containing ampicillin, X-GAL and IPTG (Appendix 4) to select for
recombinant plasmids by colour change. Plates were incubated at
37°C overnight. Bacteria containing plasmid without an insert
ligated in the lacZ gene expressed functional p-galactosidase
activity and converted X-GAL to a blue colour, but bacteria
containing plasmids with inserts were defective for p-galactisidase
enzyme and were white.
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White colonies which were picked for analysis. The miniprep method
of Serghini et al (1989) was used. 1.5ml of an overnight culture of
transformed bacteria was pelleted, resuspended in 50pl TNE (Appendix
4) and vortexed with 50pl phenol/chloroform/isoamyl alcohol
(25/24/1) to release plasmid DNA into the aqueous phase. The
microtube was centrifuged at 12000xg for 5 minutes and the aqueous
phase collected. The DNA was precipitated by addition of ammonium
acetate to 2M final concentration and then 2 volumes of 100%
ethanol.
Plasmid DNA was prepared in a larger quantity by the alkaline lysis
technique (Birnboim & Doly, 1979). 250ml overnight cultures of
transfected bacteria were pelleted and resuspended in 2ml of GTE
buffer (Appendix 4). 0.5ml of GTE with 25mg/ml hen egg white
lysozyme (Sigma) was added to break down the bacterial cell wall and
the mixture incubated for 10 minutes at room temperature. 5ml of
fresh 0.2M NaOH/1% SDS was stirred into the mixture and incubated
for 10 minutes on ice, and a further 10 minutes on ice was allowed
after addition of 3.75ml of 3M potassium acetate pH5.5. This step
precipitated the bacterial chromosomal DNA but left the plasmid DNA
in solution. The supernatant was collected after centrifugation at
15000xg for 10 minutes in a Beckman JA-20, and the plasmid DNA was
precipitated with 0.6 of a volume of isopropanol for 20 minutes at
20°C. The pellet was washed with 70% ethanol before being dissolved
in 2ml of TE (Appendix 4). RNA was removed by RNase A digestion
(20pg/ml at 37°C for 20 minutes). The solution was extracted with
phenol once, and with phenol/chloroform once before precipitation of
the DNA by addition of an equal volume of 4M ammonium acetate and
two volumes of ethanol. Further purification of plasmid DNA was
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obtained by addition of 0.4 volumes of a solution containing 30% PEG
8000 and 1.6M NaCl, incubation at 4°C overnight and subseguent
centrifugation at 12000xg for 10 minutes (Lis, 1980).
The plasmid containing the ovine IFN-g seguence was designated
pOVifn.
The insert was excised from the plasmid by EcoRI and HindiII
digestion, and was gel purified twice on Seaplague low-melting
agarose to remove any plasmid DNA. This fragment was used as a
probe in hybridization experiments.
4.2.3 SEQUENCING PLASMID INSERT.
4.2.3.1 PREPARATION OF SINGLE-STRANDED DNA TEMPLATE FOR SEQUENCING.
The method of production of ssDNA from pTZ18R has been described
(Zoller & Smith, 1983). E. coli strain JM101 containing the
relevant plasmid was grown in 2xYT (Appendix 4) + 150pg/ml
ampicillin to an ODseonm of 0.5-0.8. 400pl of this was infected
with M13K07 helper phage at a moiety of infection (MOI) of 10 (10
pfu/cell). This was shaken for 1 hour at 37°C, and then 10ml of
2xYT with kanamycin (70pg/ml) and ampicillin (150pg/ml) added. This
culture was shaken at 37°C overnight.
Purification of the ssDNA was achieved by firstly removing all cells
by repeated centrifugation and then a final filtration through a
0.22pm filter. The phage particles were precipitated on ice for 30
minutes with 1/4 volume of 20% PEG 8000 in 3.5M NaCl.
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Centrifugation at 12000xg for 30 minutes at 4°C yielded a pellet
which was resuspended in NTE prior to phenol/ chloroform extraction
and ethanol precipitation.
4.2.3.2 SEQUENCING OF PLASMID INSERT.
DNA seguence was obtained using the Sanger dideoxynucleotide chain
termination method (Sanger et al, 1977). A BIORAD Segui-Gen Nucleic
Acid Sequencing Cell was used to run a 6% acrylamide/7.5M
urea/0.5xTBE gel. Polymerization was initiated with lpl/ml 6.6M
TEMED (BIORAD) and lpl/ml 25% ammonium persulphate.
Labelling and chain termination was performed using a USB Sequenase
kit to incorporate 35S-dCTP. The gel was run at 2500V for 4 hours.
Samples were loaded at 0 or 2 hours to allow different separation of
parts of the sequence. The gel was dried onto 3M filter paper for 2
hours at 80°C and autoradiographed on Kodak X-AR film overnight.
4.2.4 OVINE INTERFERON-GAMMA CLONING FROM LAMBDA PHAGE LIBRARY.
4.2.4.1 LAMBDA PHAGE LIBRARIES USED -- Aqtll AND AZAP.
Two lambda phage cDNA libraries were obtained from Dr. Wayne Hein,
Basel Institute for Immunology. T lymphocytes activated with
Concanavalin A for 24 hours or 72 hours were the source of RNA. The
cDNA inserted was synthesized from a mix of this RNA. The initial
generation of the Agtll library has been described (Hein et al,
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1989). Both \gtll (Young & Davis, 1983b) and \ZAP I (Short et al,
1988) libraries were obtained in amplified form. The initial titres
of the unamplified libraries were unknown.
4.2,4.2 BACTERIAL STRAINS USED IN PHAGE WORK.
A number of strains of E. coli were used during screening of lambda
phage, and also during the production of lysogens. (Young et al,
1985; Short et al, 1988)
STRAIN GENOTYPE PHAGE
Y1090 AlacU169 proA+ Alon araD139 Agtn
strA supF rtrpC22::TnlO)
(pMC9)
Y1089 lacU169 proA+Alon araD139 Agtn
strA hflA150 TchrrrTnlOl
(pMC9)
BB4 supF58 supE44 hsdR514 qalK2 AZAP I
(rk-, mk+) qalT22 trpR55 metBl
tonA lambda- A(arq-lac)U169
fF' proAB lacIqZAM15 TnlO(tetR)l
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4.2.4.3 SCREENING A BACTERIOPHAGE LIBRARY.
The \ZAP library was screened on E. coli strain BB4. The AEJtll
library was screened on E. coli strain Y1090. Initial infection of
the bacteria was the same for both A strains (Current Protocols in
Molecular Biology, eds: Ausubel FM et_al).
The specific cell strain was grown to saturation in LB broth with
0.2% maltose. 0.6ml of this culture was added to phage stock
containing approximately 10000 phage and the mix incubated at room
temperature for 20 minutes to allow phage adsorption. The tubes
were then incubated at 37°C for a further 10 minutes to allow phage
DNA injection. 7.5ml of warm LB top agarose was added to the cells,
mixed and poured on a 150mm bacterial plate containing solid LB
bottom agar (Young et al, 1985). At this point the screening method
determined the incubation regime and subsequent treatment. Two main
methods of screening were used: (i) DNA hybridization with a
labelled probe, (ii) detection of fusion proteins with labelled
antibodies.
4.2.4.4 SCREENING /ZAP LIBRARY BY OLIGONUCLEOTIDE HYBRIDIZATION.
The plates prepared in 4.2.4.3 were incubated at 37°C overnight and
then allowed to cool for 30 minutes. Nitrocellulose filters
(Millipore, HATF13750) were applied sequentially to each plate for 2
minutes, marked with a needle for orientation later and then air-
dried. The filters were alkali denatured for 2 minutes, neutralized
for 2 minutes and equilibrated for 2 minutes before baking at 80°C
in a vacuum oven for 2 hours. (Appendix 4 for solutions).
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A complementary oligonucleotide was designed from the bovine
interferon-gamma sequence. This oligonucleotide was used in the PCR
but subsequently discarded. It had the following sequence from the
3' end of the cDNA:
PRIMER SEQUENCE NUCLEOTIDE
344E (3') 5'-TGACTTCTCTTCCGCTTTCT-3' 540-560
The oligonucleotide was labelled by 5' end-labelling using T4 kinase
to incorporate 32P-ATP (400Ci/mmol) (Appendix 4).
The filters were washed three times in 3xSSC/0.1%SDS at 20°C, and
once at 65°C in the same solution for 90 minutes to remove bacterial
debris. They were then prehybridized in prehybridization solution
(Appendix 4) for 1 hour at 37°C. Filters were then hybridized with
labelled oligonucleotide probe for 16 hours at 42°C in hybridization
solution (Appendix 4), washed in 6xSSC/0.05% sodium pyrophosphate at
20°C for 75 minutes with 5 changes of solution, and then in the same
wash buffer at 55°C for 30 minutes. The filters were exposed to
radiographic film (Kodak X-AR) at -70°C for 18 hours to register
areas where specific hybridization had occurred.
4.2.4.5 SCREENING A ZAP WITH THE PCR PRODUCT.
4.2.4.5.1 LABELLING pOVifn FOR USE IN SOUTHERN HYBRIDIZATIONS.
The insert from pOvifn was labelled to high specificity with a-32P-
dCTP (400 Ci/mmol or 3000 Ci/mmol, Amersham). 25-100ng of DNA was
heat denatured and annealed to random hexanucleotides. It was
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extended by Klenow fragment of E. coli DNA polymerase (NBL, UK) to
incorporate the labelled nucleotide. Incorporation of label was
assessed by trichloroacetic acid precipitation on glass filters, and
Cherenkow counting. DNA was labelled to between 5 x 10s and 1 x 109
cpm/pg.
4.2.4.5.2 HYBRIDIZATION PROTOCOL.
Lambda phage were plated out as above. The filters were
prehybridized in Prehybridization solution 1 for 3 hours (Appendix
4). The probe was generated by random-primed radiolabelling
(Feinberg & Vogelstein, 1983) of the PCR product cut from the
plasmid, to a specificity of 3.7 x 107 cpm/pg. The filters were
hybridized for 3 days at 42°C in Hybridization solution 1 (Appendix
4), before washing with 2 x SSC/ 0.1% SDS four times of 10 minutes,
and 0.2 x SSC/ 0.1% SDS four times of 20 minutes at 65°C. The dried
filters were autoradiographed against Kodak X-AR film.
4.2.4.6 ANALYSING AZAP BY PCR.
The AZAP library was assessed for the presence of interferon-gamma
seguence by PCR (modified from Saiki et al, 1988). One microlitre
of dilutions of the library representing 10s pfu/pl and ten-fold
dilutions were added to PCR using primers 343E and 474F and the
original conditions were used (see section 4.2.2.1). After 30
cycles lOpl of the reaction products were separated by
electrophoresis on a 1% agarose gel and the gel viewed under UV
light.
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4.2.4.7 ANTIBODY SCREENING OF A at 11.
4.2.4.7.1 PRETREATING SERA TO REMOVE ANTI-E. COLI ANTIBODIES.
To remove the E. coli reactivity contained in the polyclonal rabbit
sera it was incubated with E. coli proteins (Young & Davis, 1983a).
Briefly E. coli Y1090 cells were grown to saturation, pelleted and
resuspended in 1/30 volume of TE. The cells were freeze-thawed
three times to lyse them, and then sonicated on ice. The
supernatant was coated onto Hybond C (Amersham) nitrocellulose and
the antisera incubated with this coated nitrocellulose for 24 hours
at 4°C. This was repeated.
Test strips of Y1090 protein spotted on Hybond C were processed as
for phage filters. Serum was only used when Y1090 reactivity had
decreased at 1/500 dilution.
4.2,4.7.2 SCREENING Adtll WITH ANTI-BOVINE INTERFERON-GAMMA RABBIT
SERA.
The Agtll library was plated out at 20000 pfu per 150mm bacterial
plate in 0.7% LB agarose onto 1.5% LB agarose containing ampicillin.
Ten plates were used. They were incubated at 42°C for 3.5 hours,
before a dry nitrocellulose filter (Millipore, HAHY 13750),
previously soaked in lOmM IPTG (Appendix 4), was laid on the top
agar. The plates were incubated for 3 hours at 37°C. The filters
were removed and replaced with similar ones for a further 3 hours.
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All the filters were then treated in a similar manner, and all
procedures were carried out at 4°C. Filters were initially washed
in TNT (Appendix 4) for 10 minutes and then blocked in 5% dried
cow's milk (Marvel, Cadburys) in TNT buffer overnight. Filters were
incubated for 2.5 hours in pre-absorbed rabbit antisera at 1/500 in
blocking buffer. They were washed in blocking buffer three times
over 30 minutes. Filters were then incubated in 1/2500 anti-rabbit
IgG biotin (Sigma) in blocking buffer for 2 hours before washing
again. Incubation in 1/4000 Extravidin Alkaline Phosphatase (Sigma)
in blocking buffer for 1 hour was followed by development with
nitroblue tetrazolium and bromo-chloro indolyl phosphate in 0.1M
Trizma pH9.0, 3.6mM MgCl2 (Leary et al, 1983).
Phage plagues corresponding to positive spots were picked within a
core of material and released into SM media (Appendix 4). The phage
stock were titrated and plated out for repeated screening. This
regime was followed until a pure phage stock was obtained. The
phage stock was designated A 1.14.
4.2.4.8 ISOLATION OF LAMBDA PHAGE DNA.
The next stage in the procedure was to isolate phage DNA from plate
lysates (Sambrook et al, 1989). In brief, five tubes of Y1090
bacteria (lOOpl) were infected with 105 pfu of phage and allowed to
stand for 10 minutes at 20°C. The cultures were then incubated at
37°C for 20 minutes to allow DNA inoculation of the bacteria before
the cultures were plated out as above and incubated at 42°C for 16
hours. 3ml of TM solution (Appendix 4) was added to each plate
whcih was then rotated for 2 hours to elute the phage. The
resulting phage suspension was centrifuged at 4000xg for 10 minutes
to remove bacterial debris. Bacterial nucleic acids were digested
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with RNAase (lpg/ml) and DNAase I (lpg/ml) for 15 minutes at 37°C.
The phage were precipitated by incorporation of PEG 8000 to 10% and
NaCl to 1M, and left for 1 hour on ice before centrifugation at
lOOOOxg for 10 minutes at 4°C. The phage were then resuspended in
0.5ml of TE and disrupted with 0.1% SDS for 5 minutes at 68°C, and
the protein removed by phenol/chloroform extraction, followed by
chloroform extraction. The DNA was precipitated with an equal
volume of isopropanol at -70°C resuspended in TE prior to analysis.
4,2.4.9 PRODUCTION OF LYSOGEN FROM PHAGE.
A large quantity of fusion-protein was produced from extracts of
lysogenic E. coli infected with ^1.14. The method used has been
described (Young & Davis, 1983a). The essential details are
described.
E. coli Y1089 was grown in LB/Ampicillin/0.2% maltose overnight at
37°C. 50pl of the culture was diluted into 2ml of LB/lOmM MgSCU,
and lOOpl aliquots were dispensed to four tubes. These were
inoculated with 107, 5 x 107 and 2 x 10s pfu of Al-14 phage. The
fourth tube received no phage. The tubes were kept at room
temperature for 20 minutes to allow phage DNA inoculation, and then
lOpl of the mix was diluted in 10ml of LB/lOmM MgSO-i. lOOpl of this
was plated onto LB/lOmM MgSCU/Ampicillin plates. The plates were
incubated at 30°C for 24 hours to allow growth of individual
lysogenic colonies. Individual colonies from each plate were picked
and replica-plated onto two plates. One was incubated at 30°C, the
other at 42°C. Colonies which grew at 30°C but not at 42°C had been
infected with A1.14 phage which is lytic at 42°C. They were grown
in liquid culture (LB/Ampicillin) overnight at 30°C, and 125pl
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aliquot of this was diluted into 10ml of media and grown at 30°C
with shaking to an ODeoonm of 0.45. The culture tube was transfered
to a 43°C water bath for 20 minutes to inactivate the Agtll encoded
temperature-sensitive repressor. The culture was induced to produce
protein with IPTG at a final concentration of lOmM, and further
cultured for 2 hours at 37°C. A similar culture did not have IPTG
added to induce protein production. 1.5ml of each culture was
centrifuged (12000xg for 30 minutes) and then vortexed with lOOpl of
extraction buffer (Appendix 4). The resulting suspension was
freeze-thawed twice in liquid nitrogen to disrupt the bacteria prior
to analysis.
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4.2.4,10 ATTEMPTING TO OBTAIN A 1.14 INSERT BY PCR USING AGT11-
SPECIFIC PRIMERS.
Primers specific to the flanking region of the Agtll EcoRI site were
synthesized by the Oswel DNA Service. As the Agtll seguence has not
been published the primers were taken from the lacZ gene which
contains the EcoRI site of Agtll.
PRIMER SEQUENCE NUCLEOTIDES
AGT11 (5') 5'-GCACGCGGAAGAAGGC-3' 2928-2943
AGT11 (3') 5'-GACACCAGACCAACTGG-3' 3048-3064
The template was prepared similarly to the assessment of the AZAP








4.3.1 POLYMERASE CHAIN REACTION TO CLONE PART OF THE OVINE
INTERFERON-GAMMA GENE.
4.3.1.1 PCR USING PRIMERS 343E AND 344E.
Analysis of initial polymerase chain reactions on 1.5% agarose gels
showed a reaction tube contained a discrete product of approximately
300bp (Figure 27). Attempts to clone this were unsuccessful.
Subseguent PCRs gave a fainter band of 300bp amongst a smear of DNA.
The band was purified and cloned as described (4.2.2.2-4.2.2.5) into
pTZ18R. White colonies were subseguently cultured overnight in
medium and the plasmid DNA was then isolated. Restriction enzyme
digestion with EcoRI and Hind III was used to release inserts from
the plasmids. Electrophoresis on a 2% agarose gel did not yield the
expected single band of 322bp so to analyse the true nature of the
inserts single-stranded DNA was produced as template for seguencing.
Two representative seguences are shown in Figure 28. They both
contain multiple copies of the primers. The junction between the
primers show a region of complementarity which has aided the
production of these "primer-dimers".
343E 5' GGGCCTCTCTTCTCAGAAATT 3'
3' TCTTTGGCCTTCTCTTCAGT 5' 344E
Excess primer concentrations have produced concatamers of primers.
The band at 320bp probably did represent the desired PCR product but
contaminating DNA was cloned. The obvious way of avoiding the
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primer-dimer formation was to change one of the primers such that
complementary 3' ends were avoided. Therefore primer 474F was
subsequently used in place of 344E.
4.3.1.2 PCR USING PRIMERS 343E AND 474F.
The new primer 474F and the original primer 343E were used in a
polymerase chain reaction. This reaction succeeded in synthesizing
a product of approximately 300bp in length. The product was cloned
successfully into pTZ18R and grown in E. coli JM101.
Four of the plasmids were sequenced. Sequence autoradiographs from
two of the plasmids are shown (Figure 29). All four isolates were
found to contain the same insert. The plasmid containing the ovine
sequence described here is subsequently referred to as pOVifn. The
section of the ovine IFN-g sequence present in the plasmid is known
as OVifn.
The nucleotide and amino acid sequence of the inserts compared to
the bovine sequence are shown in Figures 30. Comparison with bovine
IFN-g showed a high degree of identity at the amino acid level
(98%). Comparisons with known IFN-g sequences from other species
showed less identity with human (63%), and even less with the rodent
sequences (mouse 41%, rat 40%). Subsequent descriptions of both
ovine (Mclnnes et al, 1990; Radford et al, 1991) and porcine IFN-g
(Dijkmans et al, 1990) further confirmed the identity of the
sequence cloned. The porcine sequence was 86% identical at the
amino acid level.
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4.3.2 OVINE INTERFERON-GAMMA CLONING FROM LAMBDA PHAGE LIBRARIES.
4.3.2.1 SCREENING OF AZAP LIBRARY BY OLIGONUCLEOTIDE.
The use of oligonucleotide 344E to screen the phage library was
unsuccessful. No positive plaques were isolated using the method
described.
4.3.2.2 SCREENING OF AZAP LIBRARY USING Ovifn AS PROBE.
The probe was generated by random-primed labelling of Ovifn,
incorporating 32P-dCTP in the reaction. The probe was at an
activity of 3.7 x 107 cpm/pg. The probing of the \ZAP library did
not yield any positive plagues.
4.3.2.3 ANALYSING AZAP LIBRARY BY PCR.
PCRs were performed using 343E and 474F primers and 105pfu or ten
fold dilutions of AZAP phage as template DNA. Analysis by
electrophoresis on 2% agarose gel showed that a band of 302bp was
not synthesized. The positive control IFN-g PCR product was
synthesized when pOVifn was used as template.
4.3.2.4 SCREENING Aat 11 LIBRARY WITH ANTI-BOVINE INTERERON-GAMMA
RABBIT SERA.
The lack of success in attempting to isolate a phage clone of ovine
IFN-g by DNA hybridization technigues, and the subseguent doubts
over the presence of such a clone in the \ZAP library, prompted the
use of another method for screening the remaining Agtll library.
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The availability of the rabbit antisera to the bovine recombinant
IFN-g allowed the screening of the ^gtll for a clone which encoded
ovine IFN-g within a fusion protein.
When the antisera, preabsorbed against E. coli Y1090 bacterial
proteins to remove antibodies reactive with E. coli, was used to
screen the library, one plaque (^1.1) gave a positive signal on
duplicate filters. This plaque was taken through secondary and
tertiary screens, and eventually to purity. It then became known as
>1.14.
Attempts to isolate the cDNA insert from the phage failed despite
repeated phage preparations and different restriction enzyme
digestions.
4.3.2.5 ANALYSIS OF A 1.14 CLONE BY COOMASSIE STAINING AND WESTERN
BLOTTING OF LYSOGEN CULTURES.
4.3.2.5.1 ANALYSIS OF PROTEINS FROM LYSOGENIC CULTURES.
It was decided that the preparation of lysogens may give a clearer
idea if the phage clone was truly of ovine IFN-g. Preparations of
lysogenic cultures were either induced with IPTG (I), or not induced
(NI). Proteins from both induced and non-induced cultures were
analysed on an 8% SDS-PAGE followed by Coomassie staining, and also
by immunoblotting using both the anti-bovine interferon-gamma rabbit
polyclonal sera (R167/8), and the monoclonal antibody to human
interferon-gamma carboxyl peptide, HB8291. An anti-CD3 polyclonal
rabbit antiseum (R181) and an anti-sheep MHC class II monoclonal
antibody (VPM37) were used as negative control antibodies. The
Coomassie stained gel (Figure 32) shows that a number of additional
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protein bands are produced in induced ,\1.14 lysogen cultures,
principally at molecular weights of =110k, 67k, 39k and 26k. The
protein at 110k is clearly of the same mass as native (3-
galactosidase.
The western blots of the induced and uninduced lysogen cultures
(Figure 33) show that R167/8 (anti-bovine rIFN-g) sera reacts with a
protein of approximately 39k molecular weight in both cultures, but
primarily the induced culture. The R181 (anti-sheep CD3) sera
reacts with many proteins in both cultures, but not with the 39k
protein. This sera had not been preabsorbed against E. coli
proteins. The monoclonal antibodies HB8291 (anti human IFN-g
carboxy peptide) and VPM37 (anti-sheep MHC class II) also react
faintly with the 39k protein. Although this is difficult to see in
the figure, it was more obvious in the original blot. These results
suggest that phage /1.14 encodes a protein which reacts non-
specifically with immunoglobulin of both mouse and rabbit origin.
4.3.2.6 ATTEMPTING TO OBTAIN THE A 1.14 CLONE INSERT BY PCR.
The phage ^1.14 was used as template in a PCR as described in the
section 4.2.5.10, using the ^gtll primers. The agarose gel showed
that the PCR had generated a fragment of between lOObp and 200bp for
A1.14 which was the same size as that generated using a known phage
without an insert. The primers used were best estimates using the
known sequence of the lacZ gene.
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The initial isolate from the primary screening of Agtll (/l.l) was
analysed by performing PCR on phage DNA with primers 343E and 474F.
Control PCRs on a negative phage isolate, and also on plasmid pOVifn
were also included in the experiment. This PCR on^l.l failed to
give a band of 322bp on a 2% agarose gel.
The result above and the failure to obtain the DNA insert from the
phage led to the discontinuation of the work with ^1.14. The
western blots enhanced the belief that the phage probably did not
encode an ovine IFN-g protein, but the reaction with VPM37 would
tend to suggest that it produced a protein which merely reacts with
immunoglobulin.
In retrospect it would have been useful to have analysed the ASftll
library by PCR for IFN-g sequences using the oligonucleotide primers
343E and 474F. This may have yielded information on the presence or
absence of an ovine IFN-g cDNA clone, and hence saved some time.
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4.4 DISCUSSION.
The cloning of part of the ovine IFN-g gene using PCR
oligonucleotides based on the bovine seguence demostrates that
cytokine cloning across species using PCR is possible. This has
been confirmed by other reports on the PCR cloning of ovine IFN-g
(Mclnnes et al. 1990; Radford et al, 1991), IL-2 (Goodall et al,
1990), ILl-p (Fiskerstrand & Sargan, 1990), and TNF-a (Green &
Sargan, 1991). Each ovine seguence was cloned using bovine-derived
primers in the PCR. Ovine TNF-a has been cloned by PCR using
consensus primers derived by comparison of human, murine and rabbit
TNF-a seguences (Green & Sargan, 1991) Sequences which are highly
species-specific, such as IL-4 (typically 40% amino acid identity
between species), are likely to be difficult to clone by PCR unless
species are closely related (P Wood, personal communication).
The complete ovine IFN-g amino acid sequence of Mclnnes et al (1990)
has 96% identity with bovine IFN-g. This is comparable with other
cytokine genes cloned in both species. Ovine interleukin-2 has 96%
identity with the bovine IL-2 (Goodall et al, 1990), and ovine IL-1 (3
has 84.9% identity with bovine IL-ip (Fiskerstrand & Sargan, 1990).
Comparison of ovine TNF-a with bovine TNF-a is not possible as
bovine TNF-a has not been cloned and sequenced.
Radford et al (1991) cloned ovine IFN-g by PCR and derived two
different sequences from two of the clones. The two sequences
varied at three nucleotides, of which two fall within the region of
OVifn. Mclnnes et al (1990) also cloned ovine IFN-g by PCR but only
reported one sequence. The two nucleotide changes in one of Radford
et al's clones have identity with the described sequence here and
are at variance with the Mclnnes et al sequence, whilst in the other
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clone the converse is true. At one further position (369 on Figure
31) the three ovine sequences vary. OVifn has a T, but Mclnnes et
al and Radford et al record a C, which is also the nucleotide
present in the bovine sequence. None of the three nucleotide
variations alters the amino acid sequence.
The variable nucleotides between Radford et al's clones were assumed
to be due to variations between mRNA transcripts or reverse
transcription reaction products and it is possible that the changes
are reverse transcription or PCR-generated errors. Radford et al
also reported a nucleotide deletion and insertion at the 5' end of
the gene which altered five amino acids. They commented that they
believed this sequence region to be incorrect. This could possibly
be a reverse transcription or PCR-generated error. All four
sequences were derived from cloned PCR-generated DNA and it is known
that Tag polymerase enzyme used in these reactions has a relatively
high error rate with no proof-reading ability. The three common
variations would be consistent with the mutational base pair
substitutions incorporated by Tag polymerase described in other
papers. Tindall & Kunkel (1988) described that of 23 base pair
transitions detected in a Forward Mutational Assay (detects loss of
a-complementation in p-galactosidase when a 390bp single-stranded
gap is filled by Tag polymerase), 18 were of the T -> C type.
Similarly Keohavong & Thilly (1989) described twelve mutations
detected by denaturing gradient gel electrophoresis after PCR using
Tag polymerase, all of which were of the A-T to G-C type. Saiki et
al (1988) found ten of thirteen transitional errors were A*T to G-C.
It would however be unlikely that independently derived sequences
would contain the same errors. The finding of the common sites of
nucleotide changes in the four described sequences makes it unlikely
that these are reverse transcription errors. The changes are more
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likely to be mRNA encoded, and hence to represent allelic variation
in the sheep IFN-g genomic DNA sequence. There would be little
selection against these variations as they are silent nucleotide
substitutions. Similar polymorphic variation occurs in ovine TNF-a
(Green & Sargan, 1991).
Analysis of the sequences described for human IFN-g (Gray et al,
1982; Gray & Goeddel, 1982; Devos et al, 1982; Taya et al, 1982)
reveals only one nucleotide variation. This occurs in the Gray et
al sequence at the carboxyl terminus where an A replaces a G, in
turn altering the amino acid from glutamine to arginine. Gray &
Goeddel (1982) report that sequencing of six cDNA clones from four
individuals revealed only this one change in one clone. They
suggested from this, and an absence of restriction length
polymorphisms, that the IFN-g gene and surrounding region are
relatively conserved. The two variants of ovine IFN-g and similar
variants of ovine TNF-a suggest that limited polymorphism of
cytokines may occur in sheep.
Much effort was expended in attempting to clone ovine IFN-g from
phage libraries. Two cDNA libraries were used and a variety of
detection methods. The failure to clone the ovine sequence could be
for many reasons, but there are two major requirements for success
in colony hybridization experiments. Firstly, the library must
contain recombinant phage encoding the desired sequence. If the
desired mRNA is an unstable species or is found at low frequency in
cells, the conversion to cDNA may not yield sufficient clones for
detection later. A high number of individual recombinant phage
formed during the creation of the library may offset the low initial
proportion of desired recombinants. This is conveniently measured
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as the titre of the library before amplification. Unfortunately the
titres were not known for the libraries used, and only amplified
libraries were used.
During preparation of the library the input mRNA should be enriched
for the desired sequences by appropriate stimulation of the cells
before lysis to boost the transcription of the desired mRNA. Both
libraries used contained cDNA derived from a mixture of 24 and 72
hour concanavalin A-stimulated lymphocytes. These cells are still
actively proliferating at these times and should contain mRNA for
IFN-g (Efrat et al, 1982). Indeed, bovine IFN-g was cloned from a
phage library containing cDNA derived from lymphocytes stimulated
with concanavalin A for 17 hours (Cerretti et al, 1986).
The second requirement is to have a sensitive probe that will detect
the small quantities of either DNA or protein in a phage plaque.
Both random-primed 32P-labelled Ovifn and 32P-end-labelled
oligonucleotide probes were used to detect IFN-g DNA sequences in
the libraries. Both were calculated to be labelled at more than 1 x
107 cpm/pg which is a commonly quoted minimum activity required
(Sambrook et al, 1989). The lack of success using these probes
could therefore be due to absence of a clone in the library or
excess washing of the filters. Standard conditions for the
hybridization and washing of membranes hybridized with the
oligonucleotide probe were used (Sambrook et al, 1989). The washing
conditions for the Ovifn probe may have been a problem when the
melting temperature for the probe-insert duplex is calculated.
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With a wash solution containing 0.2 x SSC (i.e. 0.033M Na+), the
melting temperature can be calculated according to the equation of
Bolton & McCarthy (1962):
Tm = 81.5 - 16.6(logio[Na+]) + 0.41(% G+C) - (600/n)
The % G+C is 32 for OVifn, and the probe length (n) is 302. This
gives a Tm of 67°C. The wash temperature used of 65°C could have
removed a significant amount of the probe from the filters.
Further experiments to demonstrate the presence or absence of an
IFN-g-specific sequence in the library by using the oligonucleotides
already used to clone Ovifn in a PCR with phage DNA as template
showed that no clones were detectable by this sensitive method.
This is much the more likely explanation for the repeated failure to
clone by this method.
Screening the Agtll library using the antisera against recombinant
bovine IFN-g was as frustrating as screening the AZAP library with
the DNA probes. Although antibody screening is useful when a
specific antisera or monoclonal antibody is available, it
theoretically has less chance of success than using a DNA
hybridization technique. Any phage containing the desired cDNA
sequence must also have it in the correct orientation for
expression. It must also be in the correct translational reading
frame. Consequently only one in six phage containing the desired
DNA are likely to be expressed correctly. The library must be
relatively enriched for the cDNA desired. Afftll libraries suffer
from the fact that nonabundant mRNAs are represented very rarely, if
at all, and often encode only a 3'-terminal portion of the gene
(Snyder et al, 1987). Also Agtll libraries contain non-recombinant
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phage as there is no elimination step during amplification of the
library. A further problem with expression screening of libraries
is that the antibody probe may be directed against a contaminant in
the original antigen preparation, or that other proteins may share
epitopes with the protein of interest (Young & Davis, 1983a). The
clones thus isolated have to be taken to the seguencing stage before
they can be discarded in confidence.
The isolation of an immunoreactive phage led to much work to verify
its true nature. The production of lysogenic colonies and
subsequent culture to obtain protein for SDS-PAGE immunoblotting did
not resolve the potential of the phage clone, and its subcloning and
sequencing were a major problem which could not be resolved. A
larger (3-galactosidase fusion protein should be seen on an SDS-PAGE
after protein synthesis by a lysogenic culture, but its absence does
not eliminate the possibility of this phage clone expressing ovine
IFN-g sequences unfused to P-gal. The phenomenon of has been
reported, especially when using genomic libraries, and may be due to
degradation or anomolous translation initiation (Young & Davis,
1983). Unfused proteins may still be under the influence of the
lacZ promoter (Snyder et al, 1987).
Restriction endonuclease digestion of phage DNA did not release a
fragment which could be subcloned. This may be due to loss of
restriction sites during the library production as other workers
have suffered similar problems (C. Fiskerstrand, personal
communication). This is a not-uncommon finding with ^gtll, where
positive appearing phage plaques cannot be subcloned as the
restriction digest sites appear to have been disrupted during the
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library generation. It was for this reason that AZAP was originally
devised, with its easy recovery of the insert from within the
Bluescript phagemid (Short et al. 1988).
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Figure 27.
Agarose gel of products of polymerase chain reaction utilizing IFN-
g-specific primers. A 300bp DNA band is marked.
 
Figure 28.
Primers 343E and 344E that were used in initial PCR experiments are
shown. Plasmid 14 and plasmid 19 were synthesized by PCR and their
sequences are shown. The origin of the "primer-dimers" are
indicated.
Figure 28.
343E (5') 5'-GGGCCTCTCTTCTCAGAAATT-3' 238-258
344E (3') 5'-TGACTTCTCTTCCGGTTTCT-3' 541-560
Plasmid 14:
| 344E || 344E || 344E--*—-|
TGACTTCTCTTCCGGTTTCTTGACTTCTCTTCCGGTTTCTTGACTTCTCTTCCGGCTTTCTGAGAAGAGAGGCCCAATTTCTGAGAAGAGAGGCCCAATTTCTGAGAAGAC
| AA 343E || 343E || 343E--
Plasmid 19:
| 343E | GG 343E |
GGGCCTCTCTTCTCAGAAATT* *GCCTCTCTTCTCAGAAATTGGAAGAGAAGTC*AGAAAGCGGAAGAGAAGTCA
| CC 344E A| C---344E |
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Figure 29.
Autoradiograph of sequencing gel of pOVifn. Clones 4 and 5 are
shown side by side. The eight tracks in lane P were run for 4
hours, and those in lane S for 2 hours. The first four tracks in
each lane reading from the left are adenine (A), cytosine (C),

































































Comparison of amino acid sequences of bovine IFN-g (BOV) and that
predicted for ovine IFN-g from the nucleotide sequence of plasmid
OVifn (OVifn). Identity is indicated I and non-identity by X.
Figure 30.
|—SIGNAL SEQUENCE-j 1 50




BOV QIVSFYFKLF ENLKDNQVIQ RSMDIIKQDM FQKFLNGSSE KLEDFKKLIQ IPVDDLQIQR KAINELIKVM
! 111111!! I llllllllll 1111111111 11111! 1111 llllimil 111111111! Illlllllll
OVifn QIVSFYFKLF ENLKDNQVIQ RSMDIIKQDM FQKFLNGSSE KLEDFKRLIQ IPVDDLQIQR KAINELIKVM
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Comparison between the nucleotide sequeneces of OVifn, ovine IFN-g
derived by Mclnnes et al (1990) (OVmc), ovine INF-g derived by
Radford et al (1991) (OVra), and bovine IFN-g (Cerretti et al,
1986) (BOV). Differences between sequences are marked. Where two




OVmc AAG GAG TAT TTT AAT GCA AGT AAC CCA GAT GTA GCT AAG GGT GGG CCT CTC
OVra cT
BOV G
OVifn OLIGO 343E >|TTG AAG AAT TGG AAA GAG GAG AGC GAC AAA AAG ATT ATT
OVmc T
OVra tc
BOV T ..A ..T A
















OVifn ATC AAG GTG ATG AAT GAC|<—-REVERSE OLIGO 474F-—-|





7-15% gradient SDS-PAGE gel of lysogenic cultures of >,1.14 stained
with coomassie blue. Cultures were induced or non-induced with
IPTG.
Lane
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Figure 33.
Immunoblot of lysogenic cultures either induced (I) or non-induced
(NI) with IPTG to express recombinant protein. Blots were run under
non-reducing conditions. Blots developed to show reactivity with HB
8291 (anti-human IFN-g peptide), VPM37 (anti-ovine class II), NRS
(preimmune rabbit sera), or R167/8 (anti-recombinant bovine IFN-g).
Specific bands seen only in HB 8291 and R167/8 are marked «.
Molecular weights are indicated down the sides.
 
5 CYTOKINE mRNA LEVELS IN ACTIVATED LYMPHOCYTES.
5.1 INTRODUCTION.
5.1.1 CELL SUBSETS INVOLVED IN IFN-q PRODUCTION IN VITRO.
Most cells involved in the immune response are capable of secreting
a number of cytokines. T cells, B cells, NK cells, monocytes and
macrophages can all produce several cytokines following activation
(Arai et al, 1990). These cytokines are produced by cells which
have been induced from the resting state to the G1 phase of the cell
cycle (Stadler et al, 1981). Several cytokines may be produced by a
cell following a single stimulus, but different stimuli may induce
different combinations of cytokines (Gauchat et al, 1991).
Examination of T cell subsets for the production of cytokines,
including IFN-g, has concentrated on the CD4/CD8 division. Intra¬
cellular immunofluorescent staining of human mononuclear cells
freshly isolated from blood has demonstrated that in vitro anti-CD3
stimulation induces IFN-g production by cells expressing T cell
antigens CD2, CD3 and CD4 or CD8 or natural killer cell markers CD16
(Andersson et al, 1988). Staining for CD45R isoforms indicated that
production was predominantly by CD45RO+ cells, i.e. memory cells.
The overall picture that emerges is that early IFN-g production is
by memory CDS'" and CD4+ cells, and later production is supplemented
by virgin T cells, and an unknown group of cells, probably NK cells.
Similar studies in mice by the same authors confirm the role of CD8+
cells in IFN-g production during a mitogen response, where 90-95% of
IFN-g-producing cells were of this phenotype (Sander et al, 1991).
Human CD4+ T cell clones stimulated by Concanavalin A, or ionophore
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and phorbol esters nearly all produced IL-2, IL-4 and IFN-g
(Palliard et_al, 1988). All CD8+ T cell clones produced IL-2 and
IFN-g, but only a third to a guarter of them produced IL-4.
Stimulation of T helper cells by specific antigen also results in
synthesis of IFN-g (Landolfo et al, 1982; Conta et al, 1983;
Kasahara et al, 1983). Human rabies vaccine recipients have rabies
virus-specific CD4+, class II restricted T cells, and CD8+ T cells,
which both produce IFN-g when exposed to rabies antigens (Celis et
al, 1986). Patients immunized against influenza virus have CD8+
cells which secrete IFN-g on re-exposure to influenza antigens
(Ennis & Meager, 1981; Yamada et al, 1986).
Much recent work has been prompted by the observation that isolated
murine CD4+ T cell clones can be categorized into two major groups,
known as T helper 1 and 2 (ThI and TH2) (Mosmann & Coffman, 1989).
These two groupings synthesize different cytokines during
activation. ThI cells synthesize IFN-g, IL-2, LT (lymphotoxin), GM-
CSF (granulocyte-macrophage colony stimulating factor), TNF and IL-
3, and are involved in promoting delayed type hypersensitivity (DTH)
and immunoglobulin isotype class-switching to IgG2a. Th2 cells
synthesize IL-3, IL-4, IL-5, IL-6, IL-10, and lesser amounts of TNF-
a and GM-CSF. They are involved in B cell growth and
differentiation, and isotype class-switching to IgM, IgGl, IgA and
IgE. Mouse CD8+ T cell clones mainly produce the THt~cell cytokine
pattern, although IL-2 production is commonly low or absent (Fong &
Mosmann, 1990). Two further T helper groups have been identified
from mouse T cell clone cytokine secretion profiles, the Thp group
and the Tho group (Mosmann & Moore, 1991). The THp group produce
only IL-2 and are thought to be T cells that have not been
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stimulated recently, whilst the ThO group produce IL-2, IFN-g, GM-
CSF, IL-3, IL-4, IL-5 and IL-10. The role of these two groups is
unclear at present.
The different cytokine profiles have been used to predict the
expected roles of the two subsets in normal responses to immunogens.
The ThI response is expected to result in the enhancement of various
cytotoxic mechanisms. IFN-g enhances the synthesis of Fc receptors
for IgG2a antibodies on macrophages, and also causes class-switching
to IgG2a antibodies. The macrophages are activated by both IFN-g
and LT to kill intracellular parasites and tumour cells. The
combination of these responses would enhance the antibody-mediated
macrophage cytotoxicity. ThI cells are expected to cause DTH
responses, and in the absence of a TH2 response would give a DTH in
the presence of little or no antibody. IFN-g acts to reduce the
proliferation and activation of Th2 cells.
Th2 cell responses are primarily expected to help in the synthesis
of a good antibody response to an antigen. Most of the cytokines
synthesized by Th2 cells are primarily active on B cells. Antibody
class-switching to IgE mediated by IL-4 is accompanied by increased
levels of Fc receptors for IgE on B cells (Rousset et al, 1988), and
IL-3 and IL-4 act synergistically as growth factors for mucosal mast
cells, which also possess Fc receptors for IgE. IL-5 induces the
proliferation and differentiation of eosinophils. Elevated IgE
concentrations, high numbers of mucosal mast cells and circulating
eosinophils are all present in nematode responses.
The presence of similar helper T cell subsets in humans is still the
subject of debate, and they have not been demonstrated for any other
species.
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The differential synthesis of some cytokines has been related to the
presence/absence of CD45R (Leukocyte Common Antigen) isoforms on
CD4+ cells. CD45 antigen has a number of molecular isoforms which
are dependent on the exons used in the mRNA synthesis and the
different isoforms are believed to define cells involved in cell-
mediated or humoral immune responses. CD45RA isoform contains the A
exon in the molecule, the CD45RB isoform contains the CD45RB exon,
whilst the CD45RO contains neither of the exons.
Morimoto et al in 1985 defined two subsets of T cells, CD45RO CD4+
cells which mainly provide help for immunoglobulin synthesis by B
cells and CD45RA+B+ CD4+ cells which exert no helper functions, but
induce CD8+ T cells to become suppressive (Morimoto et al, 1986).
CD4+ T cells expressing CD45RO antigen are known to proliferate in
response to soluble recall antigen, and are thus defined as memory
cells, whilst CD45RA+ CD4+ cells do not proliferate to soluble
recall antigen, and are thus naive cells. Further study has
redefined the initial two subsets into three depending on the degree
of expression of each isoform of CD45 as assessed by FACS
brightness: CD45RAtorisIht Bb3ris,ht -- naive cells; CD45RAdu11
-- memory cells for IFN-g production; CD45RAdu11 Baul1 -- memory
cells for B cell help (Mason & Powrie, 1990).
All these experiments demonstrate cytokine production after in vitro
polyclonal stimululation. Few experiments have been performed to
assess the relative contributions of T cell subsets to IFN-g
production during an immune response in vivo.
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5.1.2 CELL SUBSETS INVOLVED IN IFN-g PRODUCTION IN VIVO.
The cells synthesizing specific cytokines has been examined during
an in vivo immune response. Gessner et al (1989) examined the
secretion of IFN-g by mouse spleen cells in response to infection
with lymphocytic choriomeningitis virus using a cell spot ELISA. In
vitro negative selection of T cell subsets demonstrated that T cells
were the major producers of IFN-g, and that production was egually
divided between CD4+ and CD8+ cells. IFN-g production during an in
vivo immune response to a thymus-independent antigen has been shown
by immunohistochemical staining of spleen cells to be egually
divided between CD4 and CD8 cells, with a small contribution by NK
cells (10%). The peak production of IFN-g was found days 6-7 after
immunization (Van den Eertwegh et al, 1991).
If either Tm or TH2 cells were to be activated in isolation, the
predicted immune response would be of delayed type hypersensitivity
or antibody dependent hypersensitivity respectively. This suggests
that during the production of hypersensitivity the balance between
the two types of helper cells is shifted, perhaps by excess or
absence of IFN-g or IL-10, and this shift determines whether a
mainly cellular- or a mainly antibody-dependent hypersensitivity is
induced. In vivo evidence for the separation of helper T cells into
ThI and Th2 phenotypes has been identified in the murine response to
Leishmania infection. C57BL/6 mice resolve infection and have high
levels of IFN-g mRNA in their draining lymph node and spleen
indicating the excessive activation of Thi cells, compared with
BALB/c mice which suffer fatal progressive disease and produce IL-4
mRNA in their lymph node as a result of excess activation of TH2
cells in the absence of Thi cells (Heinzel et al, 1989). T cells
from resistant BALB/c mice secrete IFN-g (detected as macrophage
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activating factor), but susceptible mice secrete IL-3 and IL-4 which
inhibit the leishmanicidal activity induced by IFN-g (Liew et al,
1989).
5.1.3 REGULATION OF CYTOKINE GENES.
The regulatory DNA seguences of the cytokines have been examined to
determine the mechanism of the differential induction patterns. The
regulatory gene sequences of the cytokines seem to have only limited
homology except for a lObp consensus sequence in the 5' flanking
regions of some, including hGM-CSF, mGM-CSF, hIL-2, mIL-2, hIL-3,
mIL-3, hIL-4, mIL-4, hIL-5, and hG-CSF (Stanley et al, 1985; Arai et
al, 1990). Human IFN-g has a sequence which resembles the consensus
sequence but it is in the reverse orientation. The factor(s) which
transmit the activation signals from the secondary messengers, i.e.
protein kinase C and calcium influx, to the nucleus are at present
unknown, but there is a suggestion that the nuclear factor AP-1,
which binds to phorbol ester-responsive elements (TREs) (Angel et
al, 1987), may regulate both IL-2 and IFN-g genes as they both have
the TRE sequence motif in their 5' flanking regions (Taniguchi,
1988).
The cytokine genes may also be regulated post-transcriptionally.
Within the 3' untranslated region of many cytokines are particular
conserved motifs of AU rich sequences, which have been shown to
destabilizee mRNA species previously highly stable. The AT-rich
sequence from human GM-CSF was inserted into the 3' coding region of
the rabbit (3-globin gene rendering this previously very stable gene
unstable. The sequences were proposed to be recognition signals for
an mRNA degradation pathway (Shaw & Kamen, 1986). They are
currently thought to be used by cytokines and proto-oncogenes.
163
5.1.4 MEASURING mRNA IN ACTIVATED LYMPHOCYTE POPULATIONS.
Cells communicate with each other not only by cell-cell contact, but
by the release of soluble mediators (cytokines) such as interferons,
growth factors and interleukins. These factors are secreted from T
cells which are bound to antigen presenting cells, and secretion
occurs principally from the side of the T cell contacting the APC
(Poo et al, 1988). The presence of these cytokines has typically
been assessed by bioassay on sensitive cell lines or by immunoassay
with antibodies to the cytokine. Both types of approach have
several limitations. The free cytokine detected in supernatants is
only representative of the difference between the amount of cytokine
secreted and the amount of cytokine consumed by cells, bound to
receptors or bound to natural antagonists. The detectable cytokine
may at worst only represent the amount of cytokine that has leaked
into the tissue fluid being assayed. The bioassays are typically
time-consuming and commonly of debatable specificity due to the
pleiotropy and redundancy of cytokines (Paul, 1989). The
immunoassays are dependent on the availability of appropriate
antibodies.
The measurement of cellular cytokine mRNA levels may represent more
accurately the amount of cytokine production at any one time. This
assumption has been tested for the measurement of IL-2. IL-2
secretion and IL-2 mRNA concentrations measured by northern blotting
were found to correlate (Gauchat et al, 1986). mRNA and protein
concentrations of both IFN-g and IL-2 produced by mitogen-activated
CD8+ T cell clones were strongly correlated, although IL-2 protein
concentrations were sometimes low in the presence of high
concentrations of mRNA (Fong & Mosmann, 1990). Correlations for -
other cytokines will depend on the stability of the mRNA, as very
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short or long half-lives may upset the correlation. The assessment
of cytokine mRNA levels may be made using hybridization methods with
complementary probes such as cDNAs, cRNAs or oligonucleotides. This
method.of Northern blotting is certainly the simplest method but is
regarded as being relatively insensitive, although advances in the
generation of high specific activity labelled probes have improved
sensitivity (Feinberg & Vogelstein, 1983). Northern blotting has
become the standard method for some groups analysing cytokine mRNA
(Gauchat et al, 1991). Ribonuclease protection analysis is a more
sensitive method and has been used for cytokine analysis (Lowry et
al, 1989) but requires relatively large amounts of mRNA. The
polymerase chain reaction is the most sensitive method available for
cytokine gene detection (Dallman et al, 1991) but its very
sensitivity makes it more difficult to use as a quantitative
measure. Quantitation has been attempted with a variety of internal
checks to assess the semi-quantitative nature of the assay. The
control genes used in the PCR techniques have included cellular
actin (Dallman et al, 1991), cloned and cellular aldolase A (Chelly
et al, 1988), and a synthetic cRNA containing primer sites for
multiple cytokines each producing a similar sized product when
specifically subjected to PCR (Wang et al, 1989). Measurement of
product synthesized varied from specific hybridization to
radioactive counting of 32P-labelled primer incorporated in the
product. The ability to quantitate the amount of mRNA is dependent
on the efficiency of the cDNA synthesis, the efficiency of the PCR,
and the amount of template in the reaction.
The sensitivity of the PCR technique has also allowed the analysis
of mRNA within single cells. This technique, known as single-cell
RNA phenotyping, is claimed to be able to detect less than 100 mRNA
molecules (Rappolee et al, 1989). This degree of amplification was
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achieved after 60 cycles of the PCR. The technique allows the in
vivo or in vitro study of short-lived, low-copy number mRNA
transcripts isolated from small numbers of cells.
5.1.5 OBJECTIVES.
The production of IFN-g during an in vivo immune response has not
been studied extensively with respect to the T cell subsets
producing it. Although it is known that CD4+ and CD8* T cells
synthesize IFN-g in vitro, the relative contributions during an in
vivo response are ill defined.
A qualitative PCR was developed which would allow the detection of
IFN-g mRNA transcripts within isolated cell populations. Initial
development was made using mRNA from Concanavalin A-stimulated
cells. Optimization of the PCR was performed with regard to Mg++
concentration and also the number of cycles required to allow
detection of PCR product during its exponential increase phase. A
new technique of cell separation was used to allow rapid isolation
of the T cell populations to high purity without recourse to a
fluorescence activated cell sorter (FACS). This new technique,
known as magnetic activated cell sorting (MACS), allows isolation of
cells much quicker than FACS (10s cells in 1\ hours by MACS,
compared with 6 hours by FACS at 5,000 cells per hour) and without
cellular activation by antibody cross-linking due to the small size
of the superparamagnetic beads (<100nm) (Miltenyi et al, 1990). The
beads are made of ferritin bound to dextran, and subsequently
coupled to biotin. The beads do not affect cell viability. The
technique has been used previously to deplete human bone marrow of T
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cells prior to transplantation (Kogler et al. 1990). It gave
recovery of cells between 50% and 70% depending on cell phenotype,
and had less than 0.1% clonable T cells remaining.
An in vivo immune response to antigen by a primed sheep was studied
at the lymph node level and the IFN-g mRNA levels in isolated cells
assessed to discern the population of T cells responsible for its
synthesis.
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5.2 MATERIALS AND METHODS.
5.2.1 OPTIMIZATION OF THE PCR FOR SEMI-QUANTITATIVE ANALYSIS.
5.2.1.1 OPTIMIZATION OF THE PCR MgClz CONCENTRATION.
The PCR of interferon-gamma, using the primers 343E and 474F was
optimized with respect to magnesium concentration. PCR x 10 buffer
contained lOOmM Trizma.Cl pH8.4, 500mM KC1 and lmg/ml gelatin. All
other factors were as in section 4.2.2.1. Different concentrations
of magnesium chloride were included in each reaction tube (1,2,3,4,5




35 cycles were performed. A lOpl aliquot of each reaction was run
on a 2% agarose gel.
5.2.1.2 OPTIMIZING CYCLE LENGTH FOR THE PCR.
mRNA was extracted from lymphocytes stimulated with Concanavalin A
for 24 hours. cDNA was synthesized as before (section 4.2.1) and
used as template DNA. The PCR was performed using the reaction
conditions optimized above in a volume of 150pl. From the end of
the 18th cycle onwards and after every third subsequent cycle, a
10pl sample was removed from the reaction tube. These were
electrophoresed on a 2% agarose gel and then transfered to Hybond N
(Amersham) by Southern blotting overnight. Prehybridization was
carried out for 2 hours at 65°C in Prehybridization solution 1
(Appendix 4) containing 20pg/ml of denatured salmon sperm DNA
(Sigma). The previously cloned PCR product was labelled by random
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primed synthesis to incorporate a-32P-dCTP before hybridization at
65°C for 16 hours in hybridization solution 1 (Appendix 4). The blot
was washed twice at 20°C in 2 x SSC/0.1% SDS, once in 1 x SSC/0.1%
SDS at 65°C, and stringently washed twice with 0.5 x SSC/0.1% SDS at
65°C for 10 minutes. The blot was autoradiographed on Kodak S film
at -70°C for 72 hours with an intensifying screen.
5.2.1.3 INDUCTION OF INTERFERON-GAMMA BY CONCANAVALIN A.
Efferent lymph fluid draining from a chronically-cannulated
prefemoral lymph node was collected overnight into a bottle
containing heparin (500IU), penicillin (5000IU) and streptomycin
(5000pg). Cells were washed twice in ice-cold Hanks Buffered Salt
Solution and counted. An aliguot of cells were lysed in 9ml of 4M
GTC solution (Appendix 4). A further 10s cells were cultured in
each flask at 5 x 106 cells/ml in Iscoves medium (Sigma)
supplemented with BSA (500pg/ml), human transferrin (25pg/ml),
palmitic, oleic and linoleic oils (all at lpg/ml), fungizone
(252pg/ml), penicillin (50U/ml) and streptomycin (50pg/ml).
Concanavalin A (Sigma) was added to each flask at lOpg/ml. Cells
were incubated at 37°C in 5% carbon dioxide. Cells and supernatant
were harvested at intervals after stimulation by centrifugation at
400xg for five minutes. Supernatant was immediately frozen at -70°C
until assayed for ovine interferon-gamma using the ELISA kit for
bovine IFN-g from Australia (Commonwealth Laboratories, Victoria,
Australia). Cells were resuspended and lysed in 9ml of 4M GTC
solution. DNA was sheared by forcing the lysate through a 19G
needle five times.
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RNA was isolated by ultracentrifugation over 2ml of 5.7M caesium
chloride (DEPC-treated) in an SW41 rotor at 28000 RPM for 16 hours
at 20°C in a Beckman L70 ultracentrifuge. Careful removal of the
supernatant was followed by resuspension of the RNA in 360pl of TES
(Appendix 4) for 10 minutes. RNA was precipitated by addition of
40pl of 3M sodium acetate pH5.5 and 1ml of 100% ethanol. After 2
hours at -70°C the RNA was pelleted at 12000xg for 20 minutes and
the pellet resuspended in 360pl of DEPC-treated distilled water.
The RNA was precipitated again by the same method. RNA
concentration and purity were measured using UV spectrophotometry at
both 260nm and 280nm.
Interferon-gamma mRNA was analysed using the optimized semi¬
quantitative PCR described previously. Ten micrograms of total RNA
was entered in a cDNA synthesis reaction using the Amersham cDNA
Synthesis Kit. lOpCi of a-32P-dCTP was included in the reaction to
assess the synthesis of the cDNA. Fifty microlitre PCR reactions
were performed on one tenth of the cDNA synthesized. Ten microlitre
aliquots were removed from all the reactions after 20, 25 and 30
cycles and electrophoresed on a 2% agarose gel. The gel was treated
as described for a Southern blot, transferred in 20 x SSC onto
Hybond C (Amersham) and hybridized using a-32P-dCTP-random-primed
labelled pOVifn as probe. The probe was labelled to 6.5 x 10s
cpm/pg. The membrane was prehybridized, hybridized and washed as in
5.2.1.2.
Media taken at the same intervals was analysed using the Bovine
Interferon-gamma ELISA kit available from Commonwealth Serum
Laboratories, Parkville, Victoria, Australia. This kit was
developed using two high affinity monoclonal antibodies against
bovine interferon-gamma (Rothel et al, 1990; Wood et al, 1990). The
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ELISA takes the form of a sandwich immunoassay with a polystyrene
plate precoated with one of the two monoclonal antibodies, and
horseradish peroxidase-conjugated second monoclonal as the detector.
Standard solutions containing bovine interferon-gamma are included
in the kit. The kit is claimed to detect down to at least 50 pg/ml
of bovine interferon-gamma. The kit is designed to be used as a
test for Mycobacterium tuberculosis infection in cattle, when used
in conjunction with a lymphocyte stimulation assay in response to M.
tuberculosis and M. avium. The kit was assessed against ovine IFN-
g in the original paper (Rothel et al, 1990) and has also been
validated for use with ovine interferon-gamma by comparison with a
standard anti-viral assay (G. Enterican, personal communication).
5.2,2 CELL ISOLATION USING MAGNETIC CELL SORTER (MACS).
Efferent lymphatic cells (2-3 x 10s) were washed once in PBS/1%
BSA/0.1% sodium azide/5mM EDTA (MACS buffer) and resuspended at 2-3
x 107/ml before incubation with anti-sheep CD4 (SBU-T4) or anti-
sheep CD8 (SBU-T8) (Maddox et al, 1985) for 60 minutes, followed by
washing once in MACS buffer and centrifugation at 1500RPM for 8
minutes. a-Amanitin (Sigma) was included in this staining mix at
lOpg/ml to inhibit RNA polymerase II transcription of mRNA (Holmes &
Higgins, 1990). Cells were then incubated with anti-mouse
immunoglobulin biotin (Boehringer Mannheim) at 1/1000 for 60
minutes, washed once and then incubated with streptavidin
(Boehringer Mannheim) at 1/1000 for 20 minutes. Cells were washed
in MACS buffer again and then incubated with MACS biotin-microbeads
for 5 minutes immediately prior to separation. All incubations were
performed on ice. A MACS A2 separation column (3 x 107 cell
capacity) was pre-cooled and eguilibrated with ice-cold MACS buffer
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prior to the cells being loaded. The non-magnetic cells were washed
through with 15ml of MACS buffer, a 24G 1" needle determining the
flow rate (approximately 0.6ml/hr). The magnetic cells were washed
back up the column with MACS buffer to release non-magnetic cells
trapped in the matrix, and then washed through with a further 10ml
of buffer. The non-magnetic cells were collected as they left the
column, while the magnetic cells were released by the removal of the
column from the magnetic field. The magnetic cells were flushed
through the column in 15ml of MACS buffer. 25pl aliguots of the
pre-separation, non-magnetic, and magnetic fractions were stained
with 50pl of 1/1000 anti-mouse Ig fluoroscein isothiocyanate (FITC)
for 30 minutes. The guality of the selection was assessed on the
FACScan as described previously (section 3.2.5), and by cell count.
5.2.3 ANALYSIS OF IFN-g mRNA DURING THE SECONDARY RESPONSE TO
OVALBUMIN IN ISOLATED LYMPHOCYTE POPULATIONS.
On the day prior to surgery a 4 year old Finn sheep was injected
with 0.5mg of ovalbumin in PBS intravenously to enhance a subseguent
response to intradermal inoculation. The sheep had been injected
with lmg of ovalbumin in complete Freund's adjuvant nearly three
years previously. The prefemoral lymph node of the sheep was
cannulated by standard technigues (Hall & Morris, 1962). Lymphatic
fluid was collected into a 250ml sterile bottle containing heparin
and a penicillin/streptomycin mix. The fluid was discarded for the
first six days to allow the effects of the surgery to settle down.
On the seventh day after surgery the sheep was inoculated
intradermally into the drainage area of the prefemoral lymph node
with 250pg of ovalbumin in 1ml of PBS. Collections of lymphatic
fluid were made each day. Cell counts and fluid volume produced
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were measured continuously. Approximately 1 x 10s washed
unfractionated cells were lysed in 9ml of 4M GTC. A sample of
lymphatic supernatant was stored at -70°C for later analysis by the
bovine IFN-g ELISA kit (Rothel et al, 1990).
Each day a sample of efferent lymphatic cells was stained as in
section 5.2.2 for separation into CD4+ and CD8+ populations by MACS.
The released magnetic cells were counted and assessed for purity by
FACS. The cells were centrifuged and then lysed in 4M GTC and
stored at -20°C until the RNA was isolated by ultracentrifugation
over a 5.7M cesium chloride gradient as in section 5.2.1.3
Each RNA preparation was measured by UV spectroscopy at OD260nm.
RNA from unseparated, CD4+ and CD8+ cells was converted to cDNA
(section 5.2.1.3), and was then incorporated in the PCR described in
section 5.2.1.3. 10pl of each of the PCR reactions was taken at 15,
20, 25 and 30 cycles. These were separated on a 2% agarose gel,
transfered to Hybond N and hybridized with labelled pOVifn, as
described in section 5.2.1.2. The membrane was autoradiographed on
Kodak-AR film for 48 hours at -70°C.
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5.3 RESULTS.
5.3.1 OPTIMIZATION OF THE PCR PROTOCOL.
Assessment of the role of magnesium in the optimization of the
polymerase chain reaction was performed to enable a semi¬
quantitative type of PCR to be made later. Varying the magnesium
concentration had a marked effect on the products formed during the
PCR (Figure 34). At both ImM and 2mM MgCl2 the products visible on
an ethidium bromide-stained gel were seen to be very largely the
single 302bp band expected. At higher molarities up to six
secondary bands of greater molecular size were visible. These bands
were up to 1Kb in size, although the principal three bands were less
than 564bp. Smearing of DNA of less than 302bp length was more
apparent in reactions that contained lower concentrations of
magnesium. A concentration of 2mM MgCl2 was chosen as the optimum
for all further polymerase chain reactions involving these
particular primers as the larger bands seemed of more importance
than the lower smearing because of their uniformity. This
concentration is not unexpected because Tag polymerase requires a
free magnesium concentration of approximately ImM (Innis et al,
1988). The free Mg concentration is less than the total
concentration because deoxynucleotides bind Mg ions in equimolar
concentrations, and the total deoxynucleotide concentration in the
PCR is 0.8mM. Hence the free Mg concentration in the optimized PCR
is 1.2mM.
To assess the number of cycles required before reagents become
limiting a PCR was performed in which product was sampled at
intervals and assessed by both ethidium bromide staining and
Southern hybridization using the pOVifn probe. A reaction was
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prepared using the conditions described in the materials and methods
section. Samples taken at 3 cycle intervals from the 18th cycle
onwards were analysed by Southern hybridization probed with labelled
pOVifn. This revealed that the PCR product first became visible at
the 21st cycle (Figure 35). The PCR product also appeared at the
21st cycle on the ethidium bromide stained gel. This probably
indicates that the probe was not labelled as efficiently as desired;
it should detect much less than lOng of DNA which is reckoned to be
the limit for ethidium bromide staining. The blot did reveal
additional bands present of smaller length than the 302bp product.
These continued to accumulate until the last cycle point sampled
(cycle 42).
Previous workers have determined that for a semi-guantitative
assessment of mRNA levels in cells, the reaction samples should be
taken whilst the PCR product is accumulating in an exponential
manner before the nucleotides, primers or enzyme become limiting.
The amount of amplified product is proportional to the abundance of
the starting material (Chelly et al, 1988). From the gel and blot
shown this would seem to be between the 24th cycle and the 30th
cycle. This particular result, however, would only apply if the
quantity of IFN-g mRNA in twelve-hour stimulated lymphocytes is
typical of the amounts that are required to be amplified. A time
course was performed to determine if the IFN-g mRNA at twelve hours
was the peak level of IFN-g mRNA.
5.3.2 INDUCTION OF INTERFERON-GAMMA BY CONCANAVALIN A.
RNA was isolated from lymphocytes that had been stimulated with
Concanavalin A for a variety of time periods up to 48 hours. The
cDNA synthesis was assessed by a-32P-dCTP incorporation and
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Cherenkov counting of the acid-precipitatable material (Table 4).
These figures indicate that the cDNA synthesis reactions
incorporated between 0.07% and 0.29% of the radioactivity included
in the reaction. The figure of 0.29% is high in comparison with the
other figures, and cannot be explained by the general assumption
that mitogen stimulation induces an overall increase in mRNA levels,
as the incorporation of label in cDNA synthesised from RNA at 12, 36
and 48 hours are consistently at the 0.1% level. Although the
incorporation figures for 2 and 24 hours are discrepant with respect
to the other figures, the cDNA was included in the subsequent
polymerase chain reaction.
A Southern blot of the time course at the three different sampling
points revealed some variation in the detection of PCR product
(Figure 36). The blot for product accumulated by 20 cycles showed a
single band for each timepoint of the expected size. This first
appeared faintly at 1 hour, but increased until 3 hours at which
point it reached a plateau until the last sample at 48 hours. The
band at 24 hours was greater than the other bands and this probably
represents the greater amount of cDNA synthesised from the RNA
available for use as PCR template.
The blot for product accumulated at 25 cycles showed a similar
pattern but of greater intensity.
The blot for 30 cycles showed a different pattern. In each lane
where previously one band was visible, two bands could now be seen.
One band was of the same size as the previously seen PCR products,
but the other was approximately 150bp larger. The second band was
of the same intensity as the first throughout the timepoints. This
suggests that the additional band was not present at all after 20 or
176
25 cycles, as a band would have been visible on both the stained gel
and the blot. Study of the photograph of the gel showed that the
loading wells appeared to have an unusual fluorescence pattern. It
is possible that the wells have all torn at the top edge when the
comb was removed. This would allow leakage of PCR product into a
small crevice 1mm further back from the leading edge of the well.
DNA would run along the bottom of the gel and this would correspond
to a shift in size on a blot of l-2mm. The presence of two bands
demands that the amount of product present after 30 cycles must be
interpreted with some care in this experiment.
The time-course of IFN-g protein accumulation was assessed with the
bovine IFN-g ELISA kit (Figure 37). The concentration of IFN-g
rises significantly from about 6 hours although IFN-g protein is
detectable from 3 hours post-stimulation. The concentration
increases considerably until 48 hours and has decreased a little by
72 hours.
In summary, IFN-g mRNA begins to accumulate 1 hour after stimulation
with concanavalin A, and rises until 3 hours when it becomes
maximal. It remains at this level until at least 24 hours, and
begins to decrease by 36 hours. The IFN-g protein is detectable
from 3 hours and accumulates linearly until 48 hours. The best time
to sample the PCR seems to be at 25 cycles.
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5.3.3 IN VIVO IMMUNE RESPONSE TO OVALBUMIN.
5.3.3.1 QUALITY OF CELL SEPARATION.
The MACS technique was found to give consistently good results using
a biotin bridge method for coupling the biotin microbeads to the
cell surface. CD4+ cells typically comprised 50-65% of the efferent
lymphatic output, and 3 x 107 cells could routinely be purified to
95% by overloading the A2 MACS column with CD4+ cells (Figure 38).
CD8+ cells represented 10-20% of the efferent lymphatic output, and
could be purified to 90% (Figure 39). Overloading of the column was
more difficult due to the excessive number of cells required to
achieve this (>3 x 10s) as the lymph production was usually 5 x
106/ml and 70-80ml per day i.e. 3.5-4 x 10s cells. Typically only
1.5-2 x 107 CD8+ cells were purified on each occasion. As the
column capacity was 3 x 107 cells, other cell phenotypes could be
retained on it, and this explains the lower purity obtained for the
CD8+ cells.
5.3.3.2 IFN-q mRNA SYNTHESIS BY LYMPHOCYTES.
A DNA band of the correct size for the IFN-g PCR product was seen by
30 cycles of the PCR in all the reactions from cDNA of unseparated
cells, including that using cDNA derived from day 0 (Figure 40).
The intensity of the signal from each day was approximately
equivalent and showed no signs of diminishing towards the end of the
seven days. Although some variability in signal strength was
noticeable, this was not considered significant because of the
inherent problems associated with quantitation by PCR discusssed
earlier. CD4+ cells showed a variable level of PCR product with
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each day. At day 0, PCR product only became visible after 30 cycles
and even then at low level. By day 1 the level of PCR product was
high and detectable at 25 cycles. This level was maintained over
days 2 and 3, but was less by days 4 and 6. Day 7 registered as a
high level of IFN-g mRNA, visible as PCR product by 25 cycles. CDS""
cells, like the CD4+ cells, did not produce IFN-g mRNA at day 0, but
IFN-g mRNA was synthesized at high levels from day 1 to day 6 with
little variation in levels detected. The level was much reduced on
day 7.
5.3.3.3 IFN-q PRODUCTION MEASURED BY ELISA.
The concentration of IFN-g in each day's lymph fluid was assayed
using the bovine ELISA kit. The output is show graphically in
Figure 41. The concentration of IFN-g rose significantly to a peak
at day 3, and then declined until it returned to normal by day 7.
The IFN-g concentration detected for days 1 and 2 was not
significantly elevated. The peak concentration (day 3) was two and
a half times background.
179
5.4 DISCUSSION.
The analysis of mRNA by PCR techniques has been adapted to the
analysis of cytokine mRNA levels in activated cell populations in
vitro and in vivo. Methods for semi-quantitating the presence of
cytokine transcripts have been described which involve the
sequential assay of specific PCR product as the number of cycles
increases (Dallman et al, 1991). The PCR technique is claimed to be
up to one thousand times more sensitive than Northern blotting,
capable of detecting only ten thousand molecules (Wang et al, 1989).
A time course for induction of IFN-g mRNA has previously been
described in which lymphocyte stimulation was by phytohaemagglutinin
and detection was undertaken by in vitro translation of recovered
mRNA in Xenopus laevis oocytes (Efrat et al, 1982). The synthesized
IFN-g protein was then detected by an antiviral plaque assay. This
method detected IFN-g mRNA initially at 6 hours post-stimulation,
with rapid accumulation until a plateau was reached at 16 hours.
The kinetics of synthesis of IFN-g mRNA in vitro have also been
studied using Northern blotting (Efrat et al, 1984; Granelli-Piperno
et al, 1986; Gauchat et al, 1988). Following phytohaemagglutinin
stimulation of human PBLs, IFN-g mRNA concentrations peak at 24
hours and decline slightly by 48 hours. The results described in
5.3.1 indicate that IFN-g mRNA induced by Concanavalin A from sheep
lymphocytes can reach relatively stable and high levels by 3 hours
post-stimulation. This is likely to reflect the sensitivity of the
PCR technique, although it is possible that ovine IFN-g mRNA is
induced more rapidly.
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Intracellular immunofluorescent staining of human mononuclear cells
freshly isolated from blood has demonstrated that in vitro anti-CD3
stimulation induces IFN-g production with a biphasic peak in the
number of producing cells (Andersson et al, 1988). At the 6 hour
peak the IFN-g-producing cells were small resting lymphocytes, but
by the 24 hour peak a mixture of small lymphocytes and blast
transformed lymphocytes were stained. Studies by the same group
have demonstrated a similar biphasic peak of production during
stimulation by ionomycin and phorbol esters (Andersson et al, 1990).
The single peak of IFN-g production at 24 hour described in 5.3.1
indicates that ovine IFN-g synthesis kinetics are similar to that
described in other species, although the mRNA transcription appears
to peak much earlier.
There is no doubt that ovine lymphocytes have the capability of
rapidly synthesizing IFN-g protein which aids the commencement of an
active immune response. The IFN-g response of lymphocytes to an in
vivo primary antigenic stimulation has been studied at the protein
level. Immunization of antigenically naive sheep with inactivated
maedi-visna virus to give a primary immune response (not an
antiviral response) leads to no detectable synthesis of IFN-g in
efferent lymph (P. Bird, personal communication). Emery et al,
1990, found a similar result with inoculation of ovalbumin into
antigenically naive sheep. These results are predictable as most
IFN-g synthesis from CD4+ or CD8+ T cells is from the "memory"
subset. The CD4+ and CD8+ T cells in rats and humans responsible
for synthesis of IFN-g in response to Concanavalin A stimulation, or
ionomycin and phorbol ester stimulation are thought to be of the
memory phenotype, i.e. previously activated T cells (Mason & Powrie,
1990; Sanders et al, 1988; Andersson et al, 1990). These cells have
been subdivided on the basis of their cell surface leucocyte common
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antigen isoform. Memory type cells bear the CD45RAciui:L
phenotype and. secrete IFN-g, or the CD 4 5 RA^"13^1111 phenotype and
give B cell help. Naive cells (CD45RAfc>risht BbriSfht: ) secrete
little IFN-g in response to mitogen stimulation (Mason & Powrie,
1990).
In vivo synthesis of IFN-g during a secondary immune response has
been studied in sheep inoculated with ovalbumin and a variety of
adjuvants (Emery et al, 1990). In their experiment, IFN-g protein
was detected, using the same bovine IFN-g ELISA kit as used here,
from within 2 hours of antigen administration, and peak
concentrations occurred 6-16 hours later. The peaks contained three
to seven times the guantities of IFN-g measured prior to
inoculation, and the IFN-g concentration remained at least double
background up to 7 days post-inoculation. In the experiments
described here the concentration of IFN-g rose significantly to a
peak at day 3, and then declined until it returned to prestimulation
concentrations by day 7. The IFN-g concentration detected for days
1 and 2 was not significantly elevated. The peak concentration (day
3) was two and a half times background. The major differences
between the two experiments are that Emery's sheep were given their
primary inoculation in adjuvant only one month prior to the
secondary inoculation, whereas the sheep in this experiment received
its primary dose of lmg ovalbumin in Complete Freund's Adjuvant
nearly three years prior to the secondary dose, but did receive
0.5mg of ovalbumin in PBS intravenously on the day prior to
lymphatic vessel cannulation (one week before secondary antigenic
stimulation).
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Production of IFN-g has been attributed to T cells and natural
killer cells (Sandvig et al, 1987; Andersson et al, 1988). The
slower response of lymph node cells in the sheep described here may
reflect the progressive loss of memory T cells from the lymph node,
or the activation of memory T cells which have been quiescent for
many months compared with activation of cells only recently
committed to being memory T cells in Emery et al's experiment. A
noticeable response would be delayed until the recruitment of
sufficient memory cells from elsewhere in the sheep. Emery et al's
sheep would have higher concentrations of anti-ovalbumin antibodies
and also ovalbumin-specific B cells present in the lymph node. When
the ovalbumin was injected into the sheep, it would be rapidly bound
by both free antibodies and also B cell surface antibodies. It
would thus be rapidly presented to specific T cells, hence
stimulating earlier T cell activation and cytokine secretion.
This is the first reported analysis of IFN-g mRNA transcription in
efferent lymph draining a lymph node during a secondary immune
response. It represents a novel method of studying the
contributions of different cellular populations to IFN-g production
at a time when the antibodies required to stain ovine lymphocytes
intracellularly for IFN-g are not available.
The efferent lymph sample on day 0 was taken prior to the sheep
being stimulated with ovalbumin and at least seven days post
surgery. The presence of IFN-g mRNA on day 0 in unfractionated
cells can be seen to be due to the involvement of neither CD4+ nor
CD8* T cells. This observation leads to a conclusion that another
cell type within efferent lymph actively contains IFN-g mRNA, even
if these cells only synthesize or secrete IFN-g protein at low
levels. Evidence from intracellular staining of human lymphocytes
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has demonstrated that only half the cells stimulated by anti-CD3
antibodies to produce IFN-g protein were CD3+ , and CD4+ or CD8+,
and that 25% were CD16+ cells (presumptive natural killer, NK,
cells) (Sandvig et al, 1987; Andersson et al, 1988). The remaining
25% of IFN-g producing cells were IL-2R+, erythrocyte-rosetting
cells but could not be ascribed to the B cell, T cell or monocyte
lineages. Stimulation of human PBLs by ionomycin and phorbol ester
indicated that 20% of lymphocytes produce IFN-g with a biphasic
peak. Of the IFN-g-producing cells at the 6 hour peak, 96% were
CD3+, 44% CD4+, 57% CD8+, 10% CD45FT (stains B cells, NK cells and
virgin T cells), and 85% UCHL1+ (stains memory T cells). At the 24
hour peak, 80% were CD3+, 44% CD4+, 37% CD8+, 21% CD45R+ , and 77%
UCHL1+. The identity of the 20% CD3~ cells in these latter figures
was not determined for technical reasons, but were likely to be NK
cells. There are no significant numbers of NK cells in sheep
efferent lymph. Cell staining demonstrates cells are either CD4+ T
cells (=50%), CD8+ T cells (=20%), Jj/b TcR T cells( = 15%), or B
lymphocytes(=15%). As B cells are not thought to synthesize any
lymphokines, the only remaining source of the IFN-g mRNA would
appear to be the jf/b T cells. Human T cells clones expressing the
jf/b T cell receptor have been found to potentially synthesize many
cytokines. They synthesize less IL-2 and GM-CSF but more IFN-g than
a/p T cell clones when stimulated by Concanavalin A. The production
of IL-4, IL-5, and TNF-a was not significantly altered between a/p
and jf/b T cell clones (Morita et al, 1991). The cytokine synthesis
profile of sheep jf/b T cells is unknown at present, but would be a
suitable subject for further study.
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The activation requirements of jr/b T cells are not fully understood,
but they commonly exhibit reactivity to heat-shock proteins (Born et
al, 1990), mycobacterial antigens (O'Brien et al, 1989; Holoshitz et
al, 1989), and other microorganisms (Munk et al, 1990).
There is likely to be an active inflammatory response to the
lymphatic cannulation surgery, which may involve T cell cytokine
synthesis. One week post-surgery it is known that cellular
morphology and lymphocyte surface molecules have returned to basal
levels. It is possible that cells involved in the inflammatory
response may still contain mRNA for cytokines including IFN-g. This
could be due to a continuing immune response by CD4~ CD8- T cells
(i.e. the f/b T cells) or natural killer cells. Both of these cell
types seem to be less specific in their activation requirements.
Cytokine mRNA which was synthesized in the immediate post-surgery
period may still be present in cells due to stabilization of mRNA by
cellular proteins, possibly involving the 3' AU rich regions.
The mRNA may be present at high levels in a small population of
cells which are poor at secreting IFN-g protein. As no IFN-g
protein was detectable on day 0, the IFN-g mRNA detected in the
unseparated cells may be explained in a number of ways: (i) it may
be mRNA undergoing translation into protein; (ii) there may be a
block in secretion of active protein; (iii) the mRNA detected may be
regulated post-transcriptionally; (iv) consumption of IFN-g by cells
may be so extensive that none is detectable using this method.
Cytokines contain AU-rich 3' regions which destabilize the
transcript and regulate their concentration post-transcriptionally
(Shaw & Kamen, 1986). A higher number of cells expressing IFN-g
mRNA and at a higher level, in the absence of detectable IFN-g
protein, has previously been reported for rat OX-22low CD4+ cells in
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comparison with OX-22h±s,h CD4+ cells following Concanavalin A-
stimulation for 24 hours (McKnight et al, 1991). (OX-22 monoclonal
antibody recognizes exon B of the CD45R gene). This was determined
to be due to more rapid initial induction of IFN-g mRNA in the 0X-
22low CD4+ cells, followed by active down-regulation.
In conclusion, this section of work has developed a technique for
the sensitive assessment of IFN-g mRNA synthesis by PCR. This has
been combined with a recently developed technique for relatively
rapid and large-scale cell separation (MACS) to assess the
contribution to IFN-g mRNA synthesis by CD4+ and CD8+ T cells during
an in vivo immune response. Although these techniques could only be
applied in one experimental sheep due to time considerations, the
results gained suggest that this method of analysis should be
capable of attributing IFN-g synthesis to individual cell groupings
during responses to different immune stimuli. At the current stage
of development the assay developed should be interpreted as
primarily qualitative, although gross differences in IFN-g mRNA
concentration can be appreciated. The use of control genes, such as
actin, found at relatively constant concentration within the cDNA
preparations can allow a semi-quantitative assessment of IFN-g mRNA
concentration. This gene can also eliminate errors due to unequal
amounts of template cDNA being used. This additional control could
not be included in the experiment presented here due to time
considerations.
The isolation of ovine genes for many other cytokines, e.g. IL-2,
IL-4, IL-10, means the technique should be capable of assessing the
role of many cytokines during in vivo immune responses. The sheep
lymphatic vessel cannulation model may now be about to yield much
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more specific information on the immune activity within and draining
from lymph nodes. For each lymphokine the PCR procedure would need
to be optimized as described for IFN-g.
The technigues may be used with a variety of cellular
differentiation markers to assess the role of different cell subsets
in IFN-g and other lymphokine synthesis. Currently the cytokine
synthesis profiles of T cells expressing ovine MHC class II
molecules DR and DQ are being assessed within the department. The
possible future availability of markers for memory T cells, naive T
cells, natural killer cells, or suppressor cells may allow the use
of these techniques in other situations.
The techniques described here are unlikely to be sufficient for the
analysis of cytokine production by relatively infrequent cell types,
such as //6 T cells. A modification of the mRNA isolation procedure
would be required, such as that described by Rappolee et al (1989),
which can isolate total RNA for PCR from 1-105 cells. Infrequent
cell types may benefit from the use of MAC separation followed by
additional purification by FAC sorter.
The potential for the technique is dependent on the further




Submarine electrophoresis in 2% agarose of PCR products synthesized
using primers 343E and 474F in the ovine IFN-g PCR. Varying
magnesium concentrations were used to determine the optimum
required. The 302bp PCR product of Ovifn is marked with >>.
Lane Mg concentration







A Anglian buffer (6.7mM)
 
Figure 35.
A Southern hybridization of a polymerase chain reaction using
primers 343E and 474F specific for ovine IFN-g sampled at 3 cycle
intervals from cycle 18 (lane a) until cycle 42 (lane i). Lane n
was a PCR containing no target DNA. Lane p was a PCR containing
linearized pOvifn as target DNA. Membrane was hybridized with
radio-labelled Ovifn. The specific product is marked «.
 
Figure 36.
Southern hybridization of polymerase chain reactions using cDNA
derived from cells stimulated with concanavalin A for varying time
periods. Aliguots removed from PCRs after 20 (A), 25 (B), and 30
(C) cycles. Hybridization with radio-labelled pOvifn.















Kinetics of ovine IFN-g appearance in supernatant from lymphocytes
stimulated with concanavalin A for varying time periods.








A. FACS profile of efferent lymph cells stained with SBU-T4 prior
to purification by MACS.







A. FACS profile of efferent lymph cells stained with SBU-T8 prior
to purification by MACS.







Southern hybridization of PCR to determine ovine IFN-g mRNA
appearance in prefemoral efferent lymph cells from a primed sheep on
successive days before and after stimulation with ovalbumin. Cells
were either unseparated (A), or separated by MACS purification into
CD8+ (B), or CD4+ (C). 25 rounds of PCR were performed.
Hybridization was with radio-labelled pOvifn.
 
Figure 41.
Kinetics of ovine IFN-g appearance in prefemoral efferent lymph
fluid from a primed sheep on successive days before and after
stimulation with ovalbumin. Quantitation of IFN-g was by ELISA and
















Percentage incorporation of radioactive dCTP into single-stranded
cDNA. mRNA is from concanavalin A-stimulated lymphocyte time
course. Measurement is by TCA precipitation and Cherenkov counting.








































































SBU-T4 anti-ovine CD4 IgG2a
SBU-T8 anti-ovine CD8 IgG2a
SW73.2 anti-ovine MHC class 11 IgG2a (rat)
VPM5 anti-ovine igM IgGl
VPM16 anti-ovine MHC class 11 igGi
VPM19 anti-ovine MHC class 1 IgGl
VPM36 anti-ovine MHC class 11 DQa IgGl
VPM37 anti-ovine MHC class 11 DR8 IgGl
VPM38 anti-ovine MHC class 11 DRa igGi





Sodium citrate, pH7. 25mM
Sarkosyl 0.5%
p-mercaptoethanol 0.1M
























































Kanamycin (sigma) 70 pg/ml
X-GAL (Northumbria Biologicals Limited, Cramlington, UK) 80pg/ml




































5 x Denhardt's solution
Sodium pyrophosphate 0.05%













































Adolf GR, Maurer-Fogy I, Kalsner I & Cantell K. 1990. Purification
and characterization of natural human interferon wl. Journal of
Biological Chemistry, 265: 9290-9295
Adolf GR. 1990. Monoclonal antibodies and enzyme immunoassays
specific for human interferon (IFN) wl: evidence that IFN-wl is a
component of human leukocyte IFN. Virology, 175: 410-417
Allen GK, Grathaus GD & Rosenguist BD. 1988. Partial purification
and characterization of bovine fibroblast interferon. American
Journal of Veterinary Research, 49: 758-761
Altmann DM, Sansom D & Marsh SGE. 1991. What is the basis for HLA-DQ
associations with autoimmune disease?. Immunology Today, 12: 267-270
Alton K, Stabinsky Y, Richards R, Ferguson B, Goldstein L, Altrock
B, Miller L & Stebbing N. 1983. In "The Biology of the Interferon
System 1983". (E. De Maeyer & H. Schellekens, eds), Elsevier,
Amsterdam, pll9-128
Altrock BW. 1986. Monoclonal antibodies which specifically bind to
human immune interferon. United States Patent 4,599,306
Amit AG, Mariuzza RA, Phillips SEV & Poljak RJ. 1986. Three-
dimensional structure of an antigen-antibody complex at 2.8A
resolution. Science, 233: 747-753
Anderson KP, Fennie EH & Yilma T. 1988. Enhancement of a secondary
antibody response to vesicular stomatitis virus "G" protein by IFN-g
treatment at primary immunization. Journal of Immunology, 140: 3599-
3604
Andersson G, Larhammar D, Widmark E, Servenius B, Peterson PA & Rask
L. 1987. Class II genes of the human Major Histocompatibility
Complex. Organization and evolutionary relationship of the DRp
genes. Journal of Biological Chemistry, 262: 8748-8758
Andersson L & Rask L. 1988. Characterization of the MHC class II in
cattle. The number of DQ genes varies between haplotypes.
Immunogenetics, 27: 110-120
204
Andersson U, Andersson J, Lindfors A, Wagner K, Moller G & Heusser
CH. 1990. Simultaneous production of interleukin 2, interleukin 4
and interferon-g by activated human blood lymphocytes. European
Journal of Immunology, 20: 1591-1596
Andersson U, Sander B, Andersson J & Moller G. 1988. Concomitant
production of different lymphokines in activated T cells. European
Journal of Immunology, 18: 2081-2084
Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat
C, Herrlich P & Karin M. 1987. Phorbol ester-inducible genes contain
a common cis element recognised by a TPA-modulated trans-acting
factor. Cell, 49: 729-739
Anichini A, Castelli C, Sozzi G, Fossati G & Parmiani G. 1988.
Differential susceptibility to recombinant interferon-g-induced HLA-
DQ antigen modulation among clones from a human metastatic melanoma.
Journal of Immunology, 140: 183-191
Arai K, Lee F, Miyajima A, Miyatake S, Arai N & Yokota T. 1990.
Cytokines: coordinators of immune and inflammatory responses. Annual
Review of Biochemistry, 59: 783-836
Arawaka T, Hsu Y-R, Graham Parker C & Lai P-H. 1986. Role of
polycationic C-terminal portion in the structure and activity of
recombinant human interferon-g. Journal of Biological Chemistry,
261: 8534-8539
Atassi MZ. 1984. Antigenic structure of proteins. European Journal
of Biochemistry, 145: 1-20
Babbitt B, Allen G, Matsueda E, Haber E & Unanue E. 1985. Binding of
immunogenic peptides to la histocompatibility molecules. Nature,
317: 359-361
Babiuk LA & Rouse BT. 1977. Bovine type II interferon: activity in
heterologous cells. Intervirology, 8: 250-256
Basham TY & Merigan TC. 1983. Recombinant interferon-g increases
HLA-DR synthesis and expression. Journal of Immunology, 130: 1492-
1494
205
Basham TY, Bourgeade MF, Creasey AA & Merigan TC. 1982. Interferon
increases HLA synthesis in melanoma cells: interferon-resistant and
-sensitive cell lines. Proceedings of the National Academy of
Sciences USA, 79: 3265
Basta PV, Sherman PA & Ting JP-Y. 1988. Detailed delineation of an
interferon-gamma responsive element important in human HLA-DR alpha
gene expression in a glioblastoma multiforme line. Proceedings of
the National Academy of Sciences USA, 85: 8618-8622
Belosevic M, Davis CE, Meltzer MS & Nacy CA. 1988. Regulation of
activated macrophage antimicrobial activities. Identification of
lymphokines that cooperate with IFN-g for induction of resistance to
infection. Journal of Immunology, 141: 890-896
Benacerraf B. 1981. Role of MHC gene products in immune regulation.
Science, 212: 1229-1238
Berzofsky JA, Cease KB, Cornette JL, Spouge JL, Margalit H, Berkower
IJ, Good MF, Miller LH & DeLise C. 1987. Protein antigenic
structures recognized by T cells: potential applications to vaccine
design. Immunological Reviews, 98: 9-52
Beverley PCL, O'Flynn K, Wallace D, Lamb JR, Boylston AW & Linch DC.
1986. Regulation of activation and proliferation in T cells. In
Leukocyte Typing II. Vol 1, Hayes Reinherz, Nadler and Bernstein,
editors: Springer-Verlag, New York p427-439
Bielefeldt-Ohmann H & Martinod SR. 1990. Interferon immunomodulation
in domestic food animals. Advances in Veterinary Science and
Comparative Medicine, 35: 215-230
Birnboim HC & Doly J 1979. A rapid alkaline extraction method for
screening recombinant plasmid DNA. Nucleic Acids Research, 7: 1513—
1523
Bjerrum & Schafer-Nielsen. 1986. Analytical Electrophoresis, Dunn
MJ, editor: Verlag Chemie, Wienheim, p315
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL & Wiley
DC. 1987. Structure of the human class I histocompatibility antigen,
HLA-A2. Nature, 329: 506-512
206
Blalock JE, Georgiades JA, Langford MP & Johnson HM. 1980. Purified
human immune interferon has more potent anticellular activity than
fibroblast or leukocyte interferon. Cellular Immunology, 49: 390-394
Blanchard DK, Djeu JY, Klein TW, Friedman K & Stewart WE II. 1986.
Interferon-gamma induction by lipopolysaccharide: dependence on
interleukin 2 and macrophages. Journal of Immunology, 136: 963-970
Bolton ET & McCarthy BJ. 1962. A general method for the isolation of
RNA complementary to DNA. Proceedings of the National Academy of
Sciences USA, 48: 1390-1397
Born W, Hall L, Dallas A, Boymel J, Shinnick T, Yougn T, Brennan P &
O'Brien R. 1990. Recognition of a peptide antigen by heat shock
reactive /6 T lymphocytes. Science, 249: 67-69
Brandhuber BJ, Boone T, Kenney WC & McKay DB. 1987. Three-
dimensional structure of interleukin-2. Science, 238: 1707-1709
Breathnach R & Chambon P. 1981. Organization and expression of
eucaryotic split genes coding for proteins. Annual Reviews in
Biochemistry, 50: 349-383
Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ & Wiley DC.
1988. A hypothetical model of the foreign antigen binding site of
class II histocompatibility molecules. Nature, 332: 845-850
Burton LE, Gray PW, Goeddel DV & Rinderknecht E. 1985. In "The
Biology of the Interferon System 1984". (H. Kirchner & H.
Schellekens, eds). Elsevier, Amsterdam, p403-309
Buus S, Colon S, Smith C, Freed JH, Miles C & Grey HM. 1986.
Interaction between a "processed" ovalbumin peptide and la
molecules. Proceedings of the National Academy of Sciences USA, 83:
3968-3971
Capon DJ, Shepard HM & Goeddel DV. 1985. Two distinct families of
human and bovine interferon-a genes are coordinately expressed and
encode functional polypeptides. Molecular and Cellular Biology, 5:
768-779
Celis E, Miller RW, Wiktor TJ, Dietzschold B & Koprowski H. 1986.
Isolation and characterization of human T cell lines and clones
reactive to rabies virus: antigen specificity and production of
interferon-g. Journal of Immunology, 136: 692-697
207
Cerretti DP, McKereghan K, Larsen A, Cosman D, Gillis S & Baker PE.
1986. Cloning, seguence, and expression of bovine interferon-g.
Journal of Immunology, 136: 4561-4564
Charley B, McCullough K & Martinod S. 1988. Antiviral and antigenic
properties of recombinant porcine interferon gamma. Veterinary
Immunology and Immunopathology, 19: 95-103
Charron DJ & McDevitt HO. 1979. Analysis of HLA-D region-associated
molecules with monoclonal antibody. Proceedings of the National
Academy of Sciences USA, 76: 6567-6571
Chelly H, Kaplan J-C, Maire P, Gautron S & Kahn A. 1988.
Transcription of the dystrophin gene in human muscle and non-muscle
tissues. Nature, 333: 858-860
Chiang YW, Roth JA & Andrews JJ. 1990. Influence of recombinant
bovine interferon gamma and dexamethasone on pneumonia attributable
to Haemophilus somnus in calves. American Journal of Veterinary
Research, 51: 759-762
Chirgwin JJ, Przbyla AE & MacDonald RJ. 1979. Isolation of
biologically active ribonucleic acid from sources enriched in
ribonuclease. Biochemistry, 18: 5294-5299
Chou PY & Fasman GD. 1974. Biochemistry, _13: 211-221
Chou PY & Fasman GD. 1974. Prediction of protein conformation.
Biochemistry, 13: 222-245
Chung CT, Niemeda SL & Miller RH. 1989. One step preparation of
competent Escherichia coli: Transformation and storage of bacterial
cells in the same solution. Proceedings of the National Academy of
Sciences USA, 86: 2172-2175
Claesson-Welsh L & Peterson PA. 1985. Implications of the invariant
g chain on the intracellular transport of class II
histocompatibility antigens. Journal of Immunology, 135: 3551-3557
Clevers H, MacHugn ND, Bensaid A, Dunlap S, Baldwin CL, Kausal A,
lams K, Howard CJ & Morrison WI. 1990. Identification of a bovine
surface antigen uniquely expressed on CD4/CD8-negative, T cell
receptor gamma/delta-positive T lymphocytes. European Journal of
Immunology, 20: 809-815
208
Coffman RL & Carty J. 1986. A T cell activity that enhances
polyclonal IgE production and its inhibition by interferon gamma.
Journal of Immunology, 136: 949-954
Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, Ault KA,
Gimbrone MA, Strominger JL & Pober JS. 1984. Immune interferon
activates multiple class II major histocompatibility complex genes
and the associated invariant chain gene in human endothelial cells
and dermal fibroblasts. Proceedings of the National Academy of
Sciences USA, 81,: 4917-4921
Conta BS, Powell MB & Ruddle NH. 1983. Production of lymphotoxin,
IFN-g and IFN-a,p by murine T cell clones. Journal of Immunology,
130: 2231-2235
Crane SE, Buzy J & Clements JE. 1991. Identification of cell
membrane proteins that bind visna virus. Journal of Virology, 65:
6137-6143
Cresswell P. 1987. Regulation of HLA Class I and Class II antigen
expression. British Medical Journal, 43: 66-80
Croll AD, Wilkinson MF & Morris AG. 1986. Gamma-interferon
production by low-density lymphocytes induced by T-cell mitogens.
Immunology, 58: 641-646
Cullen PR, Brownlie J & Kimberlin RH. 1984. Sheep lymphocyte
antigens and scrapie. Journal of Comparative Pathology, £4: 405-415
Cullen PR. 1989. Scrapie and the sheep MHC: claims of linkage
refuted. Immunogenetics, 29: 414-416
Dallman MJ, Montgomery RA, Larsen CP, Wanders A & Wells AF. 1991.
Cytokine gene expression: analysis using Northern blotting,
polymerase chain reaction and in situ hybridization. Immunological
Reviews, 119: 163-179
Dalziel RG, Hopkins J, Watt NJ, Dutia BM, Clarke HAK & McConnell I.
1991. Identification of a putative cellular receptor for the
lentivirus visna virus. Journal of General Virology, 72: 1905-1911
Davis AR, Nayak DP, Ueda M, Hiti AL, Dowbenko D & Kleid DG. 1981.
Expression of antigenic determinants of the hemagglutinin gene of a
human influenza virus in Escherischia coli. Proceedings of the
National Academy of Sciences USA, 78: 5376-5380
209
de la Maza LM, Peterson EM, Burton LE, Gray PW, Rinderknecht E &
Czarniecki CW. 1987. The antichlamydial, antiviral, and
antiproliferative activities of human gamma interferon are dependent
on the integrity of the C terminus of the interferon molecule.
Infection and Immunity, 55: 2727-2733
Derynck R, Singh A & Goeddel DV. 1983. Expression of the human
interferon-g cDNA in yeast. Nucleic Acids Research, _11: 1819-1837
Deverson EV, Wright H, Watson S, Diamond AG & Howard JC. 1988. The
genes of the class II region of the sheep MHC. Abstracts, The
Molecular Biology of the Major Histocompatibility Complex of
Domestic Animal Species. Edited, Warner CM, Rothschild MF & Lamont
SJ. Iowa State University Press/ Ames, pl70
Devos R, Cheroutre H, Taya Y, Degrave W, Van Heuverswyn H & Fiers W.
1982. Molecular cloning of human immune interferon cDNA and its
expression in eukaryotic cells. Nucleic Acids Research, 10: 2487-
2501
Dijkema R, van der Meide PH, Pouwels PH, Caspers M, Dubbeld M &
Schellekens H. 1985. Cloning and expression of the chromosomal
immune interferon gene of the rat. The EMBO Journal, 4: 761-767
Dijkmans R, Vandenbroeck K, Beuken E & Billiau A. 1990. Seguence of
the porcine interferon-gamma (IFN-g) gene. Nucleic Acids Research,
18: 4259
Djeu JY, Sticks N, Zoon K, Stanton GJ, Timonen T & Herberman RB.
1982. Positive self-regulation of cytotoxicity in human natural
killer cell by production of interferon upon exposure to influenza
and herpes viruses. Journal of Experimental Medicine, 156: 1222-1234
Dougherty JP, Samamta H, Farrell PJ & Lengyel P. 1980. Interferon,
double-stranded RNA, and RNA degradation. Isolation of homogenous
pppA(2'5'A)n-i synthetase from Ehrich ascites tumour cells. Journal
of Biological Chemistry, 255: 3813-3816
Doyle CD & Strominger JL. 1987. Interaction betyween CD4 and class
II MHC molecules mediates cell adhesion. Nature, 330: 256-259
Dustin ML, Singer KH, Tuck DT & Springer TA. 1988. Adhesion of T
lymphoblasts to epidermal keratinocytes is regulated by
intercellular adhesion molecule 1 (ICAM-1). Journal of Experimental
Medicine, 167: 1323-1340
210
Dutia BM, Hopkins J, Allington MP, Bujdoso R & McConnell I. 1990a.
Characterization of monoclonal antibodies specific for a- and (3-
chains of sheep MHC class II. Immunology, 20.: 27-32
Dutia BM, Hopkins J, Ballingall K, Bird K, Brandon MR & McConnell I.
1990b. Expression of major histocompatibility class II molecules in
the sheep. Proceedings of the 4th World Congress on Genetics Applied
to Livestock Production. Edinburgh. 16: 400-403
Ealick SE, Cook WJ, Vijay-Kumar S, Carson M, Nagabhushan TL, Trotta
PP & Bugg CE. 1991. Three-dimensional structure of recombinant human
interferon-g. Science, 252: 698-702
Efrat S & Kaempfer R. 1984. Control of biologically active
interleukin 2 mesenger RNA formation in induced human lymphocytes.
Proceedings of the National Academy of Sciences USA, 81: 2601
Efrat S, Pilo S & Kaempfer R. 1982. Kinetics of induction and
molecular size of mRNAs encoding human interleukin-2 and g-
interferon. Nature, 297: 236-239
Emery DL, Rothel JS & Wood PR. 1990. Influence of antigens and
adjuvants on the production of gamma-interferon and antibody by
ovine lymphocytes. Immunology and Cell Biology, 68: 127-136
Emini EA, Hughes JV, Perlow DS & Boger J. 1985. Induction of
Hepatitis A virus neutralizing antibody by a virus specific
synthetic peptide. Journal of Virology, 52: 836-839
Engleman EG, Benike CJ & Charron DJ. 1980. Ia antigen on peripheral
blood mononuclear leukocytes in man. I. Functional studies of HLA-
DR-positive T cells activated in mixed lymphocyte reactions. Journal
of Experimental Medicine, 152: 114s-126s
Ennis FA & Meager A. 1981. Immune interferon produced to high levels
by antigenic stimulation of human lymphocytes with influenza virus.
Journal of Experimental Medicine, 154: 1279-1289
Entrican G, Haig DM & Norval M. 1989. Identification of ovine
interferons: differential activities derived from fibroblast and
lymphoid cells. Veterinary Immunology and Immunopathology, 21: 187—
195
211
Falcoff R, Oriel R & Iscaki S. 1972. Lymphocyte stimulation and
interferon induction by TS anti-human leukocyte globulins and their
uni- and divalent fragments. European Journal of Immunology, 2: 476-
478
Falcoff R. 1972. Some properties of virus and immune-induced human
lymphocyte interferons. Journal of General Virology, 16: 251-253
Favre C, Wijdenes J, Cabrillat H, Djossou 0, Banchereau J & De Vries
JE. 1989. Epitope mapping of recombinant human gamma interferon
using monoclonal antibodies. Molecular Immunology, 26: 17-25
Feinberg AP & Vogelstein B. 1983. A technique for radiolabeling DNA
restriction endonuclease fragments to high specific activity.
Analytical Biochemistry, 132: 6-12, Addendum 137, 266
Fellous M, Kamoun M, Gresser I & Bono R. 1979. Enhanced expression
of HLA antigens and Pa-microglobulin on interferon-treated human
lymphoid cells. European Journal of Immunology, 9: 446-449
Fellous M, Nir U, Wallach D, Merlin G, Rfubenstein M & Revel M.
1982. Interferon-dependent induction of mRNA for the major
histocompatibility antigens in human fibroblasts and lymphoblastoid
cells. Proceedings of the National Academy of Sciences USA, 79:
3082-3086
Fertsch-Ruggio D, Schoenberg DR & Vogel SN. 1988. Induction of
macrophage la antigen expression by rIFN-g and down-regulation by
IFN-a/p and dexamethasone are regulated transcriptionally. Journal
of Immunology, 141: 1582-1589
Fiskerstrand C & Sargan D. 1990. Nucleotide sequence of ovine
interleukin-1 beta. Nucleic Acids Research, _18: 7165
Fong TAT & Mosmann TR. 1990. Alloreactive murine CD8+ T cell clones
secrete the Tm pattern of cytokines. Journal of Immunology, 144:
1744-1752
Fox LK, Liggit HD, Yilma T & Corbeil LB. 1990. The effect of
interferon-gamma intramammary administration on mammary phagocyte
function. Zentralbl-Veterinarmed-[B], 37: 28-30 (Abstract)
Frasca D, Adorini L, Landolfo S & Doria G. 1985. Enhancing effect of
IFN-g on helper T cell activity and IL2 production. Journal of
Immunology, 134: 3907-3911
212
Fujisawa K, Kamikawaji N, Yasunami M, Kimura Y & Sasazuki T. 1991.
High precursor frequency of human T cells reactive to HLA-DQ
molecules expressed on mouse L cell transfectants. European Journal
of Immunology, 21: 2341-2347
Garnier J, Osguthorpe DJ & Robson B. 1978. Analysis of the accuracy
and implication of simple methods for predicting the secondary
structure of globular proteins. Journal of Molecular Biology., 120:
97-120
Gauchat J-F, Gauchat D, De Week AL & Stadler BM. 1988. Stimulation-
dependent lymphokine mRNA levels in human mononuclear cells.
European Journal of Immunology, 18: 1441-1446
Gauchat JF, Gauchat D, Qiu G, Mandallaz M & Stadler BM. 1991.
Detection of cytokine mRNA in polyclonally-, antigen- or allergen-
stimulated mononuclear cells. Immunological Reviews, 119: 147-161
Gauchat JF, Walker C, de Week AL & Stadler BM. 1986. Relation of
supernatant IL-2 to steady state levels of IL-2 mRNA. Lymphokine
Research, 5. (Supplement 1): S43-S47
Gerrard TL, Volkman DJ, Jurgensen CH & Fauci AS. 1985. Activated
human T cells can present alloantigens but cannot present soluble
antigens. Cellular Immunology, 95: 65-74
Gessner A, Moskophidis D & Lehmann-Grube F. 1989. Enumeration of
single IFN-g-producing cells in mice during viral anmd bacterial
infection. Journal of Immunology, 142: 1293-1298
Glimcher LH & Kara CJ. 1992. Sequences and factors: a guide to MHC
class-II transcription. Annual Reviews in Immunology, 10: 13-49
Go NF, Castle BE, Barrett R, Kastelein R, Dang W, Mosmann TR, Moore
KW & Howard M. 1990. Interleukin 10, a novel B cell stimulatory
factor: unresponsiveness of X-chromosome-linked immunodeficiency B
cells. Journal of Experimental Medicine, 172: 1625-1631
Gonwa T, Picker L, Raff H, Goyert S, Silver J & Stobo J. 1983.
Antigen-presenting capabilities of human monocytes correlate with
their expression of HLA-DS: an la determinant distinct from HLA-DR.
Journal of Immunology, 130: 706-711
213
Goodall DC, Emery DC, Perry ACF, English LS & Hall L. 1990. cDNA
cloning of ovine interleukin 2 by PCR. Nucleic Acids Research, 18:
5883
Gorga JC, Dong A, Manning JC, Woody RW, Caughey WS & Strominger JL.
1989. Comparison of the secondary structures of human class I and
class II major histocompatibility complex antigens by Fourier
transform infrared and circular dichroism spectroscopy. Proceedings
of the National Academy of Sciences USA, 86: 2321-2325
Granelli-Piperno A, Andrus L & Steinman RM. 1986. Lymphokine and
nonlymphokine mRNA levels in stimulated human T cells. Kinetics,
mitogen reguirements, and effects of cyclosporin A. Journal of
Experimental Medicine, 163: 922-937
Gray PW & Goeddel DV. 1982. Structure of the human immune interferon
gene. Nature, 298: 859-863
Gray PW & Goeddel DV. 1983. Cloning and expression of murine immune
interferon cDNA. Proceedings of the National Academy of Sciences
USA, 80: 5842-5846
Gray PW, Leung DW, Pennica D, Yelverton E, Najarian R, Simonsen CC,
Derynck R, Sherwood PJ, Wallace DM, Berger SL, Levinson AD & Goeddel
DV. 1982. Expression of human immune interferon cDNA in E, coli and
monkey cells. Nature, 295: 503-508
Green IR & Sargan DR. 1991. Sequence of the cDNA encoding ovine
tumor necrosis factor-a: problems with cloning by inverse PCR. Gene,
109: 203-210
Green JA, Cooperband SR & Kibrick S. 1969. Immune-specific induction
of interferon production in cultures of human blood lymphocytes.
Science, 164: 1415-1417
Griffiths CEM, Voorhees JJ & Nickoloff BJ. 1989. Gamma interferon
induces different keratinocyte cellular patterns of expression of
HLA-DR and DQ and intercellular adhesion molecule-1 (ICAM-1)
antigens. British Journal of Dermatology, 120: 1-7
Gubler U & Hoffman BJ. 1983. A simple and very efficient method for
generating cDNA libraries. Gene, 25: 263-269
214
Gustafsson K, Widmark E, Jonsson A-K, Servenius B, Sachs DH,
Larhammar D, Rask 1L & Peterson PA. 1987. Class II genes of the
human major histocompataqbility complex. Evolution of the DP region
as deduced from nucleotide sequences of the four genes. Journal of
Biological Chemistry, 262: 8778-8786
Hall JG & Morris B. 1962. The output of cells in lymph from the
popliteal lymph node of sheep. Journal of Experimental Physiology,
47: 360-369
Handa K, Suzuki R, Matsui H, Shimizu & Kumagai K. 1983. Natural
killer (NK) cells as a responder to interleukin 2 (IL2). II. IL2-
induced interferon-g production. Journal of Immunology, 130: 988-992
Hardy DA, Bell JI, Long EO, Lindsten T & McDevitt HO. 1986. Mapping
of the class II region of the human major compatability complex by
pulsed-field gel electrophoresis. Nature, 323: 453-455
Hardy KJ & Sawada T. 1989. Human g-interferon strongly upregulates
its own gene expression in peripheral blood lymphocytes. Journal of
Experimental Medicine, 170: 1021-1026
Havel1 EA & Spitalny GL. 1983. Two molecular weight species of
murine gamma interferon. Virology, 129: 508-513
Havell EA & Spitalny GL. 1984. The glycoprotein nature of murine
gamma interferon. Archives of Virology, 80: 195-207
Haynes J & Weissmann C. 1983. Constitutive, long-term production of
human interferons by hamster cells containing multiple copies of a
cloned interferon gene. Nucleic Acids Research, H: 687-706
Heath AW, Devey ME, Brown IN, Richards CE & Playfair JH. 1989.
Interferon-gamma as an adjuvant in immunocompromised mice.
Immunology, 67: 520-524
Hein WR, Dudler L, Beya MF, Marcuz A & Grossberger D. 1989. T cell
receptor gene expression in sheep: differential usage of TCR1 in the
periphery and the thymus. European Journal of Immunology, 19: 2297-
2301
Heinzel FP, Sadick MD, Holaday BJ, Coffman RL & Locksley RM. 1989.
Reciprocal expression of interferon-g or interleukin 4 during the
resolution or progression of murine Leishmaniasis. Journal of
Experimental Medicine, 169: 59-72
215
Heron I, Hokland M & Berg K. 1979. Enhanced expression of $2-
microglobulin and HLA antigens on human lymphoid cells by
interferon. Proceedings of the National Academy of Sciences USA, 75:
6215-6219
Hewitt CRA & Feldman M. 1989. Human T cell clones present antigen.
Journal of Immunology, 142: 1429-1436
Hill AVS, Allsopp EM, Kwiakowski D, Anstey NM, Twumasi P, Rowe PA,
Bennett S, Brewster D, McMichael AJ & Greenwood BM. 1991. Common
west African HLA antigens are associated with protection from severe
malaria. Nature, 352: 595-600
Hogrefe HH, McPhie P, Bekisz JB, Enterline JC, Dyer D, Webb DSA,
Gerrard TL & Zoon KC. 1989. Amino terminus is essential to the
structural integrity of recombinant human interferon-g. Journal of
Biological Chemistry, 264: 12179-12186
Holmes BD & Higgins SJ. 1990. In Transcription and translation. A
practical approach. IRL Press, Oxford. p64
Holoshitz J, Koning F, Coligan JE, De Bruyn J & Strober S. 1989.
Isolation of CD4~ CD8~ mycobacteria-reactive T lymphocyte clones
from rheumatoid arthritis synmovial fluid. Nature, 339: 226-229
Honda S, Asano T, Kajio T, Nakagawa S, Iketama S, Ichimori Y, Sugino
H, Nara K, Kakinuma A & Rung HF. 1987. Differential purification by
immunoaffinity chromatography of two carboxy-terminal portion-
deleted derivatives of recombinant human interferon-gamma from
Escherischia coli. Journal of Interferon Research, 7: 145-154
Hopkins J, Dutia BM & McConnell I. 1986. Monoclonal antibodies to
sheep lymphocytes. I. Identification of MHC class II molecules on
lymphoid tissue and changes in the level of class II expression on
lymph-borne cells following antigen stimulation in vivo. Immunology,
59: 433-438
Hopp TP & Woods KR. 1981. Prediction of protein antigenic
determinants from amino acid sequences. Proceedings of the National
Academy of Sciences USA, 78: 3824-3828
Ichimori Y, Kurokawa T, Honda S, Suzuki N, Wakimasu M & Tsukamoto K.
1985. Monoclonal antibodies to human interferon-g. I. Antibodies to
a synthetic carboxyl-terminal peptide. Journal of Immunological
Methods, 80: 55-66
216
Ichimori Y, Suzuki N, Kitada C & Tsukamoto K. 1987. Monoclonal
antibodies to human interferon-g. II. Antibodies with neutralizing
activity. Hybridoma, 6: 173-181
Imakawa K, Anthony RV, Kazemi M, Marotti KR, Polites HG & Roberts
RM. 1987. Interferon-like seguence of ovine trophoblast protein
secreted by embryonic trophectoderm. Nature, 330: 377-379
Imakawa K, Hansen TR, Malathy DV, Anthony RV, Polites HG, Marotti
KR & Roberts RM. 1989. Molecular cloning and characterization of
complementary deoxyribonucleic acids corresponding to bovine
trophoblast protein-1: a comparison with ovine trophoblast protein-1
and bovine interferon-alpha II. Molecular Endocrinology, 3: 127-139
Inaba K, Kitaura M, Kato T, Watanabe Y, Kawade Y & Muramatsu S.
1986. Contrasting effect of alpha/beta and gamma interferons on
expression of macrophage la antigens. Journal of Experimental
Medicine, 163: 1030-1035
Innis MA, Myambo KB, Gelfand DH & Brow AD. 1988. DNA seguencing with
Thermus aguaticus DNA polymerase and direct seguencing of polymerase
chain reaction-amplified DNA. Proceedings of the National Academy of
Sciences USA, 85: 9436-9440
Isaacs A & Lindenmann J. 1957. I. The Interferon. Viral
Interference. Proceedings of the Royal Society, B147: 258-267
Jameson BA & Wolf H. 1988. The antigenic index: a novel algorithm
for predicting antigenic determinants. CABIOS, 4: 181-186
Janeway CA jr, Bottomly K, Babick J, Conrad P, Conzen S, Jones B,
Kaye J, Katz M, McVay L, Murphy DB & Tite J. 1984. Quantitative
variation in la antigen expression plays a central role in immune
regulation. Immunology Today, 5: 99-105
Janin J, Wodak S, Levitt M & Maigret M. 1978. Conformation of amino
acid sidechains in proteins. Journal of Molecular Biology, 125: 357-
386
Jardetzky TS, Lane WS, Robinson RA, Madden DR & Wiley DC. 1991.
Identification of self peptides bound to purified HLA-B27. Nature,
353: 326-329
Jarpe MA & Johnson HM. 1990. Topology of receptor binding domains of
mouse IFN-g. Journal of Immunology, 145: 3304-3309
217
Johnson HM, Langford MP, Lakhchaura B, Chan Teh-Sheng & Stanton GJ.
1982. Neutralization of native human gamma interferon (HuIFN-g) by
antibodies to a synthetic peptide encoded by the 5' end of HuIFN-g
cDNA. Journal of Immunology, 129: 2357-2359
Jonsson AK, Hyldig-Nielsen JJ, Servenius B, Larhammar D, Andersson
G, Jorgensen F, Peterson PA & Rask L. 1987. Class II genes of the
human major histocompatibility complex. Comparisons of the DQ and
DX alpha and beta chains. Journal of Biological Chemistry, 262:
8767-8777
Kappes D & Strominger JL. 1988. Human class II major
histocompatibility complex genes and proteins. Annual Review of
Biochemistry, 57: 991-1028
Kappes DJ & Strominger JL. 1986. Structure and evolution of the HLA
class II SX beta gene. Immunogenetics, 24: 1-7
Karpus PA & Schulz GE. 1985. Prediction of chain flexibility in
proteins. Naturwissenschaften, 72: 212-213
Kasahara T, Hooks JJ, Dougherty SF & Oppenheim JJ. 1983.
Interleukin-2 mediated immune interferon (IFN-g) production by human
T cell subsets. Journal of Immunology, 130: 1784-1789
Kaufman JF, Auffray C, Korman AJ, Shackelford DA & Strominger JL.
1984. The class II molecules of the human and murine major
histocompatibility complex. Cell, 36: 1-13
Kawase I, Brooks CG, Kuribayashi K, Olabuenaga S, Newman W, Gillis S
& Henney CS. 1983. Interleukin 2 induces g-interferon production:
participation of macrophages and NK-like cells. Journal of
Immunology, 131: 288-292
Kelker HC, Le J, Rubin BY, Yip YK, Nagler C & Vilcek J. 1984. Three
molecular weight forms of natural human interferon-gamma revealed by
immunoprecipitation with monoclonal antibody. Journal of Biological
Chemistry, 259: 4301-4304
Kelly AP, Monaco JJ, Cho S & Trowsdale J. 1991. A new human HLA
class II-related locus, DM. Nature, 353: 571-573
218
Kennedy PGE, Narayan 0, Ghotbi Z, Hopkins J, Gendelman HE & Clements
JE. 1985. Persistent expression of la antigen and viral genome in
visna-maedi virus-induced inflammatory cells. Journal of
Experimental Medicine, 162: 1970-1982
Keohavong P & Thilly WG. 1989. Fidelity of DNA polymerases in DNA
amplification. Proceedings of the National Academy of Sciences USA,
86: 9253-9257
Kern MJ, Stuart PM, Omer KW & Woodward JG. 1989. Evidence that IFN-
gamma does not affect MHC class II gene expression at the post-
transcriptional level in a mouse macrophage cell line.
Immunogenetics, 30: 258-265
King DP & Jones PP. 1983. Induction of la and H-2 antigens on a
macrophage cell line by immune interferon. Journal of Immunology,
131: 315-318
Klein J, Bontrop RE, Dawkin RL, Erlich HA, Gyllensten UB, Heise ER,
Jones PP, Parham P, Wakeland EK & Watkins DL. 1990. Nomenclature for
the major histocompatibility complexes of different species: a
proposal. Immunogenetics, 31: 217-219
Knight E, jr, 1976. Interferon: purification and initial
characterisation from human diploid cells. Proceedings of the
National Academy of Sciences USA, 73: 520-523
Kogler G, Capdeville AB, Hauch M, Bruster HT, Gobel U, Wernet P &
Burdach S. 1990. High efficiency of a new immunological magnetic
cell sorting method for cell depletion of human bone marrow. Bone
Marrow and Transplantation, 6: 163-168
Kiipper H, Keller W, Kurz C, Forss S, Schaller H, Franze R,
Strohmaier K, Marguardt 0, Zaslarsky VG & Hofschneider PH. 1981.
Cloning of cDNA of major antigen of foot and mouth disease virus and
expression in E, coli. Nature, 289: 555-559
Kyte J & Doolittle RF. 1982. A simple method for displaying the
hydropathic character of a protein. Journal of Molecular Biology,
157: 105-131
Labdon JE, Gibson KD, Sun S & Pestka S. 1984. Some species of human
leukocyte interferon are glycosylated. Archives of Biochemistry and
Biophysics, 232: 422-426
219
Lairmore MD, Butera ST, Callahan GN & DeMartini JC. 1988.
Spontaneous interferon production by pulmonary leukocytes is
associated with lentivirus-induced lymphoid interstitial pneumonia.
Journal of Immunology, 140: 799-785
Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G & Forni E.
1985. Inhibition of interferon-gamma may suppress allograft
reactivity by T lymphocytes in vitro and in vivo. Science, 229: 176-
179
Landolfo S, Gariglio M, Gribaudo G, Jemma C, Giovarelli & Cavallo G.
1988. Interferon-g is not an antiviral, but a growth-promoting
factor for T lymphocytes. European Journal of Immunology, 18: 503-
509
Langford MP, Gray PW, Stanton GJ, Lakhchaura B, Chan Teh-Sheng &
Johnson HM. 1983. Antibodies to a synthetic peptide corresponding to
the N-terminal end of mouse gamma interferon (IFN-g). Biochemical
and Biophysical Research Communications, 117: 866-871
Langford MP, Weigent DA, Chan TS, Johnson HM & Stanton GJ. 1987.
Antibodies to the carboxyl terminus of mouse interferon-g neutralize
its immunoregulatory and antiviral activities. Journal of Interferon
Research, 7: 95-101
Langford MP, Weigent DA, Georgiades JA, Johnson HM & Stanton GJ.
1981. Antibody to Staphylococcal enterotoxin A-induced human immune
interferon (IFN-g). Journal of Immunology, 126: 1620-1623
Lanzavecchia A, Roosnek E, Gregory T, Berman P & Abrignani S. 1988a.
T cells can present antigens such as HIV gpl20 targeted to their own
surface molecules. Nature, 334: 530-532
Lanzavecchia A, Abrignani S, Scheideggger D, Obrist R, Dorken B &
Moldenhauer G. 1988b. Antibodies as antigens. The use of mouse
monoclonal antibodies to focus human T cells against selected
targets. Journal of Experimental Medicine, 167: 345-352
LaSalle JM, Ota K & Hafler DA. 1991. Presentation of autoantigen by
human T cells. Journal of Immunology, 147: 774-780
Le Moal MA, Motta I & Truffa-Bachi P. 1989. Improvement of an ELISA
for the routine titration of murine interferon-gamma. Research in
Immunology, 140: 613-624
220
Leary JJ, Brigata DJ & Ward DC. 1983. Rapid and sensitive
colorimetric method for visualising biotin-labeled DNA probes
hybridized to DNA or RNA immobilized on nitrocellulose: bio-blots.
Proceedings of the National Academy of Sciences USA, 80: 4045-4049
Lebman DA & Coffman RL. 1988. Interleukin 4 causes isotype switching
to IgE production in T cell-stimulated clonal B cell cultures.
Journal of Experimental Medicine, 168: 853-862
Leinikki PO, Calderon J, Luquette MH & Schreiber RD. 1987. Reduced
receptor binding by a human interferon-gamma fragment lacking 11
carboxyl-terminal amino acids. Journal of Immunology, 139: 3360-3366
Leist T, Titmas R, Parti S & Meager A. 1985. Antibodies to synthetic
polypeptides corresponding to hydrophilic regions of human
interferon gamma. Molecular Immunology, 22: 929-936
Leung DW, Capon DJ & Goeddel DV. 1984. The structure and bacterial
expression of three bovine distinct p-interferon genes.
Biotechnology, 2: 458-464
Lichtman A, Kurt-Jones EA & Abbas AK. 1987. B cell stimulatory
factor-1 and not interleukin 2 is the autocrine growth factor for
some helper T lymphocytes. Proceedings of the National Academy of
Sciences USA, 84; 824-827
Lichtman AH, Chin J, Schmidt JA & Abbas AK. 1988. Role of
interleukin 1 in the activation of T lymphocytes. Proceedings of the
National Academy of Sciences USA, 85: 9699-9703
Liew FY, Millott S, Li Y, Lelchuk R, Chan WL & Ziltener H. 1989.
Macrophage activation by interferon-g from host-protective T cells
is inhibited by interleukin (IL) 3 and IL4 produced by disease-
promoting T cells in Leishmaniasis. European Journal of Immunology,
19: 1227-1232
Ling PD, Warren MK & Vogel SW. 1985. Antagonistic effect of
interferon-beta on the interferon-gamma-induced expression of la
antigens in murine macrophages. Journal of Immunology, 135: 1857-
1863
Lis JT. 1980. Fractionation of DNA by polyethylene glycol (PEG)
induced precipitation. Methods in Enzymology, 65: 347-353
221
Lord SC, McMullen GL, Marzuki S & Cheetham BF. 1989. Functional
domains of human interferon gamma probed with antipeptide
antibodies. Molecular Immunology, 26: 637-640
Lowry RP, Wang K, Vernooij B & Harcus D. 1989. Lymphokine
transcription in vascularised mouse heart grafts: effects of
"tolerance" induction. Transplantation Proceedings, 21: 72-73
Lynn RC & Phillip JR. 1988. Recombinant bovine interferon alpha in
the control of bovine respiratory disease. Proceedings of the World
Congress in Buiatrics, 15th 1988: 145-149
Madden DR, Gorga JC, Strominger JL & Wiley DC. 1991. The structure
of HLA-B27 reveals nonamer self-peptides in an extended
conformation. Nature, 353: 321-325
Maddox JF, Mackay CR & Brandon MR. 1985. Surface antigens, SBU-T4
and SBU-T8, of sheep T lymphocyte subsets defined by monoclonal
antibodies. Immunology, 55: 739-748
Magazine HI, Carter JM, Russell JK, Torres BA, Dunn BM & Johnson HM.
1988. Use of synthetic peptides to identify an N-terminal epitope on
mouse g-interferon that may be involved in function. Proceedings of
the National Academy of Sciences USA, 8J5: 1237-1241
Mahdy EA, Makinen A, Chowdhary BP, Andersson L & Gustavsson I. 1989.
Chromosomal localization of the ovine major histocompatibility
complex (OLA) by in situ hybridization. Hereditas, 111: 87-90
Martinod S, McCullough K, Miozzari G St Steiger RF. 1988. Potential
use of recombinant bovine interferon alphail in the control of
bovine respiratory disease in fattening calves. Proceedings of the
World Congress in Buiatrics, 15th 1988: 150-154
Mason D & Powrie F. 1990. Memory CD4+ T cells in man form two
distinct subpopulations, defined by their expression of isoforms of
the leucocyte common antigen, CD45. Immunology, 70: 427-433
Mathis DJ, Benoist CD, Williams VE, II, Ranter MR Si McDevitt HO.
1983. The murine Ea immune response gene. Cell, 32: 745-754
Matis LA, Glimcher LH, Paul WE Si Schwartz RH. 1983. Magnitude of
response of histocompatability-restricted T-cell clones is a
function of the concentration of antigen and la molecules.
Proceedings of the National Academy of Sciences USA, 80: 6019-6023
222
Maurer DH, Hanke JH, Mickelson E, Rich RR & Pollack MS. 1987.
Differential presentation of HLA-DR, -DQ, and -DP restriction
elements by interferon-g-treated dermal fibroblasts. Journal of
Immunology, 139: 715-723
Mclnnes CJ, Logan M, Redmond J, Entrican G & Baird GD. 1990. The
molecular cloning of the ovine gamma-interferon cDNA using the
polymerase chain reaction. Nucleic Acids Research, ]J): 4012
McKnight AJ, Barclay AN & Mason DW. 1991. Molecular cloning of rat
interleukin 4 cDNA and analysis of the cytokine repertoire of
subsets of CD4~* T cells. European Journal of Immunology, 21: 1187—
1194
Millot P, Chatelin J, Dautheville C, Salmon D & Cathala F. 1988.
Sheep major histocompatibility (OLA) complex: linkage between a
scrapie susceptibility/resistance locus and the OLA complex in Ile-
de-France sheep progenies. Immunogenetics, 27: 1-11
Millot P. 1988. Sheep major histocompatibility (OLA) complex:
apparent involvement in a flock endemic infection by Corynebacterium
pseudotuberculosis. Experimental and Clinical Immunogenetics, 6:
225-235
Millot P. 1989. Author's response. Immunogenetics, 29: 417-418
Miltenyi S, Muller W, Weichel W & Radbruch A. 1990. High gradient
magnetic cell separation with MACS. Cytometry, 1_1: 231-238
Miyasaka M & Trnka Z. 1986. Lymphocyte migration and differentiation
in a large-animal model: the sheep. Immunological Reviews, :
Miyawaki T, Seki H, Taga K & Taniguchi N. 1984. Interferon-g can
augment expression ability of HLA-DR antigens on pokeweed mitogen-
stimulated human T lymphocytes. Cellular Immunology, 89: 300-309
Momburg F, Koch N, Moller P, Moldenhauer G, Butcher GW & Hammerling
GJ. 1986. Differential expression of la and la-associated invariant
chain in mouse tissues after in vivo treatment with IFN-g. Journal
of Immunology, 136: 940-947
Mond JJ, Carman J, Sarme C, Ohara J & Finkelman FD. 1986.
Interferon-g supresses B cell stimulation factor (BSF-1) induction
of class II MHC determinants on B cells. Journal of Immunology, 137:
3534-3537
223
Morimoto C, Letvin NL, Distaso JA, Brown HM & Schlossman SF. 1986.
The cellular basis for the induction of antigen-specific T8
suppressor cells. European Journal of Immunology, 16: 198-204
Morita CT, Vertma S, Aparicio P, Martinez-A C, Spits H & Brenner MB.
1991. Functioally distinct subsets of human /6 T cells. European
Journal of Immunology, 21: 2999-3007
Morris AG & Tomkins PT. 1989. Interactions of interferons in the
induction of histocompatibility antigens in mouse fibroblasts and
glial cells. Immunology, 67: 537-539
Mosmann TR & Coffman RL. 1989. TH1 and TH2 cells: different patterns
of lymphokine secretion lead to different properties. Annual Reviews
of Immunology, 7: 145-173
Mosmann TR & Moore KW. 1991. The role of IL-10 in cross-regulation
of ThI and TH2 responses. Immunology Today, 12: A49-A53
Naessens J & Howard CJ. 1991. Monoclonal antibodies reacting with
bovine B cells (BoWC3, BoWC4 and BoWC5). Veterinary Immunology and
Immunopathology, 22: 77-85
Narayan 0 & Clements JE. 1990. Lentiviruses. Virology, 2nd edition,
edited by Fields BN, Knipe DM, Chanick RM, Hirsch MS, Melnick JL,
Monath TP & Roizman B, : 1571-1589
Narayan 0, Sheffer D, Clements JE & Tennekoon G. 1985. Restricted
replication of lentiviruses. Visna viruses induce a unigue
interferon during interaction between lymphocytes and infected
macrophages. Journal of Experimental Medicine, 162: 1954-1969
Nash AD, Barcham GJ, Andrews AE & Brandon MR. 1992. Characterisation
of ovine alveolar macrophages: regulation of surface antigen
expression and cytokine production. Veterinary Immunology and
Immunopathology, 31: 77-94
Nathan CF, Murray HW, Wiebe ME & Rubin BY. 1983. Identification of
interferon-g as the lymphokine that activates human macrophage
oxidative metabolism and antimicrobial activity. Journal of
Experimental Medicine, 158: 670-689
Naylor SL, Sakaguchi AY, Shows TB, Law ML, Goeddel DV & Gray PW.
1983. Human immune interferon gene is located on chromosome 12.
Journal of Experimental Medicine, 157: 1020-1027
224
Newton RC. 1985. Effect of interferon on the induction of human
monocyte secretion of interleukin-1 activity. Immunology, 56: 441-
449
Nishi T, Fujita T, Nishi-Takaoka C, Matsumoto T, Sato M, Oka T, Itoh
S, Yip YK, Vilcek J & Taniguchi T. 1985. Cloning and expression of a
novel variant of human interferon-gamma cDNA. Journal of
Biochemistry, 97: 153-159
Nishimura Y, Iwanaga T, Inamitsu T, Yanagawa Y, Yasunami M, Kimura
A, Hirokawa K & Sasazuki T. 1990. Expression of the human MHC, HLA-
DQw6 genes alters the immune response in C57BL/6 mice. Journal of
Immunology, 145: 353-360
Noelle R, Krammer PH, Ohara J, Uhr JW & Vitertta ES. 1984. Increased
expression of la antigens on resting B cells: an additional role for
B-cell growth factor. Proceedings of the National Academy of
Sciences USA, 81: 6149-6153
Norval M, Head KW, Else RW, Hart H & Neill WA. 1981. Growth in
culture of adenocarcinoma cells from the small intestine of sheep.
British Journal of Experimental Pathology, 62: 270-282
Nouri-Aria KT, Williams R & Eddleston ALWF. 1988. An enzyme
immunoassay for the measurement of HLA-DR antigen expression.
Journal of Immunological Methods, 111: 83-88
O'Brien RL, Happ MP, Dallas A, Palmer E, Kubo R & Born WK. 1989.
Stimulation of a major subset of lymphocytes expressing T cell
receptor /S by an antigen derived from Mycobacterium tuberculosis.
Cell, 57: 667-674
Ono SJ, Bazil V, Sugawara M & Strominger JL. 1991. An isotype-
specific trans-acting factor is defective in a mutant B cell line
that expresses HLA-DQ, but not -DR or -DP. Journal of Experimental
Medicine, 173: 629-637
Oshima S & Eckels DD. 1990. Selective expression of class II MHC
isotypes on MLC-activated human T lymphocytes. Human Immunology, 27:
208-219
Outteridge PM, Stewart DJ, Skerman TM, Dufty JH, Egerton JR, Ferrier
G & Marshall DJ. 1989. A positive association between resistance to
ovine footrot and particular lymphocyte antigen type. Australian
Veterinary Journal, 66: 175-179
225
Outteridge PM, Windon RG, Dineen JK & Dawkins HJS. 1984.
Associations between lymphocyte antigens in sheep and responsiveness
to vaccination against intestinal parasites. Proceedings of Workshop
at Sydney University. 22-23 October 1983, on behalf of the
Australian Wool Corporation. Edited by: Dineen JK & Outteridge PM.
pl03-111 (Abstract)
Owerbach D, Rutter WJ, Shows TB, Gray P, Goeddel DV & Lawn RM. 1981.
Leukocyte and fibroblast interferon genes are located on human
chromosome 9. Proceedings of the National Academy of Sciences USA,
78: 3123-3127
Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ & Davies
DR. 1989. Structure of an antibody-antigen complex: crystal
structuref of the HyHEL-10 Fab-lysozyme complex. Proceedings of the
National Academy of Sciences USA, 86: 5938-5942
Palliard X, De Waal Malefijt R, Yssel H, Blanchard D, Chretien I,
Abrams J, De Vries J & Spits H. 1988. Simultaneous production of IL-
2,IL-4, and IFN-g by activated human CD4+ and CD8+ T cell clones.
Journal of Immunology, 141: 849-855
Parslow TG, Blair DL, Murphy WJ & Granner DK. 1984. Structure of the
5' ends of immunoglobulin genes: a novel conserved sequence.
Proceedings of the National Academy of Sciences USA, 8JL: 2650-2654
Paul WE. 1989. Pleiotropy and redundancy: T cell-derived lymphokines
in the immune response. Cell, ^7: 521-524
Perussia B, Dayton ET, Lazarus R, Fanning V & Trinchieri G. 1983.
Immune interferon induces the receptor for monomeric IgGl on human
monocytic cells. Journal of Experimental Medicine, 158: 1092-1113
Pestka S, Langer JA, Zoon KC & Samuel CE. 1987. Interferons and
their actions. Annual Review of Biochemistry, 56: 727-777
Peterson M & Miller J. 1990. Invariant chain influences the
immunological recognition of MHC class II molecules. Nature, 345:
172-174
Pollikoff R, Donikian MA, Padron A & Liu OC. 1962. Tissue
specificity of interferon prepared in various tissue cultures.
Proceedings of the Society of Experimental Biology and Medicine,
110: 232-234
226
Poo WJ, Conrad L & Janeway CA jr. 1988. Receptor-directed focusing
of lymphokine release by helper T cells. Nature, 332: 378-380
Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Fray D,
Adolf GR & Feldman M. 1987. HLA class II induction in human islet
cells by interferon gamma plus tumour necrosis factor or
lymphotoxin. Nature, 326: 304-306
Puri NK & Brandon MR. 1987b. Sheep MHC class II molecules. II.
Identification and characterization of four distinct subsets of
sheep MHC class II molecules. Immunology, 62: 575-580
Puri NK, Gorrell MD & Brandon MR. 1987a. Sheep MHC class II
molecules. I. Immunochemical characterization. Immunology, 62: 567-
573
Puri NK, Mackay CR & Brandon MR. 1985. Sheep lymphocyte antigens
(OLA). II. Major histocompatibility complex class II molecules.
Immunology, 56: 725-733
Puri NK, Walker ID & Brandon MR. 1987c. N-terminal amino acid
seguence analyses of the a and p polypeptides from four distinct
subsets of sheep major histocompatibility complex class II
molecules. Journal of Immmunology, 139: 2996-3002
Radford AJ, Hodgson AL, Rothel JS & Wood PR. 1991. Cloning and
sequencing of the ovine gamma-interferon gene. Australian Veterinary
Journal, 68: 82-84
Radka SF, Charron DJ & Brodsky FM. 1986. Review: class II molecules
of the major histocompatibility complex considered as
differentiation markers. Human Immunology, 16: 390-400
Rappolee DA, Wang A, Mark D & Werb Z. 1989. Novel method for
studying mRNA phenotypes in single or small numbers of cells.
Journal of Cellular Biochenmistry, 39: 1-11
Rinaldo CR, jr, Overall JC, Cole BC & Glasgow LA. 1973. Mycoplasma-
associated induction of interferon in ovine leukocytes. Infection
and Immunity, 8: 796-808
Rinaldo CR, jr, Overall JC & Glasgow LA. 1975. Viral replication and
interferon production in fetal and adult ovine leukocytes and spleen
cells. Infection and Immunity, 12: 1070-1082
227
Rinderknecht E, O'Connor BH & Rodriguez H. 1984. Natural human
interferon-g. Complete amino acid seguence and determination of
sites of glycosylation. Journal of Biological Chemistry, 259: 6790-
6797
Roberts RM, Imakawa K, Niwano Y, Kazemi M, Malathy PV, Hansen TR,
Glass AA & Kroenenberg LH. 1989. Interferon production by the
preimplantation sheep embryo. Journal of Interferon Research, 9:
175-187
Roehm NW, Leibson HJ, Zlotnik A, Kapppler J, Marrack P & Cambier JC.
1984. Interleukin-induced increase in la expression by normal mouse
B cells. Journal of Experimental Medicine, 160: 679-694
Rollini P, Mach B & Gorski J. 1987. Characterization of an HLA-DR
beta pseudogene in the DRw52 supertypic group. Immunogenetics, 25:
336-342
Rollini P, Mach B & Gorski J. 1985. Linkage map of three HLA-DR p-
chain genes: evidence for a recent duplication event. Proceedings of
the National Academy of Sciences USA, 82: 7197-7201
Rosa FM & Fellous M. 1988. Regulation of HLA-DR gene by IFN-g.
Transcriptional and post-translational control. Journal of
Immunology, 140: 1660-1664
Rose K, Simona MG, Offord RE, Prior CP, Otto B & Thatcher DR. 1983.
A new mass-spectrometric C-terminal seguencing technigue finds a
similarity between g-interferon and aa-interferon and identifies a
proteolytically clipped g-interferon that retains full antiviral
activity. Biochemistry Journal, 215: 273-277
Rothbard JB & Taylor WR. 1988. A sequence pattern common to T cell
epitopes. The EMBO Journal, 7: 93-100
Rothel JS, Jones SL, Corner LA, Cox JC & Wood PR. 1990. A sandwich
enzyme immunoassay for bovine interferon-g and its use for the
detection of tuberculosis in cattle. Australian Veterinary Journal,
67: 134-137
Rousset F, de Waal Malefijt R, Slierendregt B, Aubry J-P, Bonnefoy
J-Y, Defrance T, Bancherau J & de Vries J. 1988. Regulation of Fc
receptor for IgE (CD23) and class II MHC antigen expression on
Burkitt's lymphoma cell lines by human IL-4 and IFN-g. Journal
Immunology, 140: 2625-2632
228
Rudensky AY, Preston-Hurlburt P, Hong S-C, Barlow A & Janeway CA jr.
1991. Sequence analyusis of peptides bound to MHC class II
molecules. Nature, 353: 622-627
Russell JK, Hayes MP, Carter JM, Torres BA, Dunn BM, Russell SW St
Johnson HM. 1986. Epitope and functional specificity of monoclonal
antibodies to mouse interferon-g: the synthetic peptide approach.
Journal of Immunology, 136: 324-3328
Russell JK, Magazine HI, Torres BA St Johnson HM. 1988. Steric
relationship of amino-terminal and carboxy-terminal domains of
murine interferon-gamma as assessed by monoclonal antibodies.
Journal of Interferon Research, 8: 433-439
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT,
Mullis KB St Erlich HA. 1988. Primer-directed enzymatic amplification
of DNA with a thermostable DNA polymerase. Science, 239: 487-491
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlick HA &
Annheim N. 1985. Enzymatic amplification of p-globin genomic
sequences and restriction site analysis for diagnosis of sickle cell
anaemia. Science, 230: 1350-1354
Sakaguchi M, Honda S, Ozawa M St Nishimura 0. 1988. Human interferon-
gamma lacking 23 COOH-terminal amino acids is biologically active.
FEBS Letters, 230: 201-204
Saksela E, Timonen T St Cantell K. 1980. Cellular interactions in the
augmentation of human NK activity by interferon. Annals of the New
York Academy of Sciences, 350: 102-111
Sambrook J, Fritsch EF St Maniatis T. 1989. Molecular cloning: a
laboratory manual. 2nd Edition. Cold Spring Harbor Laboratory Press.
Sander B, Cardell S St Moller E. 1991. Interleukin 4 and interferon
gamma production in restimulated CD4+ and CD8+ cells indicates
memory type responsiveness. Scandanavian Journal of Immunology, 33:
287-296
Sanders ME, Makgoba MW St Shaw S. 1988. Human naive and memory T
cells: reinterpretation of helper-inducer and suppressor-inducer
subsets. Immunology Today, 9: 195-199
229
Sandvig S, Laskay T, Andersson J, De Ley M & Andersson U. 1987.
Gamma-interferon is produced by CD3+ and CD3- lymphocytes.
Immunological Reviews, 97: 51-65
Sanger F, Nicklen S, & Coulson AR. 1977. DNA sequencing with chain
terminating inhibitors. Proceedings of the National Academy of
Sciences USA, 74: 5463-5467
Scahill SJ, Devos R, Van der Heyden J & Fiers W. 1983. Expression
and characterization of the product of a human immune interferon
cDNA gene in Chinese hamster ovary cells. Proceedings of the
National Academy of Sciences USA, 80: 4654-4658
Schulz RM & Kleinschmidt WJ. 1983. Functional identity between
murine g interferon and macrophage factor. Nature, 305: 239-240
Scott PC, Choi C-L & Brandon MR. 1987. Genetic organization of the
ovine MHC class II region. Immunogenetics, 25: 116-122
Scott PC, Maddox JF, Gogolin-Ewens & Brandon MR. 1991a. Nucleotide
sequence, polymorphism, and evolution of ovine MHC class II DQA
genes. Immunogenetics, 34: 69-79
Scott PC, Maddox JF, Gogolin-Ewens KJ & Brandon MR. 1991b. The
nucleotide sequence and evolution of ovine MHC class II p genes: DQB
and DRB. Immunogenetics, 34: 80-87
Seelig GF, Wijdenes J, Nagabhusan TL & Trotta PP. 1988. Evidence for
a polypeptide segment at the carboxyl terminus of recombinant human
g interferon in expression of biological activity. Biochemistry, 27:
1981-1987
Serghini MA, Ritzenthaler C, & Pinck L 1989. A rapid and efficient
"miniprep" for isolation of plasmid DNA. Nucleic Acids Research, 17:
3604
Shackelford DA & Strominger JL. 1983. Analysis of the oligo¬
saccharides on the HLA-DR and DC1 B cell antigens. Journal of
Immunology, 130: 274-282
Shackelford DA, Mann DL, van Rood JJ, Ferrara GB & Strominger JL.
1981. Human B-cell alloantigens DC1, MT1, and LB12 are identical to
each other but distinct from the HLA-DR antigen. Proceedings of the
National Academy of Sciences USA, 78: 4566-4570
230
Shaw ARE, Chan JKW, Reid S & Seehafer J. 1985. HLA-DR synthesis,
induction and expression in HLA-DR-negative carcinoma cell lines of
diverse origins by interferon-g but not by interferon-p. Journal of
the National Cancer Institure, 74: 1261-1267
Shaw G & Kamen R. 1986. A conserved AU seguence from the 3'
untranslated region of GM-CSF mRNA mediates selective mRNA
degradation. Cell, 46; 659-667
Shaw S, Johnson AM & Shearer G. 1980. Evidence for a new segregant
series of B cell antigens that are encoded in the HLA-D region and
that stimulate secondary allogeneic proliferative and cytotoxic
responses. Journal of Experimental Medicine, 152: 565-580
Shephard HM, Eaton D, Gray P, Naylor P, Hollingshead P & Goeddel D.
1985. "The Biology of the Interferon System 1984" (Kirchner H &
Schellekensl H, eds). Elsevier, Amsterdam: pl47
Sheriff S, Silverton EW, Padlan EA, Cohen GH, Smith-Gill SJ, Finzel
BC & Davies DR. 1987. Three-dimensional structure of an antibody-
antigen complex. Proceedings of the National Academy of Sciences
USA, 84: 8057-8079
Short JM, Fernandez JM, Sorge JA & Huse WD. 1988. \ZAP: a
bacteriophage \ expression vector with in vivo excision properties.
Nucleic Acids Research, 16: 7583-7600
Shows T, Naylor S, Goeddel DV & Lawn RM. 1982. Clustering of
leukocyte and fibroblast interferon genes on human chromosome 9.
Science, 218: 373-374
Snyder M, Elledge S, Sweetser D, Young RA & Davis RW. 1987. \gtll:
gene isolation with antibody probes and other applications. Methods
in Enzymology, 154: 107-128
Sordillo LM & Babiuk LA. 1991. Controlling acute Escherichia coli
mastitis during the periparturient period with recombinant bovine
interferon gamma. Veterinary Microbiology, 28: 189-198
Southern EM. 1975. Detection of specific seguences among DNA
fragments separated by gel electrophoresis. Journal of Molecular
Biology, 98: 503-517
231
Spies T, Sorrentino R, Boss JM, Okado K & Strominger JL. 1985.
Structural organization of the DR subregion of the human major
histocompatibility complex. Proceedings of the National Academy of
Sciences USA, 82: 5165-5169
Stadler BM, Dougherty SG, Farrar JJ & Oppenheim JJ. 1981.
Relationship of cell cycle to recovery of IL-2 activity from human
mononuclear cells, human and mouse T cell lines. Journal of
Immunology, 127: 1936-1940
Stanley E, Metcalf D, Sobieszczuk P, Gough NM & Dunn AR. 1985. The
structure and expression of the murine gene encoding granulocyte-
macrophage colony stimulating factor: evidence for utilisation of
alternative promoters. The EMBO Journal, 4: 2569-2573
Stanley KK. 1983. Solubilization and immune-detection of (J-
galactosidase hybrid proteins carrying foreign antigenic
determinants. Nucleic Acids Research, 1_1: 4077-4092
Steeg PS, Moore RN, Johnson HM & Oppenheim JJ. 1982. Regulation of
murine macrophage la antigen expression by a lymphokine with immune
interferon activity. Journal of Experimental Medicine, 156: 1780-
1793
Stewart WE, II. 1979. The Interferon System. New York: Springer-
Verlag. pl56
Stockinger B, Pessara U, Lin RH, Habicht J, Grez M & Koch N. 1989. A
role of la-associated invariant chains in antigen processing and
presentation. Cell, 56: 683-689
Stone-Wolff DS, Yip YK, Kelker HC, Le J, Henriksen-DeStefano D,
Rubin BY, Rinderknecht E, Aggarwal BB & Vilcek J. 1984.
Interrelationships of human interferon-gamma with lymphotoxin and
monocyte cytotoxin. Journal of Experimental Medicine, 159: 828-843
Struhl K. 1985. A rapid method for creating recombinant DNA
molecules. Biotechniques, 3: 452-453
Stzein MB, Steg PS, Johnson HM & Oppenheim JJ. 1984. Regulation of
human peripheral blood monocyte DR antigen expression in vitro by
lymphokines and recombinant interferons. Journal of Clinical
Investigation, 73: 556-565
232
Sullivan KE, Caiman AF, Nakanishi M, Tsang SY, Wang Y & Peterlin BM.
1987. A model for the transcriptional regulation of MHC class II
genes. Immunology Today, 8: 289-293
Swenson CE, Popescu MC & Ginsberg RS. 1988. Preparation and use of
liposomes in the treatment of microbial infections. CRC Critical
Reviews of Microbiology, _15 : Suppl 1: S1-S31 (abstr)
Tanaka S, Oshima T, Ohsuye K, Ono T, Mizono A, Ueno A, Nakazato H,
Tsujimoto M, Higashi N & Noguchi T. 1983. Expression in Escherischia
coliof chemically synthesized gene for the human immune interferon.
Nucleic Acids Research, 11: 1707-1723
Tanier JA, Getzhoff ED, Alexander H, Houghton RA, Olson AJ, Lerner
RA & Hendrickson WA. 1984. The reactivity of anti-peptide antibodies
is a function of the atomic mobility of sites in a protein. Nature,
312: 127-134
Taniguchi T. 1988. Regulation of cytokine gene expression. Annual
Reviews of Immunology, 6: 439-464
Taya Y, Devos R, Tavernier J, Cheroutre H, Engler G & Fiers W. 1982.
Cloning and structure of the human immune interferon chromosomal
gene. The EMBO Journal, _1: 953-958
Teyton L, 0'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P &
Peterson PA. 1990. Invariant chain distinguishes between the
exogenous and endogenous antigen presentation pathways. Nature, 348:
39-44
Tindall KR & Kunkel TA. 1988. Fidelity of DNA synthesis by the
Thermus aquaticus DNA polymerase. Biochemistry, 27: 6008-6013
Todd I, Pujol1-Borrell R, Hammond LJ, Bottazzo GF & Feldmann M.
1985. Interferon-gamma induces HLA-DR expression by thyroid
epithelium. Clinical and Experimental Immunology, 61: 265-273
Tonnelle C, De Mars R & Long EO. 1985. D0(3: a new (3 chain gene in
the HLA-D region with a distinct regulation of expression. The EMBO
Journal, 4: 2839-2847
Tosi R, Tanigaki N, Centis N, Ferrara GB & Pressman D. 1978.
Immunological dissection of human la molecules. Journal of
Experimental Medicine, 148: 1592-1611
233
Trent JM, Olson S, Lawn RM. 1982. Chromosomal localization of human
leukocyte, fibroblast, and immune interferon genes by means of in
situ hybridization. Proceedings of the National Academy of Sciences
USA, 79: 7809-7813
Triebel F, De Rocquefeuil S, Blanc C, Charron D & Debre P. 1986.
Expression of MHC class II and Tac antigens on human T cell clones
that can stimulate in MLR, AMLR, PLT and can present antigen. Human
Immunology, 15: 302
Trowsdale J & Kelly A. 1985. The human HLA class II alpha chain gene
DZ alpha is distinct from genes in the DP, DQ and DR subregions. The
EMBO Journal, 4: 2231-2237
Tulip WR, Varghese JN, Webster RG, Air GM, Laver WG & Colman PM.
1990. Crystal structure of neuraminidase-antibody complexes. Cold
Spring Harbor Symposium on Quantitative Biology, 54: 257-263
Unanue ER, Beller DI, Lu CY & Allen PM. 1984. Antigen preentation:
comments on its regulation and mechanism. Journal of Immunology,
132: 1-5
van den Eertwegh AJM, Fasbender MJ, Schellekens MM, van Oudenaren A,
Boersma MJA & Claessen E. 1991. In vivo kinetics and
characterization of IFN-g-producing cells during a thymus-
independent immune response. Journal of Immunology, 147: 439-446
van der Poel JJ, Groenen MAM, Dijkhof RJM, Ruyter D & Giphart MJ.
1990. The nucleotide sequence of the bovine MHC class II alpha
genes: DRA, DQA, and DYA. Immunogenetics, 31: 29-36
Walrand F, Picard F, McCullough K, Martinod S & Levy D. 1989.
Recombinant bovine interferon-gamma enhances expression of class I
and class II bovine lymphocyte antigens. Veterinary Immunology and
Immunopathology, 22: 379-383
Wang AM, Doyle MV & Mark DF. 1989. Quantitation of mRNA by the
polymerase chain reaction. Proceedings of the National Academy of
Sciences USA, 86: 9717-9721
Watts TH, Brian AA, Kappler JW, Marrack P & McConnell HM. 1984.
Antigen-presentation by supported planar membranes containing
affinity purified I-A. Proceedings of the National Academy of
Sciences USA, 8],: 7564-7568
234
Weismann C & Weber H. 1986. The Interferon Genes. Progress in
Nucleic Acid Research and Molecular Biology, 33: 251-300
Westhof E, Altschuh D, Moras D, Bloomer AC, Mondragon A, Klug A &
van Regenmortel MHV. 1984. Correlation between segmental mobility
and the location of antigenic determinants in proteins. Nature, 311:
123-126
Wheelock EF. 1965. Interferon-like virus-inhibitor induced in human
leukocytes by phytohaemagglutin. Science, 149: 310-311
Whiting CV & Bland PW. 1990. An immunoassay for the quantitation of
cell membrane MHC class II antigen. Journal of Immunological
Methods, 133: 169-174
Wietzerbin J, Stefanos S, Lucero M, Falcoff E, O'Malley JA &
Sulkowski E. 1979. Physico-chemical characterization and partial
purification of mouse immune interferon. Journal of General
Virology, 44; 773-781
Wilson V, Jeffreys AJ, Barrie PA, Boseley PG, Slocombe PM, Easton A
& Burke DC. 1983. A comparison of vertebrate interferon gene
families detected by hybridization with human interferon DNA.
Journal of Molecular Biology, 166: 457-475
Wiranoska-Stewart M, Lin LS, Braude IA & Stewart WE II. 1980.
Production, partial purification and characterization of human and
murine interferons-Type II. Molecular Immunology, 17: 625-633
Wong GHW, Clark-Lewis I, McKimm-Breshkin JL, Harris AW & Schrader
JW. 1983. Interferon-g induces enhanced expression of la and H-2
antigens on B lymphoid, macrophage, and myeloid cell lines. Journal
of Immunology, 131: 788-793
Wong GHW, Clark-Lewis I, Harris AW & Schrader JW. 1984. Effect of
cloned interferon-g on expression of H-2 and la antigens on cells of
hemopoietic, lymphoid, epithelial, fibroblastic and meuronal origin.
European Journal of Immunology, 14: 52-56
Wood PR, Rothel JS, McWaters PGD & Jones SL. 1990. Production and
characterization of monoclonal antibodies specific for bovine gamma-
interferon. Veterinary Immunology and Immunopathology, 25: 37-46
235
Yamada YK, Meager A, Yamada A & Enrtis FA. 1986. Human interferon-a
and -g production by lymphocytes during the generation of influenza-
specific cytotoxic T lymphocytes. Journal of General Virology, 67:
2325-2334
Yannish-Perron C, Veira J & Messing J. 1985. Improved M13 phage
cloning vectors and host strains: nucleotide seguences of M13mpl8
and pUC19 vectors. Gene, 33: 103-119
Yilma T, Owens S & Adams DS. 1988. High levels of interferon in
synovial fluid of retrovirus-infected goats. Journal of Interferon
Research, 8: 45-50
Yip YK, Barrowclough BS, Urban C & Vilcek J. 1982. Purification of
two subspecies of human g (immune) interferon. Proceedings of the
National Academy of Sciences USA, 79: 1820-1824
Young RA & Davis RW. 1983a. Yeast RNA polymerase II genes: Isolation
with antibody probes. Science, 222: 778-782
Young RA & Davis RW. 1983b. Efficient isolation of genes by using
antibody probes. Proceedings of the National Academy of Sciences
USA, 80: 1194-1198
Young RA, Bloom BR, Grosskinsky CM, Ivanyi J, Thomas D & Davis RW.
1985. Dissection of Mycobacterium tuberculosis antigens using
recombinant DNA. Proceedings of the National Academy of Sciences
USA, 82: 2583-2587
Yu DTY, LMcCune JM, Fu SM, Winchester RJ & Kunkel HG. 1980. Two
types of la-positive T cells. Synthesis and exchange of la antigens.
Journal of Experimental Medicine, 152: 89s-98s
Zink MC & Narayan 0. 1989. Lentivirus-induced interferon inhibits
maturation and proliferation of monocytes and restricts the
replication of caprine arthritis-encephalitis virus. Journal of
Virology, 63: 2578-2584
Zlotnik A, Roberts WK, Vasil A, Blumenthal E, Larosa F, Leibson HJ,
Endres RO, Graham SD jr, White J, Hill J, Henson P, Klein JR, Bevan
MJ, Marrack P & Kappler JW. 1983a. Coordinate production by a T cell
hybridoma of gamma interferon and three other lymphokine activities:
multiple activities of a single lymphokine?. Journal of Immunology,
131: 794-800
236
Zlotnik A, Shimonkevitz RP, Gefter ML, Kappler J & Marrack P. 1983b.
Characterization of the g-interferon-mediated induction of antigen-
presenting ability in P388D1 cells. Journal of Immunology, 131:
2814-2820
Zoller M & Smith M. 1983. Oligonucleotide-directed mutagenesis of
DNA fragments cloned in M13 vectors. Methods in Enzymology, 100:
468-500
237
